<!-- This content is only licensed for consumption by authorized users affiliated with PubMed Central. Usage by any individual not directly associated with PubMed Central is prohibited. -->
<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" id="a613485649" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">ACS Chem Neurosci</journal-id><journal-id journal-id-type="iso-abbrev">ACS Chem Neurosci</journal-id><journal-id journal-id-type="publisher-id">cn</journal-id><journal-id journal-id-type="coden">acncdm</journal-id><journal-title-group><journal-title>ACS Chemical Neuroscience</journal-title></journal-title-group><issn pub-type="epub">1948-7193</issn><publisher><publisher-name>American Chemical Society</publisher-name></publisher><self-uri>pubs.acs.org/chemneuro</self-uri></journal-meta>
<article-meta><article-id pub-id-type="pmid">40305656</article-id><article-id pub-id-type="pmc">PMC12100652</article-id>
<article-id pub-id-type="doi">10.1021/acschemneuro.5c00106</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Monomers, Dimers,
and Oligomers of Pyroglutamate-Modified
&#x003b1;&#x02011;Synuclein Fragments Exhibit Distinct Biophysical Characteristics</article-title></title-group><contrib-group id="CONTRIB-GROUP-d14e22-autogenerated"><contrib id="ath1" contrib-type="author"><contrib-id contrib-id-type="paragon-plus" authenticated="true">7507806</contrib-id><name><surname>Bluhm</surname><given-names>Alexandra</given-names></name><xref rid="aff1" ref-type="aff"/></contrib><contrib id="ath2" contrib-type="author"><contrib-id contrib-id-type="paragon-plus" authenticated="true">7507784</contrib-id><name><surname>Xiang</surname><given-names>Wei</given-names></name><xref rid="aff2" ref-type="aff"/></contrib><contrib id="ath3" contrib-type="author"><contrib-id contrib-id-type="paragon-plus" authenticated="true">2139674</contrib-id><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-0752-8735</contrib-id><name><surname>Wien</surname><given-names>Frank</given-names></name><xref rid="aff3" ref-type="aff"/></contrib><contrib id="ath4" contrib-type="author"><contrib-id contrib-id-type="paragon-plus" authenticated="true">6824962</contrib-id><name><surname>Thureau</surname><given-names>Aurelien</given-names></name><xref rid="aff3" ref-type="aff"/></contrib><contrib id="ath5" contrib-type="author"><contrib-id contrib-id-type="paragon-plus" authenticated="true">7507792</contrib-id><name><surname>Chevreuil</surname><given-names>Maelenn</given-names></name><xref rid="aff4" ref-type="aff"/></contrib><contrib id="ath6" contrib-type="author"><contrib-id contrib-id-type="paragon-plus" authenticated="true">1104222</contrib-id><name><surname>Raynal</surname><given-names>Bertrand</given-names></name><xref rid="aff4" ref-type="aff"/></contrib><contrib id="ath7" contrib-type="author"><contrib-id contrib-id-type="paragon-plus" authenticated="true">7577206</contrib-id><name><surname>Geissler</surname><given-names>Stefanie</given-names></name><xref rid="aff5" ref-type="aff"/></contrib><contrib id="ath8" contrib-type="author"><contrib-id contrib-id-type="paragon-plus" authenticated="true">7577209</contrib-id><name><surname>Wermann</surname><given-names>Michael</given-names></name><xref rid="aff5" ref-type="aff"/></contrib><contrib id="ath9" contrib-type="author"><contrib-id contrib-id-type="paragon-plus" authenticated="true">4492060</contrib-id><name><surname>Schilling</surname><given-names>Stephan</given-names></name><xref rid="aff5" ref-type="aff"/><xref rid="aff6" ref-type="aff"/></contrib><contrib id="ath10" contrib-type="author"><contrib-id contrib-id-type="paragon-plus" authenticated="true">7083759</contrib-id><name><surname>B&#x000e9;nas</surname><given-names>Philippe</given-names></name><xref rid="aff7" ref-type="aff"/></contrib><contrib id="ath11" contrib-type="author"><contrib-id contrib-id-type="paragon-plus" authenticated="true">7507801</contrib-id><name><surname>Hartlage-R&#x000fc;bsamen</surname><given-names>Maike</given-names></name><xref rid="aff1" ref-type="aff"/></contrib><contrib id="ath12" contrib-type="author"><contrib-id contrib-id-type="paragon-plus" authenticated="true">7507803</contrib-id><name><surname>Schulze</surname><given-names>Anja</given-names></name><xref rid="aff5" ref-type="aff"/><xref rid="aff6" ref-type="aff"/></contrib><contrib id="ath13" contrib-type="author" corresp="yes"><contrib-id contrib-id-type="paragon-plus" authenticated="true">343067</contrib-id><name><surname>Sauter</surname><given-names>Claude</given-names></name><xref rid="cor2" ref-type="corresp"/><xref rid="aff7" ref-type="aff"/></contrib><contrib id="ath14" contrib-type="author" corresp="yes"><contrib-id contrib-id-type="paragon-plus" authenticated="true">6807329</contrib-id><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-9959-283X</contrib-id><name><surname>Ro&#x000df;ner</surname><given-names>Steffen</given-names></name><xref rid="cor1" ref-type="corresp"/><xref rid="aff1" ref-type="aff"/></contrib><aff id="aff1">
<label>&#x02020;</label>
<institution content-type="dept">Paul
Flechsig Institute &#x02212; Centre for Neuropathology and Brain Research</institution>, <institution>University of Leipzig</institution>, <postal-code>04103</postal-code>
<city>Leipzig</city>, <country country="DE">Germany</country>
</aff><aff id="aff2">
<label>&#x02021;</label>
<institution content-type="dept">University
Hospital Erlangen, Department Molecular Neurology</institution>, <institution>Friedrich-Alexander-University Erlangen-N&#x000fc;rnberg</institution>, <postal-code>91054</postal-code>
<city>Erlangen</city>, <country country="DE">Germany</country>
</aff><aff id="aff3">
<label>&#x000a7;</label>
<institution content-type="dept">Synchrotron
SOLEIL</institution>, <institution>L&#x02019;Orme des Merisiers Saint
Aubin</institution>, <postal-code>91410</postal-code>
<city>Gif-sur-Yvette</city>, <country country="FR">France</country>
</aff><aff id="aff4">
<label>&#x02225;</label>
<institution content-type="dept">Plateforme
de biophysique mol&#x000e9;culaire</institution>, <institution>C2RT,
Institut Pasteur, Universit&#x000e9; Paris Cit&#x000e9;</institution>, <postal-code>75015</postal-code>
<city>Paris</city>, <country country="FR">France</country>
</aff><aff id="aff5">
<label>&#x022a5;</label>
<institution-wrap><institution-id institution-id-type="Ringgold" specific-use="source:pplus">28433</institution-id><institution>Fraunhofer
Institute for Cell Therapy and Immunology</institution></institution-wrap>, <institution content-type="dept">Department of Molecular Drug Design and Target Validation</institution>, <postal-code>06120</postal-code>
<city>Halle (Saale)</city>, <country country="DE">Germany</country>
</aff><aff id="aff6">
<label>#</label>
<institution content-type="dept">Faculty of
Applied Biosciences and Process Engineering</institution>, <institution>Anhalt University of Applied Sciences</institution>, <postal-code>06366</postal-code>
<city>K&#x000f6;then</city>, <country country="DE">Germany</country>
</aff><aff id="aff7">
<label>&#x02207;</label>
<institution content-type="dept">CNRS,
Architecture et R&#x000e9;activit&#x000e9; de l&#x02019;ARN</institution>, <institution>UPR 9002, Institut de Biologie Mol&#x000e9;culaire
et Cellulaire, Universit&#x000e9; de Strasbourg</institution>, <postal-code>67084</postal-code>
<city>Strasbourg</city>, <country country="FR">France</country>
</aff></contrib-group><author-notes><corresp id="cor1">
<label>*</label>Email: <email>steffen.rossner@medizin.uni-leipzig.de</email>. Phone: <phone>+49-3419725758</phone>.</corresp><corresp id="cor2">
<label>*</label>Email: <email>c.sauter@ibmc-cnrs.unistra.fr</email>. Phone: <phone>+33-388417102</phone>.</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>30</day><month>4</month><year>2025</year></pub-date><pub-date date-type="collection" publication-format="electronic"><day>21</day><month>5</month><year>2025</year></pub-date><volume>16</volume><issue>10</issue><fpage>1919</fpage><lpage>1936</lpage><history>
<date date-type="received"><day>12</day><month>2</month><year>2025</year></date>
<date date-type="accepted"><day>17</day><month>4</month><year>2025</year></date>
<date date-type="rev-recd"><day>26</day><month>3</month><year>2025</year></date>
<date date-type="online"><day>30</day><month>4</month><year>2025</year></date>
</history><permissions><copyright-statement>&#x000a9; 2025 The Authors. Published by American Chemical Society</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>The Authors</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" content-type="AuthorChoicev2" start_date="2025-04-30"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense" start_date="2025-04-30">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is licensed under CC-BY 4.0</license-p></license></permissions><abstract><p>&#x003b1;-Synuclein
(aSyn) aggregation represents a key
event in
the neurodegenerative cascade of synucleinopathies. Initially, aSyn
appears as an intrinsically disordered protein. However, its structural
flexibility allows aSyn to either adopt &#x003b1;-helical conformations,
relevant for physiological functions at presynaptic vesicles, or form
&#x003b2;-strand-rich aggregates, leading to toxic oligomers. This relation
between structure, function, and toxicity can be influenced by post-translational
modifications such as the recently identified glutaminyl cyclase-catalyzed
pyroglutamate (pE) modification. Here, we investigated (i) structural
characteristics of monomeric, dimeric, and oligomeric states of N-terminal
truncated, pE-modified aSyn variants, pE24-, pE62-, and pE79-aSyn
by a complementary biophysical approach including DLS, SEC-MALS, SRCD,
SEC-SAXS, and AUC and (ii) the toxicity of oligomeric pE-aSyn variants
compared to full-length aSyn. Overall, pE62-aSyn showed an immediate
fibril formation, reflecting the aggregation-prone properties of this
particular variant. Furthermore, in a membrane-like environment, the
secondary aSyn structure shifted toward &#x003b1;-helical folding depending
on the degree of N-terminal truncation. pE79-aSyn showed a significantly
reduced level of structural adaptation, reflecting compromised functions
at presynaptic vesicles. In addition, the comparative analysis indicates
the presence of a dimeric aSyn intermediate, the initial and potentially
crucial step in aSyn aggregation, and supports the hypothesis of a
toxic porous oligomeric state. For the first time, based on SAXS data,
EOM models of the dimeric aSyn state are proposed.</p></abstract><abstract abstract-type="graphical"><graphic xlink:href="cn5c00106_0011.jpg" position="float"/></abstract><abstract abstract-type="toc-graphic"><graphic xlink:href="cn5c00106_0009.jpg" id="tgr1" specific-use="not-for-print" position="float"/></abstract><kwd-group><kwd>&#x003b1;-synuclein</kwd><kwd>N-terminal truncation</kwd><kwd>pyroglutamate
modification</kwd><kwd>biophysical characterization</kwd><kwd>EOM
modeling</kwd></kwd-group><funding-group><award-group id="fnd-1"><funding-source>
<institution-wrap><institution>Alzheimer Forschung Initiative</institution><institution-id institution-id-type="doi" vocab="open-funder-registry" vocab-identifier="10.13039/open_funder_registry">10.13039/100010146</institution-id></institution-wrap>
</funding-source><award-id>NA</award-id></award-group></funding-group><funding-group><award-group id="fnd-2"><funding-source>
<institution-wrap><institution>H2020 Research Infrastructures</institution><institution-id institution-id-type="doi" vocab="open-funder-registry" vocab-identifier="10.13039/open_funder_registry">10.13039/100010666</institution-id></institution-wrap>
</funding-source><award-id>101004806</award-id></award-group></funding-group><funding-group><award-group id="fnd-3"><funding-source>
<institution-wrap><institution>Deutsche Forschungsgemeinschaft</institution><institution-id institution-id-type="doi" vocab="open-funder-registry" vocab-identifier="10.13039/open_funder_registry">10.13039/501100001659</institution-id></institution-wrap>
</funding-source><award-id>RO2226/13-1</award-id></award-group></funding-group><funding-group><award-group id="fnd-4"><funding-source>
<institution-wrap><institution>Centre National de la Recherche Scientifique</institution><institution-id institution-id-type="doi" vocab="open-funder-registry" vocab-identifier="10.13039/open_funder_registry">10.13039/501100004794</institution-id></institution-wrap>
</funding-source><award-id>NA</award-id></award-group></funding-group><funding-group><award-group id="fnd-5"><funding-source>
<institution-wrap><institution>LabEx consortia ?NetRNA?</institution><institution-id institution-id-type="doi" vocab="open-funder-registry" vocab-identifier="10.13039/open_funder_registry">NA</institution-id></institution-wrap>
</funding-source><award-id>ANR-10-LABX-0036_NETRNA</award-id></award-group></funding-group><funding-group><award-group id="fnd-6"><funding-source>
<institution-wrap><institution>Research Academy of Leipzig University</institution><institution-id institution-id-type="doi" vocab="open-funder-registry" vocab-identifier="10.13039/open_funder_registry">NA</institution-id></institution-wrap>
</funding-source><award-id>NA</award-id></award-group></funding-group><funding-group><award-group id="fnd-7"><funding-source>
<institution-wrap><institution>University of Strasbourg Institute of Advanced Science</institution><institution-id institution-id-type="doi" vocab="open-funder-registry" vocab-identifier="10.13039/open_funder_registry">NA</institution-id></institution-wrap>
</funding-source><award-id>USIAS-W21RSAUT</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>document-id-old-9</meta-name><meta-value>cn5c00106</meta-value></custom-meta><custom-meta><meta-name>document-id-new-14</meta-name><meta-value>cn5c00106</meta-value></custom-meta><custom-meta><meta-name>production-flag-MathML-config-version</meta-name><meta-value>3</meta-value></custom-meta><custom-meta><meta-name>production-flag-journal-citation-display-style</meta-name><meta-value>acs-titles</meta-value></custom-meta><custom-meta><meta-name>production-flag-journal-date-display-style</meta-name><meta-value>dates-used-rcd-rvd-acc</meta-value></custom-meta><custom-meta><meta-name>production-flag-si-avail</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>document-id-alt-64</meta-name><meta-value>c6653f515d53575fdd9ef3fa7a7f062b0e03ecebf84016940ff18b11c4a399d5</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="sec1"><title>Introduction</title><p>The protein &#x003b1;-synuclein
(aSyn) is
implicated in pathological
protein aggregation in synucleinopathies, including Parkinson&#x02019;s
disease (PD), dementia with Lewy bodies (DLB), and multiple system
atrophy (MSA).<named-content content-type="bibref-group">
<xref rid="ref1" ref-type="bibr"/>&#x02212;<xref rid="ref2" ref-type="bibr" specific-use="suppress-in-print"/>
<xref rid="ref3" ref-type="bibr" specific-use="suppress-in-print"/>
<xref rid="ref4" ref-type="bibr" specific-use="suppress-in-print"/>
<xref rid="ref5" ref-type="bibr"/>
</named-content> While in PD and DLB aSyn typically accumulates in Lewy bodies and
Lewy neurites in neuronal cells, MSA is characterized by aSyn accumulation
as glial cytoplasmic inclusions in oligodendrocytes.<named-content content-type="bibref-group">
<xref rid="ref1" ref-type="bibr"/>,<xref rid="ref3" ref-type="bibr"/>&#x02212;<xref rid="ref4" ref-type="bibr" specific-use="suppress-in-print"/>
<xref rid="ref5" ref-type="bibr"/>
</named-content> The formation of oligomeric aSyn assemblies appears
to be associated with neurotoxicity.<xref rid="ref6" ref-type="bibr"/> However,
a clear understanding of the formation and structure of aSyn oligomers,
including the initial step of dimer formation, is lacking.<xref rid="ref7" ref-type="bibr"/> The aSyn primary protein structure provides a
basis for understanding its multiple roles in physiology and pathology
and, in particular, in aggregation processes. aSyn, with 140 amino
acid (aa) residues, can be divided into three distinct regions: an
amphipathic N-terminal region (aa 1&#x02013;60), a hydrophobic nonamyloid-&#x003b2;
component (NAC) region (aa 61&#x02013;95), and a highly acidic, proline-rich
C-terminal region (aa 96&#x02013;140).<xref rid="ref8" ref-type="bibr"/>
</p><p>In its native state, aSyn is soluble and lacks a defined secondary
structure, appearing as an intrinsically disordered protein (IDP).<named-content content-type="bibref-group">
<xref rid="ref9" ref-type="bibr"/>,<xref rid="ref10" ref-type="bibr"/>
</named-content> However, upon membrane interaction of the N-terminus, aSyn can adopt
an &#x003b1;-helical conformation, which appears to play a critical
role in its physiological functions.<xref rid="ref11" ref-type="bibr"/> The
exact function of aSyn is intensively discussed in the field. For
example, the specific transport of aSyn to presynaptic terminals indicates
a role in synaptic function and plasticity.<named-content content-type="bibref-group">
<xref rid="ref12" ref-type="bibr"/>&#x02212;<xref rid="ref13" ref-type="bibr" specific-use="suppress-in-print"/>
<xref rid="ref14" ref-type="bibr"/>
</named-content> Burr&#x000e9; <italic toggle="yes">et al.</italic> (2010) shed light on the involvement of aSyn in neurotransmitter
release by supporting SNARE complex assembly via binding to Synaptobrevin-2.<xref rid="ref15" ref-type="bibr"/> However, as the name <bold>synucle</bold>in
implies, the protein was detected not only in <bold>syn</bold>apses
but also in the <bold>nucl</bold>eus. Evidence suggests that aSyn
can translocate to the nucleus via active transport mechanisms and
interact with nuclear components, including DNA, histones, and transcription
factors.<named-content content-type="bibref-group">
<xref rid="ref16" ref-type="bibr"/>&#x02212;<xref rid="ref17" ref-type="bibr" specific-use="suppress-in-print"/>
<xref rid="ref18" ref-type="bibr" specific-use="suppress-in-print"/>
<xref rid="ref19" ref-type="bibr" specific-use="suppress-in-print"/>
<xref rid="ref20" ref-type="bibr"/>
</named-content> Besides the described physiological functions, aSyn is also implicated
in pathological processes.<xref rid="ref5" ref-type="bibr"/> Specifically,
through interchain interactions of the aSyn NAC region, the conformation
can adapt to highly ordered &#x003b2;-strand-rich structures, leading
to the formation of toxic oligomers and fibrils that disturb physiological
processes and are thus hallmarks of synucleinopathies.<xref rid="ref21" ref-type="bibr"/>
</p><p>Villar-Piqu&#x000e9; <italic toggle="yes">et al.</italic> (2016) described the
complex relation between structure, function, and toxicity in a symbolic
&#x0201c;aSyn Bermuda triangle&#x0201d;.<named-content content-type="bibref-group">
<xref rid="ref2" ref-type="bibr"/> ,<xref rid="ref22" ref-type="bibr"/>
</named-content> The exact
triggers of aSyn misfolding, which shift the triangle from physiological
function toward pathology, are still not fully understood. However,
in familial PD the structural transition can be influenced by aSyn
mutations such as A30P, E46K, and A53T.<named-content content-type="bibref-group">
<xref rid="ref23" ref-type="bibr"/>&#x02212;<xref rid="ref24" ref-type="bibr" specific-use="suppress-in-print"/>
<xref rid="ref25" ref-type="bibr"/>
</named-content> Nevertheless, most PD
cases are sporadic and do not have genetic predisposition. Therefore,
environmental factors<named-content content-type="bibref-group">
<xref rid="ref26" ref-type="bibr"/>&#x02212;<xref rid="ref27" ref-type="bibr" specific-use="suppress-in-print"/>
<xref rid="ref28" ref-type="bibr"/>
</named-content> and/or post-translational modifications (PTM) of
aSyn can trigger the misfolding.</p><p>For a small protein of 140
aa, aSyn can undergo an extensive range
of PTMs, including phosphorylation, ubiquitination, nitration, acetylation,
and truncation, among others.<named-content content-type="bibref-group">
<xref rid="ref29" ref-type="bibr"/>&#x02212;<xref rid="ref30" ref-type="bibr" specific-use="suppress-in-print"/>
<xref rid="ref31" ref-type="bibr"/>
</named-content> In addition, proteolytic cleavage
of aSyn remains a significant but yet underestimated modification,
which may result in a loss of function of the maternal full-length
(FL) protein and in additional physiological or pathological functions
of the fragments generated. The proteolytic aSyn cleavage occurs in
health and disease.<named-content content-type="bibref-group">
<xref rid="ref32" ref-type="bibr"/>&#x02212;<xref rid="ref33" ref-type="bibr" specific-use="suppress-in-print"/>
<xref rid="ref34" ref-type="bibr" specific-use="suppress-in-print"/>
<xref rid="ref35" ref-type="bibr"/>
</named-content> C-terminal truncations by defined protease activities, such as calpains
and 20S proteasome have been linked to increased aggregation propensity
and fibril formation.<named-content content-type="bibref-group">
<xref rid="ref30" ref-type="bibr"/>,<xref rid="ref34" ref-type="bibr"/>,<xref rid="ref36" ref-type="bibr"/>&#x02212;<xref rid="ref37" ref-type="bibr" specific-use="suppress-in-print"/>
<xref rid="ref38" ref-type="bibr"/>
</named-content> Furthermore, N-terminally truncated aSyn fragments
can be generated by matrix metalloproteinases,<named-content content-type="bibref-group">
<xref rid="ref37" ref-type="bibr"/>,<xref rid="ref39" ref-type="bibr"/>,<xref rid="ref40" ref-type="bibr"/>
</named-content> Calpain-1,<xref rid="ref41" ref-type="bibr"/> Trypsin<xref rid="ref42" ref-type="bibr"/> among others<xref rid="ref32" ref-type="bibr"/> and
may serve as substrates for further PTMs.</p><p>There are, for example,
truncated aSyn peptides with an N-terminal
glutamine residue such as Q24-aSyn, Q62-aSyn, and Q79-aSyn generated
by defined protease activities.<xref rid="ref32" ref-type="bibr"/> These
fragments are potential substrates for subsequent pyroglutamate (pE)
modification catalyzed by glutaminyl cyclase (QC), an enzyme, which
cyclizes N-terminal glutamine and glutamate residues, respectively.<named-content content-type="bibref-group">
<xref rid="ref43" ref-type="bibr"/>,<xref rid="ref44" ref-type="bibr"/>
</named-content> In the pathological condition of Alzheimer&#x02019;s disease (AD),
the QC-catalyzed pE modification of N-truncated Abeta peptides has
been shown to be highly pathogenic, promoting Abeta oligomerization
and serving as the seed for plaque formation.<named-content content-type="bibref-group">
<xref rid="ref45" ref-type="bibr"/>&#x02212;<xref rid="ref46" ref-type="bibr" specific-use="suppress-in-print"/>
<xref rid="ref47" ref-type="bibr" specific-use="suppress-in-print"/>
<xref rid="ref48" ref-type="bibr"/>
</named-content>
</p><p>Previously, we have demonstrated
for the first time that QC can
catalyze the cyclization of an aSyn fragment, namely Q79-aSyn, into
pE79-aSyn.<xref rid="ref49" ref-type="bibr"/> This variant has been detected
in human PD and DLB post mortem brain tissue as well as in the brains
of PD mouse models. It was found to be colocalized to the enzymes
required for N-terminal aSyn truncation, namely, matrix metalloproteinase-3,
and QC for subsequent pE cyclization.<named-content content-type="bibref-group">
<xref rid="ref40" ref-type="bibr"/>,<xref rid="ref49" ref-type="bibr"/>
</named-content> We hypothesize
that other N-terminal truncated aSyn fragments, namely, pE24-aSyn
and pE62-aSyn, may also play a role in aSyn aggregation.</p><p>Given
the specific pathogenic profiles of oligomeric protein aggregates,
we here investigated the structural properties of monomeric, dimeric,
and oligomeric pE24-aSyn, pE62-aSyn, and pE79-aSyn in comparison to
FL-aSyn by synchrotron radiation circular dichroism (SRCD), size exclusion
chromatography coupled to multiangle light scattering (SEC-MALS) and
to small-angle X-ray scattering (SEC-SAXS), as well as by analytical
ultracentrifugation (AUC). It is noteworthy that our findings indicate
the presence of a dimeric aSyn intermediate. The formation of dimers
represents a potentially crucial step in aSyn aggregation to toxic
oligomers, as indicated here by the higher toxicity of oligomeric
FL-aSyn and pE-modified aSyn variants. Thus, aSyn dimers may serve
as new targets for future therapies or as biomarkers in PD research.</p></sec><sec id="sec2"><title>Results</title><p>In the present study, structural properties
of monomeric and oligomeric
pE24-aSyn, pE62-aSyn, and pE79-aSyn were analyzed in comparison to
FL-aSyn by SRCD and SEC-SAXS, orthogonally complemented with AUC data.
The quality of the samples was verified by dynamic light scattering
(DLS) and SEC-MALS before proceeding with the other analytical methods.
The cytotoxicity of oligomeric states of FL-aSyn and pE-aSyn variants
was shown in differentiated SH-SY5Y cells.</p><sec id="sec2.1"><title>DLS and SEC-MALS as Quality
Control of Monomeric Starting Conditions
in Aggregation Assays</title><p>To ensure comparable starting conditions
in the aggregation experiments, DLS measurements were carried out
immediately after solubilization of the FL-aSyn and pE-aSyn variants
in buffer with 20 mM Tris/HCl pH 7.2, 100 mM NaCl. Size distribution
profiles from typical quality control experiments as recommended<xref rid="ref50" ref-type="bibr"/> are presented in <xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig"/>
</xref>a.</p><fig position="float" id="fig1" fig-type="figure"><label>1</label><caption><p>Analyses of FL-aSyn and pE-aSyn variants were
performed by DLS
and SEC-MALS. (a) In DLS, the number of particles was plotted as a
function of the hydrodynamic radius (rH) of the particle size with
peaks corresponding to the major species (numbers), the monomeric
fractions of recombinant FL-aSyn and pE-aSyn variants. On each graph&#x02019;s
top right, the hydrodynamic parameters (rH, molecular weight (MW-R)
and polydispersity (Pd)) derived from the measurements are displayed.
(b) In the SEC-MALS measurements, the refractive index is plotted
as a function of the retention volume. On each peak, experimentally
derived parameters (MW and intrinsic viscosity [IV]) are presented
(top row). In the lower figures, the corresponding peak apexes are
highlighted (bottom row).</p></caption><graphic xlink:href="cn5c00106_0001" id="gr1" position="float"/></fig><p>aSyn size distributions exhibited a single peak
with a calculated
hydrodynamic radius of 1.8 nm, which could be attributed to the monomeric
species. The polydispersity ranged from 17.5% of pE24-aSyn up to 25.7%
of pE79-aSyn, which is probably due to nonglobular, most likely slightly
elongated and flexible shapes.<xref rid="ref51" ref-type="bibr"/> The estimated
molecular weights were 13.9, 13.5, 12.6, and 12.8 kDa, respectively,
for FL-aSyn, pE24-aSyn, pE62-aSyn, and pE79-aSyn (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig"/>
</xref>a). Taken together, these values
confirmed that the FL-aSyn and pE-aSyn variants were in a monomeric
state under initial conditions. These observations were verified by
SEC-MALS experiments. As shown in <xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig"/>
</xref>b, absolute molecular masses (MW) were determined
at 14.6, 11.9, 8.2, and 6.3 kDa for FL-aSyn, pE24-aSyn, pE62-aSyn,
and pE79-aSyn, respectively, which represent the expected value for
the monomeric species. It has to be noted that the intrinsic viscosity
(IV)&#x0e5f8;a parameter that gives information about the shape and
the hydration of the molecule, decreased from 0.15 dL/g for FL-aSyn
to 0.11 dL/g for pE79-aSyn. Its expression is the product of the viscosity
increment &#x003bd; and the swollen volume <italic toggle="yes">V</italic>
<sub>s</sub> = (<italic toggle="yes">&#x003bd;&#x00305;</italic> + &#x003b4;/&#x003c1;) with &#x003bd;&#x00305;
being the partial specific volume (<ext-link xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acschemneuro.5c00106/suppl_file/cn5c00106_si_001.pdf" ext-link-type="uri">Table S2</ext-link>), &#x003b4; the hydration (0.488 g/g), &#x003c1; the density of the
buffer (<ext-link xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acschemneuro.5c00106/suppl_file/cn5c00106_si_001.pdf" ext-link-type="uri">Table S2</ext-link>), [&#x003b7;] = &#x003bd;&#x000b7;(<italic toggle="yes">&#x003bd;&#x00305;</italic> + &#x003b4;/&#x003c1;). The viscosity increment
describes the elongation of the characterized molecule: a sphere has
a value of 2.5, and the value increases with elongation. Using the
IV values, it could be calculated that &#x003bd; decreased from 12.1
for FL-aSyn to 8.3 for pE79-aSyn, respectively. These values indicate
the persistence of an elongated and an intrinsically disordered state
of the proteins in solution regardless of their length.</p></sec><sec id="sec2.2"><title>SRCD: Estimation
of Secondary Structural Elements and Reversibility
of FL-aSyn and pE-aSyn Variants in Solution</title><p>The composition
of secondary structure elements of FL-aSyn and pE-aSyn variants and
their reversibility were investigated by SRCD. The aSyn proteins were
measured immediately after solubilization in buffer with 20 mM Tris/HCl
at pH 7.2 and 100 mM NaCl. The SRCD spectra were recorded from a wavelength
of 180&#x02013;260 nm (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig"/>
</xref>a).</p><fig position="float" id="fig2" fig-type="figure"><label>2</label><caption><p>SRCD spectra profiles of FL-aSyn and pE-aSyn variants in solution
within a temperature range from 27 to 97 &#x000b0;C and predicted secondary
structure content at 27 and 97 &#x000b0;C. (a) SRCD spectra from 180
to 260 nm in 20 mM Tris/HCl and 100 mM NaCl buffer (pH 7.2) are characteristic
of an unfolded and a random coiled structure with a single negative
peak at &#x0223c;199 nm. Colors of the curves indicate different temperatures
from 27 &#x000b0;C (blue) to 97 &#x000b0;C
(red), in steps of 5 &#x000b0;C and reverse directly to 27 &#x000b0;C (resulting
curve shown in orange). If present, an isosbestic point is marked
with a black dot. (b) BESTSEL calculated proportions of secondary
structure elements of FL-aSyn and pE-aSyn variants within a wavelength
range of 185&#x02013;250 nm at 27 and 97 &#x000b0;C. &#x003b1;-helices (red
colors) are divided into regular helices with a middle part of &#x003b1;-helices
(Helix1) and distorted helices with two-two residues at the ends (Helix2).
For &#x003b2;-sheets (green colors), four subcategories are defined:
parallel &#x003b2;-sheet and antiparallel &#x003b2;-sheet of three different
twists (Para), left-hand twisted (Anti1), relaxed and slightly right-hand
twisted (Anti2), and right-hand twisted (Anti3). Additionally, turns
(light green) were calculated, and all other elements were declared
as unstructured (gray).</p></caption><graphic xlink:href="cn5c00106_0002" id="gr2" position="float"/></fig><p>For all aSyn variants,
the shapes and single negative
peak &#x0223c;199
nm of far-UV spectra at 27 &#x000b0;C (blue curves) indicated a highly
unstructured IDP, which is consistent with the literature corresponding
to monomeric aSyn.<named-content content-type="bibref-group">
<xref rid="ref52" ref-type="bibr"/>&#x02212;<xref rid="ref53" ref-type="bibr" specific-use="suppress-in-print"/>
<xref rid="ref54" ref-type="bibr"/>
</named-content> The concept of a distinct melting temperature determination
(temperature at which a protein transits from folded to unfolded state)
does not directly apply to the proteins investigated, which lack a
well-defined structure. Nevertheless, CD spectroscopy is still a valuable
tool for studying temperature-dependent conformational dynamics. Since
post-translational modifications can alter the thermal stability and
its reversibility, SRCD spectra of FL-aSyn and pE-aSyn variants were
compared by heating the proteins gradually from 27 to 97 &#x000b0;C in
steps of 5 &#x000b0;C. Subtle temperature-dependent changes in the spectra
of FL-aSyn, pE24-aSyn, and pE79-aSyn were observed, such as the decrease
of the negative 199 nm peak, the increase of the 222 nm band, and
the increase of the peak at 185 nm. In comparison, the spectral curve
of pE62-aSyn over temperature appeared to be different. Although the
decrease of the negative 199 nm peak was also observed, there was
an additional temperature-dependent decrease in the peak around 222
nm.</p><p>For FL-aSyn, pE24-aSyn, and pE79-aSyn, an isosbestic point
at the
wavelength &#x0223c;209 nm was detectable, where the total absorbance
did not change (see black dotted line in <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig"/>
</xref>a). Isosbestic points indicate that the stoichiometry
of two molecular entities remain unchanged during the temperature
increase.<xref rid="ref55" ref-type="bibr"/> In contrast, no isosbestic
point could be identified for pE62-aSyn.</p><p>After heating the proteins
to 97 &#x000b0;C, the samples were cooled
directly to 27 &#x000b0;C to address the question of structural reversibility.
The resulting curves are represented in <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig"/>
</xref>a in orange. An almost identical pattern
for preheating and postheating was observed for FL-aSyn, pE24-aSyn,
and pE79-aSyn, indicating that conformational plasticity is completely
reversible upon temperature increase for these aSyn variants. For
pE62-aSyn, however, there was an irreversible change in the postheat
curve toward &#x003b2;-strand structures during heating. These data
for pE62-aSyn in combination with a macroscopic change in sample color
from transparent to opaque indicated fibrillation induced by temperature
increase.</p><p>The BESTSEL secondary structure prediction (see <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig"/>
</xref>b) confirmed the
status of
unstructured IDPs with &#x0223c;50% of unstructured content at 27 &#x000b0;C
for FL-aSyn as well as pE-variants. For all proteins investigated,
comparable secondary structure contents were predicted with 0 to &#x0223c;3%
&#x003b1;-helices, 34% &#x003b2;-strands, and &#x0223c;16% turns (see <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig"/>
</xref>b). Heated FL-aSyn
and pE-aSyn variants (97 &#x000b0;C) showed no significant conformational
changes in the secondary structure contents (see <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig"/>
</xref>b). The observation of reversibility
was also confirmed by the same predicted secondary structure content
after cooling down to 27 &#x000b0;C (data not shown).</p></sec><sec id="sec2.3"><title>SRCD: Effect
of Sodium Dodecyl Sulfate (SDS) Micelles on Folding
of FL- and pE-aSyn Variants</title><p>SDS micelles were used as a membrane-mimetic
environment,<xref rid="ref56" ref-type="bibr"/> in order to force aSyn to
structural transition and promote helical conformation. The composition
of secondary structure elements of FL-aSyn and pE-aSyn variants and
their reversibility upon a temperature change in the presence of SDS
micelles were investigated by SRCD (see <xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig"/>
</xref>).</p><fig position="float" id="fig3" fig-type="figure"><label>3</label><caption><p>Effects of SDS micelles on SRCD spectra profiles
of FL-aSyn and
pE-aSyn variants within a temperature range from 27 to 97 &#x000b0;C
and predicted secondary structure content with and without SDS micelles
at 27 &#x000b0;C. (a) SRCD spectra from 180 to 260 nm in 20 mM Tris/HCl,
100 mM NaCl buffer (pH 7.2) without (black spectra) and with the addition
of 100 mM SDS are characteristic for an &#x003b1;-helical structure
indicated by a positive peak at 190 nm and double negative peaks at
&#x0223c;208 and &#x0223c;222 nm. Colors of the curves indicate different
temperatures from 27 &#x000b0;C (black, blue) to 97 &#x000b0;C (red), in
steps of 5 &#x000b0;C and reverse directly to 27 &#x000b0;C (orange). If
present, an isosbestic point is marked with a black dot. (b) BESTSEL
calculated proportions of secondary structure elements of FL-aSyn
and pE-aSyn variants within a wavelength range of 185&#x02013;250 nm
at 27 and 97 &#x000b0;C. &#x003b1;-helices (red colors) are divided into
regular helices with a middle part of &#x003b1;-helices (Helix1) and
distorted helices with two-two residues at the ends (Helix2). For
&#x003b2;-sheets (green colors), four subcategories are defined: parallel
&#x003b2;-sheet and antiparallel &#x003b2;-sheet of three different twists
(Para), left-hand twisted (Anti1), relaxed and slightly right-hand
twisted (Anti2), and right-hand twisted (Anti3). Additionally, turns
(light green) were calculated, and all other elements were declared
as unstructured (gray).</p></caption><graphic xlink:href="cn5c00106_0003" id="gr3" position="float"/></fig><p>In order to allow direct
comparison of spectra
in the presence
or absence of SDS, each sample was first measured without SDS (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig"/>
</xref>a, black spectra),
before being diluted 1:2 in the presence of 100 mM SDS and heated
from 27 &#x000b0;C (blue) to 97 &#x000b0;C (red) and reversed directly to
27 &#x000b0;C (orange). For FL-aSyn, pE24-aSyn, and pE62-aSyn characteristic
peaks for &#x003b1;-helices were detected; a positive peak of 190 nm
with a decrease over temperature and double negative peaks &#x0223c;208
and &#x0223c;220 nm with an increase over temperature. The spectra
of pE79-aSyn differed with a single negative peak &#x0223c;200 nm.
Again, for FL-aSyn, pE24-aSyn, and pE62-aSyn, an isosbestic point
at a wavelength of &#x0223c;200 nm was determined whereas in comparison
no isosbestic point was detected for pE79-aSyn. An almost identical
pattern for preheat (blue spectra) and postheat (orange spectra) was
observed which indicates reversibility of all aSyn proteins investigated.</p><p>The predicted secondary structure content confirmed the capacity
of SDS micelles to induce an unstructured-to-helix transition for
all samples (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig"/>
</xref>b). The &#x003b1;-helical content of FL-aSyn increased from 0 to 37.1%,
that of pE24-aSyn from 0 to 22.8%, and that of pE62-aSyn from 0.3
to 14.5%, accompanied by a reduction of the &#x003b2;-strand and unstructured
contents. Also, for pE79-aSyn, the &#x003b1;-helical content increased
to 7.5% but unlike the other variants was accompanied by an increase
in unstructured content. The reversibility of thermal transition was
also confirmed by the return to a similar predicted secondary structure
content after cooling down to 27 &#x000b0;C (data not shown).</p></sec><sec id="sec2.4"><title>SEC-SAXS
and AUC of Different Oligomeric States of FL-aSyn and
pE-aSyn Variants</title><p>SAXS combined with SEC (for presentation
of setup see <ext-link xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acschemneuro.5c00106/suppl_file/cn5c00106_si_001.pdf" ext-link-type="uri">Figure S1</ext-link>) provided information
on particle size, shape, and degree of folding of different oligomeric
states of FL-aSyn and pE-aSyn variants in solution. FL-aSyn and pE-aSyn
variants were agitated and loaded onto an HPLC-SEC column.</p><p>Particles
present in the mix were separated by size, and the 214 nm-chromatograms
of the aSyn proteins collected during the SEC-SAXS experiments are
shown in <xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig"/>
</xref>a.
For each sample, three peaks with different elution times were detected,
except for pE62-aSyn, where only one main peak was detected. The most
prominent peak, numbered p1, was eluted between 29 and 32 min, depending
on the aSyn variants studied. The second peak, designated p2, was
detected between 26 and 29 min, as well as a smaller peak (p3) at
&#x0223c;19 min, for all aSyn variants except pE62-aSyn. Areas of the
chromatograms in which SAXS signals were evaluated are indicated by
color-coded boxes (p1 in orange, p2 in blue, and p3 in green). In
order to gain further insight into the oligomeric states of each of
the species within the peaks, several analyses were carried out using
the SAXS pattern shown in <xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig"/>
</xref>b and parameters listed in the <ext-link xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acschemneuro.5c00106/suppl_file/cn5c00106_si_001.pdf" ext-link-type="uri">Table S1</ext-link>. <italic toggle="yes">R</italic>
<sub>g</sub> values were evaluated
by the Guinier analysis shown in <xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig"/>
</xref>c. For FL-aSyn, <italic toggle="yes">R</italic>
<sub>g</sub>(p1) amounted to 36.9 &#x000c5;, <italic toggle="yes">R</italic>
<sub>g</sub>(p2)
to 39.5 &#x000c5;, whereas <italic toggle="yes">R</italic>
<sub>g</sub>(p3) was 64.2
&#x000c5;. For pE24-aSyn, the <italic toggle="yes">R</italic>
<sub>g</sub> values were
comparable with, <italic toggle="yes">R</italic>
<sub>g</sub>(p1) measuring 35.0
&#x000c5;, <italic toggle="yes">R</italic>
<sub>g</sub>(p2) 48.1 &#x000c5;, and <italic toggle="yes">R</italic>
<sub>g</sub>(p3) 60.7 &#x000c5;. For pE62-aSyn, the <italic toggle="yes">R</italic>
<sub>g</sub> value of the detected p1 was 27.9 &#x000c5;. <italic toggle="yes">R</italic>
<sub>g</sub> values for pE79-aSyn particles <italic toggle="yes">R</italic>
<sub>g</sub>(p1) amounted to 24.7 &#x000c5;, <italic toggle="yes">R</italic>
<sub>g</sub>(p2) to 39.8 &#x000c5;, and <italic toggle="yes">R</italic>
<sub>g</sub>(p3)
to 62.6 &#x000c5;, respectively, again in comparable order. Using an
indirect Fourier transform of the SAXS curves, the pair-distance distribution
function <italic toggle="yes">P</italic>(<italic toggle="yes">r</italic>) was calculated to
determine the maximum distance <italic toggle="yes">D</italic>
<sub>max</sub> shown
in <xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig"/>
</xref>d as well
as another estimate of <italic toggle="yes">R</italic>
<sub>g</sub> (for values
see <ext-link xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acschemneuro.5c00106/suppl_file/cn5c00106_si_001.pdf" ext-link-type="uri">Table S1</ext-link>, <italic toggle="yes">R</italic>
<sub>g</sub> GNOME). In line with the decreasing elution times of the peaks p1
to p3 of FL-aSyn, <italic toggle="yes">D</italic>
<sub>max</sub> from p1 (orange)
to p3 (green) was increasing with 145, 154, and 173 &#x000c5;. The <italic toggle="yes">D</italic>
<sub>max</sub> for the other pE-aSyn variants showed comparable
ascending values when considering p1-p3 in consistency with the lower
elution times, for pE24-aSyn with 135 166, and 217 &#x000c5;. For pE62-aSyn, <italic toggle="yes">D</italic>
<sub>max</sub> was calculated at 115 &#x000c5;. For pE79-aSyn,
values for p1, p2, and p3 ranged from 104 &#x000c5;, 145 &#x000c5; to 224
&#x000c5;. The shapes and heights of p1/p2/p3 distance distribution function
varied, but were comparable across variants. In <xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig"/>
</xref>e, the dimensionless Kratky plot, which is
an indicator for &#x0201c;globularity&#x0201d;, shows a hyperbolic Kratky
curve that plateaus at high q values for all p1 and p2 across aSyn
variants (orange and blue curves), a characteristic feature of flexible
and unstructured proteins. On the contrary, Kratky curves for all
p3 of aSyn variants (green curves) adopt a bell-shape indicating the
presence of compactly folded particles.</p><fig position="float" id="fig4" fig-type="figure"><label>4</label><caption><p>SAXS data analysis and
AUC of different oligomeric states of FL-aSyn
and pE-aSyn variants. (a) SEC separation after the aggregation assay
was performed on a Yara3000 column at a flow rate of 0.3 mL/min, and
chromatograms correspond to the absorbance recorded at 214 nm over
time. The prominent peak (p1) corresponds to the monomeric fraction,
while earlier peaks (p2, p3) correspond to larger particles (dimers,
oligomers). The boxed areas in the chromatograms represent the areas
in which SAXS signals were evaluated. The color code used throughout
the figure is orange for p1 and related plots, blue for p2, and green
for p3. (b) Corresponding SAXS curves of FL-aSyn and pE-aSyn variants
for different oligomeric states. The scattering intensity <italic toggle="yes">I</italic>(<italic toggle="yes">q</italic>) is represented as a function of scattering
vector <italic toggle="yes">q</italic>. (c) Corresponding Guinier plots calculated
using BioXtas-RAW with derived radius of gyration <italic toggle="yes">R</italic>
<sub>g</sub> included in the top right of each plot. (d) Corresponding
pair-distance distribution function <italic toggle="yes">P</italic>(<italic toggle="yes">r</italic>) calculated using GNOME, indicating maximal dimensions of the particles <italic toggle="yes">D</italic>
<sub>max</sub>. (e) The dimensionless Kratky plots are
an indicator of conformational properties of particles. The hyperbolic
Kratky curve with a plateau at high <italic toggle="yes">q</italic> observed with
monomers and dimers is characteristic of a disordered and flexible
conformation, whereas the bell-shaped curve observed with oligomers
indicates folded particles. (b&#x02013;d) were plotted using BioXtas-RAW.
(f) Analyses of FL-aSyn and pE-aSyn variants by analytical ultracentrifugation
(AUC) were performed at two concentrations. Experimentally derived
sedimentation coefficient values (Svedberg units [S]) are shown above
each detected species and have a 0.2 standard deviation.</p></caption><graphic xlink:href="cn5c00106_0004" id="gr4" position="float"/></fig><p>The SAXS analyses were orthogonally confirmed using
AUC, an approach
to study the biophysical characteristics of molecules, such as size,
shape, and stoichiometry. Ultracentrifugation combined with UV/visible
and interference detection systems enables hydrodynamic separation
of species in solution according to their sedimentation coefficient
(<italic toggle="yes">S</italic>). Using the AUC data, shown in <xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig"/>
</xref>f, oligomeric states and corresponding
hydrodynamic characteristics (<italic toggle="yes">R</italic>
<sub>H</sub>, <italic toggle="yes">f</italic>/<italic toggle="yes">f</italic>
<sub>0</sub>) were extracted and summarized
in <xref rid="tbl1" ref-type="table">Table <xref rid="tbl1" ref-type="table"/>
</xref>.</p><table-wrap position="float" id="tbl1"><label>1</label><caption><title>Structural and Hydrodynamic Parameters
Derived from SEC-MALS, AUC, DLS, and SAXS Experiments.</title></caption><graphic xlink:href="cn5c00106_0012" id="gr12" position="float"/><table-wrap-foot><fn id="t1fn1"><p>Errors: <italic toggle="yes">S</italic>
<sub>EXP</sub>: 0.1, <italic toggle="yes">R</italic>
<sub>H</sub>,<sub>EXP</sub>: 1, <italic toggle="yes">f</italic>/<italic toggle="yes">f</italic>
<sub>0</sub>: 0.1, <italic toggle="yes">R</italic>
<sub>g</sub>, <sub>EXP</sub>: 0.2 to 3.</p></fn><fn id="t1fn2"><label>a</label><p>Extracted
from SAXS experimental
data.</p></fn><fn id="t1fn3"><label>b</label><p>Extracted from AUC
experimental
data.</p></fn><fn id="t1fn4"><label>c</label><p>Theoretical value
derived from Bloomfield
model reconstruction based on SAXS and AUC data.</p></fn></table-wrap-foot></table-wrap><p>By linking the parameters extracted
from the SAXS
and AUC experiments,
the main peak p1 detected for the different aSyn variants was compatible
with the monomeric form of aSyn. The ratio, &#x003c1; =&#x0202f;<italic toggle="yes">R</italic>
<sub>g</sub>/<italic toggle="yes">R</italic>
<sub>H</sub>, was used to
get valuable information about the conformation and shape of the different
aSyn variants.<xref rid="ref57" ref-type="bibr"/> The typical ratio for
ordered and globular proteins is expected to be around 0.7, while
a ratio greater than 1 indicates more elongated/disordered conformations.
The p1 peaks are characterized by a ratio of 1.3, except for the pE62-aSyn
p2 species, where the ratio is 1.5, indicating an extended conformation.
This observation is confirmed by the shape of the distance distribution
functions, which is similar to that expected for long rods,<xref rid="ref58" ref-type="bibr"/> and by the hyperbolic Kratky curves, which plateaus
as q increases, indicating an unfolded particle with flexible conformation.
The frictional ratio, <italic toggle="yes">f</italic>/<italic toggle="yes">f</italic>
<sub>0</sub>, extracted from the AUC data tempers these observations. While <italic toggle="yes">f</italic>/<italic toggle="yes">f</italic>
<sub>0</sub> is about 1.8 for FL-aSyn
and pE24-aSyn, indicating an elongated shape, it is about 1.6 and
1.4, respectively, for pE62-aSyn and pE79-aSyn, suggesting shapes
that are probably less elongated/more compact, in agreement with the
change in intrinsic viscosity and viscosity increment.</p><p>Interestingly,
AUC analysis showed the presence of higher-order
species with higher-order oligomeric states. The aSyn variant p2 peaks
detected by AUC were compatible with dimeric states of the respective
variants. This was in agreement with the elution time, <italic toggle="yes">R</italic>
<sub>g</sub>, <italic toggle="yes">D</italic>
<sub>max</sub>, Kratky plots, as
well as MW estimations (see <ext-link xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acschemneuro.5c00106/suppl_file/cn5c00106_si_001.pdf" ext-link-type="uri">Table S1</ext-link>) measured
for FL-aSyn p2 by SEC-SAXS. To note, the radius of gyration, which
is the root-mean-square distance to the center of mass of the particle,
only increases by less than 3 &#x000c5; between the monomer and dimer
while the frictional coefficient decreases. These data point toward
a side-by-side assembly or compaction as other configurations would
have increased both <italic toggle="yes">R</italic>
<sub>g</sub> and frictional
ratio. Finally, further peaks detected by AUC were compatible with
different assemblies of the dimer such as tetramer, hexamer, or octamer
as illustrated in <xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig"/>
</xref>. The decrease in the frictional ratio values associated with
these oligomers points to a more compact arrangement of the assembly
rather than a possible elongation. This observation is compatible
with peak p3 detected by SAXS, which corresponds to a higher oligomeric
state with a more compact structure.</p></sec><sec id="sec2.5"><title>SAXS: Ensemble Modeling
of Monomeric and Dimeric States of FL-aSyn
and pE-aSyn Variants</title><p>To gain further insight into the nature
of all monomeric and dimeric states of FL-aSyn and pE-aSyn variants
isolated in SEC, an ensemble analysis was performed by the Ensemble
Optimization Method (EOM, ATSAS package) based on SAXS profiles (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig"/>
</xref>).</p><fig position="float" id="fig5" fig-type="figure"><label>5</label><caption><p>Ensemble modeling of
FL-aSyn monomers and dimers performed using
EOM 3.0 suite. Pools of 10,000 atomic models in random conformations
were generated with RANCH and ensembles of 20 models were selected
with GAJOE to reproduce the experimental data. The ensembles leading
to the best fit (lowest <italic toggle="yes">Chi</italic>
<sup>2</sup>) for the
monomeric (left panel) and dimeric (right panel) populations are depicted,
as well as corresponding theoretical SAXS curves superimposed to the
experimental data in the bottom panel, and the <italic toggle="yes">R</italic>
<sub>g</sub> distribution for the selected ensemble compared to the starting
pool. All models are represented on the same scale.</p></caption><graphic xlink:href="cn5c00106_0005" id="gr5" position="float"/></fig><p>Therefore, EOM 3.0 was first used to generate pools
of 10,000 random
models of FL-aSyn monomers and dimers. No secondary structure elements
were imposed on the monomers, while the dimers included a central
&#x003b2;-strand between aa residues 64&#x02013;71 surrounded by floppy
extremities, based on a recent model proposed by Savva &#x00026; Platts
(2024) in which two monomers are linked by short &#x003b2;-strands involving
the region of aa 60&#x02013;70. An ensemble of models was then selected
from the starting pool, which collectively fit the experimental data
best (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig"/>
</xref>). The
resulting ensembles give a good description of the possible conformational
diversity of each type of particle. Monomeric models fit well with
the idea of extended and flexible IDPs in solution, a feature confirmed
by an <italic toggle="yes">R</italic>
<sub>g</sub> distribution centered on a higher
value for the selection compared to the initial pool. As dimeric models
present a constriction zone at the center that bridges the two monomers,
their conformations are slightly more constrained and compact, leading
to an <italic toggle="yes">R</italic>
<sub>g</sub> distribution closer to that of
the original pool. Similar results were obtained for pE-aSyn monomers
(<ext-link xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acschemneuro.5c00106/suppl_file/cn5c00106_si_001.pdf" ext-link-type="uri">Figure S2</ext-link>). In the absence of a starting
model, dimeric forms of variants were not analyzed with EOM. Supporting
data for <xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig"/>
</xref> and <ext-link xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acschemneuro.5c00106/suppl_file/cn5c00106_si_001.pdf" ext-link-type="uri">Figure S2</ext-link> are available in the <ext-link xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acschemneuro.5c00106/suppl_file/cn5c00106_si_001.pdf" ext-link-type="uri">Supporting Information</ext-link>, containing models, experimental data,
and the curves calculated from the corresponding ensembles.</p><p>Although less relevant for IDPs, GASBOR predictions were carried
out with chained dummy atoms for both monomeric and dimeric forms
(<ext-link xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acschemneuro.5c00106/suppl_file/cn5c00106_si_001.pdf" ext-link-type="uri">Figure S3</ext-link>), which gave similar qualitative
results and, as expected, generated extended models. An attempt to
model the particles present in peak p3 was performed using DAMMIF,
since the Kratky plot indicated a compact structure (<ext-link xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acschemneuro.5c00106/suppl_file/cn5c00106_si_001.pdf" ext-link-type="uri">Figure S4</ext-link>). However, these populations are probably heterogeneous,
as suggested by Awasthi <italic toggle="yes">et al.</italic> (2023).<xref rid="ref59" ref-type="bibr"/> In addition, SAXS data are very noisy and the
resulting models are reminiscent of those porous, fibril building
blocks proposed by Giehm <italic toggle="yes">et al.</italic> (2011), which must
be considered with caution.</p></sec><sec id="sec2.6"><title>Bloomfield Models of the Assembly Step</title><p>In order to
further understand the assembly intermediates such as dimer, tetramer
and hexamer detected by AUC, a series of models compatible with the
hydrodynamic results available (<italic toggle="yes">S</italic>, Mw, <italic toggle="yes">R</italic>
<sub>g</sub>, <italic toggle="yes">D</italic>
<sub>max</sub>) have been generated
using a bead modeling assembly.<xref rid="ref60" ref-type="bibr"/> In these
hydrated models, aSyn monomers are represented as an array of spheres
that has the overall shape of the FL-aSyn monomer EOM models, and
the published structure of an aSyn(1&#x02013;121) truncated monomer.<xref rid="ref61" ref-type="bibr"/> The number of beads and their respective radius
were chosen to occupy a volume compatible with the mass of the hydrated
monomer. The hydrodynamic characteristics calculated from the FL-aSyn
model presented in <xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig"/>
</xref> are in good agreement with the experimental
values (see <xref rid="tbl1" ref-type="table">Table <xref rid="tbl1" ref-type="table"/>
</xref>).</p><fig position="float" id="fig6" fig-type="figure"><label>6</label><caption><p>Hydrated bead models are compatible with hydrodynamic data. The
models have been generated using a bead modeling assembly as proposed
by ref <xref rid="ref60" ref-type="bibr" specific-use="ref-style=base-text"/>. Their
calculated hydrodynamic parameters are presented in <xref rid="tbl1" ref-type="table">Table <xref rid="tbl1" ref-type="table"/>
</xref> and are in agreement with experimental
data.</p></caption><graphic xlink:href="cn5c00106_0006" id="gr6" position="float"/></fig><p>This model of the FL-aSyn monomer
was used to create
a subsequent
model for the dimer. Interestingly, SAXS measurements are in favor
of a side-by-side arrangement of the monomers to form dimers whereas
Cryo-EM data<xref rid="ref61" ref-type="bibr"/> suggest a head-to-tail assembly.
Consequently, the dimer model was created after a 180&#x000b0; turn of
one of the monomers and then assuming side-to-side contact, resulting
in compatible calculated hydrodynamic characteristics compared with
hydrodynamic experimental data (see <xref rid="tbl1" ref-type="table">Table <xref rid="tbl1" ref-type="table"/>
</xref>). For further elongation, this FL-aSyn dimer
was then used as a building block to create a stacking assembly. To
account for the spacing between dimers described in the cryo-EM structure
(&#x0223c;5 &#x000c5;) and possible flexibility, the dimers were stacked
at a 15&#x000b0; angle. All sedimentation coefficients calculated for
oligomeric intermediates, tetramer, and hexamer, were compatible with
the experimental data (see <xref rid="tbl1" ref-type="table">Table <xref rid="tbl1" ref-type="table"/>
</xref>). Overall, this shows that all of the models are in
favor of an elongation by stacking of the dimeric unit (see <xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig"/>
</xref>).</p><p>Using this
FL-aSyn model, pE-aSyn variants were generated by the
removal of beads as a function of the expected hydrated volume of
the different monomers. For all of them, the calculated sedimentation
characteristics were compatible with the experimental data, providing
evidence that the previously suggested assembly model could be applied
to all pE-aSyn variants (see <xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig"/>
</xref>).</p></sec><sec id="sec2.7"><title>Toxicity of FL-aSyn and pE-aSyn Oligomeric
States</title><p>In
order to study the toxicity of oligomeric FL-aSyn and the pE-aSyn
variants, in particular, pE24-aSyn and pE62-aSyn, a WST-1 assay was
performed using differentiated SH-SY5Y neuroblastoma cells. Comparable
experiments were previously carried out for pE79-aSyn.<xref rid="ref49" ref-type="bibr"/> For oligomer preparation for cell culture experiments,
agitated samples of FL-aSyn, pE24-aSyn or pE62-aSyn were taken from
the respective lag phase of fibril formation. In <xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig"/>
</xref>a, the statistical analysis
of the lag phase periods shows shorter lag phases with increased truncation
of the proteins. Thus, the lag time of fibril formation decreases
from an average of 17 h for FL-aSyn to 6 h for pE24-aSyn and to 53
min for pE62-aSyn, confirming the instant fibril formation of pE62-aSyn
reported above.</p><fig position="float" id="fig7" fig-type="figure"><label>7</label><caption><p>ThT lag times and cytotoxicity analysis of monomeric and
oligomeric
FL-, pE24-, and pE62-aSyn. (a) Statistical analysis of the lag phase
of the aggregated FL-, pE24-, and pE62-aSyn (55 &#x003bc;M each). The
analysis is based on a one-way analysis of variance (ANOVA) followed
by a posthoc Tukey analysis (mean &#x000b1; SD, <italic toggle="yes">n</italic> =
6; ** <italic toggle="yes">p</italic> &#x0003c; 0.01). (b) Cell viability was determined
after 72 h of treatment with the respective variants in monomeric
and oligomeric states (5 &#x003bc;M each) in differentiated SH-SY5Y
cells using the WST-1 assay (mean &#x000b1; SD, <italic toggle="yes">n</italic> =
3, ***<italic toggle="yes">p</italic> &#x0003c; 0.001 defined by one-way ANOVA followed
by Tukey posthoc analysis).</p></caption><graphic xlink:href="cn5c00106_0007" id="gr7" position="float"/></fig><p>For the toxicity assays, purified FL-aSyn, pE24-aSyn,
or pE62-aSyn
monomers and oligomers were applied on differentiated SH-SY5Y cells
at a concentration of 5 &#x003bc;M each and normalized to the vehicle
control PBS. Compared to the monomeric proteins, significant cytotoxicity
of oligomeric aggregates of FL-aSyn and pE62-aSyn was observed, whereas
oligomeric forms of pE24-aSyn only showed a tendency of reduced viability
(FL-aSyn monomers: 107% viability vs oligomers 59% viability, pE24-aSyn
monomers: 112% viability vs oligomers 96% viability, pE62-aSyn monomers:
87% viability vs oligomers 31% viability, see <xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig"/>
</xref>b). In line with this, it has been previously
shown that oligomeric pE79-aSyn induced significant cytotoxicity compared
to its monomeric state (pE79-aSyn monomers: 73% viability, pE79-aSyn
aggregates: 50% viability, for further details, see ref <xref rid="ref49" ref-type="bibr" specific-use="ref-style=base-text"/>).</p></sec></sec><sec id="sec3"><title>Discussion</title><p>In this study, the structural characteristics
of monomeric, dimeric,
and oligomeric states of pE-modified aSyn variants were investigated
in comparison to FL-aSyn. Due to the nature of the IDP aSyn, including
the lack of a well-defined structure in the native state and high
flexibility, studies of the structural properties are challenging.
Therefore, an integrative biophysical approach, including DLS, SEC-MALS,
SRCD, SAXS, and AUC was chosen to accomplish this goal.</p><p>This
study was made possible by the use of standardized oligomerization
protocols that improved the comparability of the results across different
analytical methods. The investigation of aSyn oligomeric structures,
with special focus on the initial assembly step &#x02013; the dimeric
state &#x02013; has gained interest in recent years, as aSyn oligomers
are classified as toxic and could serve as targets for therapeutic
approaches.<xref rid="ref7" ref-type="bibr"/> Standardized protocols for
the generation of such aSyn oligomers are essential for data validity
and the comparability of results. Such a detailed and reproducible
oligomerization protocol was established by Paswalski <italic toggle="yes">et al.</italic> (2016) and thus served as the basis of this work.</p><sec id="sec3.1"><title>Unstructured and Elongated
Monomeric FL-aSyn and pE-aSyn Variants</title><p>The orthogonal approach
of analysis by SEC-MALS, SRCD, SAXS, and
AUC provided detailed information on the secondary structure content,
the overall size, and low-resolution shape of the monomeric FL-aSyn
and pE-aSyn variants. The viscosity increments and the different elution
times of the prominent peak p1 on SEC reflected the different lengths
of the monomeric truncated pE-aSyn variants compared to FL-aSyn. Additionally, <italic toggle="yes">R</italic>
<sub>g</sub> values resulting from the SAXS curves were
calculated for the monomers and the <italic toggle="yes">R</italic>
<sub>g</sub> value for the FL-aSyn monomer is in agreement with previously published
data.<named-content content-type="bibref-group">
<xref rid="ref62" ref-type="bibr"/>,<xref rid="ref63" ref-type="bibr"/>
</named-content> Interestingly, the <italic toggle="yes">R</italic>
<sub>g</sub> value was smaller than expected for a completely unfolded
polypeptide with a comparable number of amino acids (52 &#x000c5;) but
larger than the theoretical <italic toggle="yes">R</italic>
<sub>g</sub> of a 140-amino
acid globular protein (15.1 &#x000c5;), reflecting a possible folding
or compression of the chain.<named-content content-type="bibref-group">
<xref rid="ref62" ref-type="bibr"/>,<xref rid="ref64" ref-type="bibr"/>
</named-content>
</p><p>Consistently,
the shorter the length of the pE-aSyn variants, the smaller the respective <italic toggle="yes">R</italic>
<sub>g</sub> values became (35.0 &#x000c5; for pE24-aSyn,
27.9 &#x000c5; for pE62-aSyn, and 24.7 &#x000c5; for pE79-aSyn). This relationship
is reflected by the decreasing <italic toggle="yes">D</italic>
<sub>max</sub> values
for FL-aSyn from 145 &#x000c5; down to 104 &#x000c5; for pE79-aSyn.</p><p>The hyperbolic Kratky curves of all analyzed aSyn variants confirmed
the intrinsically disordered nature of aSyn. In addition, EOM-generated
models for elongated monomeric states were proposed here for FL-aSyn
and, for the first time, also for pE-aSyn variants. Other characteristic
features of unfolded proteins were observed in the SRCD spectra with
a strong negative peak near 200 nm and weak negative values at 220
nm.<xref rid="ref54" ref-type="bibr"/> The lack of a defined secondary structure<named-content content-type="bibref-group">
<xref rid="ref9" ref-type="bibr"/>,<xref rid="ref10" ref-type="bibr"/>
</named-content> was reproduced for FL-aSyn as well as for all pE-aSyn variants at
27 &#x000b0;C indicating that the N-terminal truncation and pE modification
does not affect the intrinsic disorder of the truncated aSyn polypeptides.
The calculated &#x003b2;-strand content is stable across variants, reflecting
the preferred transient &#x003b2;-strand conformation of the C-terminal
residues 101&#x02013;140,<xref rid="ref62" ref-type="bibr"/> which is present
in all aSyn variants investigated here. When the pE-aSyn variants
were heated to 97 &#x000b0;C, a reduction in the negative 198 nm peak
was observed, including a shift to 202 nm and an increase in the 222
nm band. A fully reversible pattern for heating and cooling was observed,
indicating a conformational plasticity with reversibility following
temperature increase,<xref rid="ref65" ref-type="bibr"/> except for pE62-aSyn.
For all aSyn variants analyzed, again with the exception of pE62-aSyn,
an isosbestic point was observed, indicating that the stoichiometry
remained unchanged and that no secondary reactions occurred during
the temperature change.<xref rid="ref66" ref-type="bibr"/> The data obtained
for pE62-aSyn including the shortest ThT lag phase time, combined
with the observation that upon heating the sample changed color from
transparent to opaque in the cuvette, are indicative of fibrillation
and highlight the fast aggregation propensity of this particular aSyn
variant. Interestingly, a previous study also reported a high fibrillation
propensity for the almost identical truncated&#x0e5f8;albeit unmodified&#x0e5f8;form
of aSyn(61&#x02013;140).<xref rid="ref67" ref-type="bibr"/> The exact physiological
function and toxicity of the monomeric pE-aSyn variants need to be
further investigated in detail.</p></sec><sec id="sec3.2"><title>SDS Micelles Forced FL-aSyn
and pE-aSyn Variants into &#x003b1;-Helical
Structure</title><p>To investigate potential conformational changes
of the pE-aSyn variants upon lipid binding, a commonly used membrane-mimetic
reagent, SDS, was chosen due to its ability to form micelles.<named-content content-type="bibref-group">
<xref rid="ref56" ref-type="bibr"/>,<xref rid="ref68" ref-type="bibr"/>,<xref rid="ref69" ref-type="bibr"/>
</named-content> The respective aSyn proteins
folded immediately upon the addition of SDS paralleled by a significant
increase in &#x003b1;-helical content, and the shorter the pE-aSyn variants,
the lower the &#x003b1;-helical content. While the &#x003b1;-helical content
of FL-aSyn increased by 37%, the &#x003b1;-helical content of the shortest
pE79-aSyn variant increased by only &#x0223c;4%. This can be explained
by the results of an NMR study, which showed that the 1&#x02013;99
N-terminal aSyn region interacts with the SDS micelles.<xref rid="ref70" ref-type="bibr"/> The transition to &#x003b1;-helical conformation
is described as a broken &#x003b1;-helix with an antiparallel helical
conformation (from aa &#x0223c;3&#x02013;37 and aa &#x0223c;45&#x02013;92)
when bound to SDS micelles.<xref rid="ref62" ref-type="bibr"/> In contrast,
in the presence of small laminar vesicles (with a larger diameter
compared to SDS micelles), aSyn adopts a continuous, extended &#x003b1;-helical
conformation.<xref rid="ref71" ref-type="bibr"/> It would be interesting
to investigate the influence of aSyn truncations and pE-modifications
on &#x003b1;-helical adaptations in the presence of small laminar vesicles
to gain more detailed insight into aSyn-membrane interactions in physiological
and pathological conditions. However, lipid binding associated with
an &#x003b1;-helical conformation of aSyn inhibits its fibril formation.<named-content content-type="bibref-group">
<xref rid="ref69" ref-type="bibr"/>,<xref rid="ref70" ref-type="bibr"/>
</named-content> This is highlighted by the pE79-aSyn variant, which lacks most of
the aa implicated in &#x003b1;-helix formation due to truncation, thus
limiting the &#x003b1;-helical conformation. Within the amino acid sequence
of the pE79-aSyn variant, the residues for transient &#x003b2;-strand
conformation are present (101&#x02013;140), potentially allowing oligomerization
to occur.<xref rid="ref62" ref-type="bibr"/> For all aSyn variants analyzed,
except of pE79-aSyn, an isosbestic point was observed, indicating
that the stoichiometry of secondary structure elements remained unchanged
during the temperature change.<xref rid="ref66" ref-type="bibr"/>
</p></sec><sec id="sec3.3"><title>Dimeric
FL-aSyn and pE-aSyn Variants&#x0e5f8;the Smallest Oligomer</title><p>To the best of our knowledge, for the first time, a SAXS-data based
model of the dimeric state of FL-aSyn is proposed. The integrative
approach combining AUC and upstream SEC prior to SAXS analysis allowed
the separation of different aggregation states of FL-aSyn and of pE-aSyn
variants, respectively. Other studies have also been able to detect
the dimeric peak of aSyn in SEC, but either combined the data collection
with the monomeric fraction<xref rid="ref72" ref-type="bibr"/> or focused
on the overall shape of the oligomers.<xref rid="ref73" ref-type="bibr"/> Here, the separation of peaks and the analysis of their SAXS curves
indicated an <italic toggle="yes">R</italic>
<sub>g</sub> for the FL-aSyn dimer
of 39.5 &#x000c5; with a <italic toggle="yes">D</italic>
<sub>max</sub> of 154 &#x000c5;,
thereby confirming simulated <italic toggle="yes">R</italic>
<sub>g</sub> values
with 50.3 &#x000c5; for aSyn dimers of Savva and Platts (2024). Compared
with the experimental <italic toggle="yes">R</italic>
<sub>g</sub> of 36.7 &#x000c5;
and <italic toggle="yes">D</italic>
<sub>max</sub> of 145 &#x000c5; for the FL-aSyn
monomer, the size of the dimer did not increase significantly. Moreover,
the frictional ratio decreased significantly from monomer to dimer
from 1.8 to 1.6. The comparative analysis of these values indicates
the existence of an intermediate state for the dimer between the mostly
unfolded and folded states.</p><p>Interestingly, the observation of
predominantly unstructured aSyn dimers with partial local structures
was also reported by others.<xref rid="ref74" ref-type="bibr"/> A more detailed
analysis of the aSyn dimer conformation was recently performed by
computational simulation under consideration of two aSyn monomers,
so-called chains, showing intrachain &#x003b2;-hairpins consistent with
antiparallel &#x003b2;-strands between residues V63-T72 in the NAC region
(ChainA: T64-V71 and ChainB: V63-A69). Between the two hairpins, an
interchain interaction was observed.<xref rid="ref75" ref-type="bibr"/> Transferred
to the shape of dimeric FL-aSyn described here, this interchain interaction
may represent the connecting link to build a head-to-tail assembly
of the monomer. The EOM modeling, based on this hypothesis of a short
&#x003b2;-strand connector, highlights a transition from an extended,
flexible, and unstructured monomer to a more compact dimer, which
thereby is the smallest oligomer known for FL-aSyn.<xref rid="ref76" ref-type="bibr"/>
</p><p>For pE62-aSyn, an accelerated fibrillation rate was
described here.
However, despite reducing the experimental aggregation time for pE62-aSyn
from 5 to 0.5 h, neither a dimeric nor an oligomeric fraction was
detected in addition to the monomeric fraction in the SEC chromatogram
(see <xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig"/>
</xref>a), while
contradictory additional peaks were detected by AUC. The aSyn truncation
at position Q62 and thus the N-terminal part of the pE62-aSyn variant
is directly located at the beginning of the NAC region close to position
V63-T72, where the &#x003b2;-hairpin and interchain interactions can
be formed. Through the loss of steric hindrance of the N-terminus
by truncation, a gain of aggregation-promoting properties with regard
to dimerization/fibrillation can be hypothesized. These results are
supported by the assumption of a protective role of the aSyn N-terminus
against fibrillation.<xref rid="ref67" ref-type="bibr"/>
</p><p>For pE79-aSyn,
a dimeric state was detected by SAXS analysis but
not by AUC. Nevertheless, it would be interesting to analyze the overall
shape of this variant in future studies, as the conformers and interchain
interactions described for FL-aSyn would not be applicable to this
variant due to the truncation and partially missing NAC domain, so
other forms of interactions might be implicated in dimer formation.</p></sec><sec id="sec3.4"><title>aSyn Dimers as a Potential Therapeutic Target or as a Biomarker</title><p>The formation of dimers represents a potentially initial and crucial
step in aSyn aggregation to toxic oligomers or fibrils. A recent finding
underscoring this, is the 5-fold higher binding affinity of aSyn dimers
for aSyn fibril ends compared to monomeric aSyn.<xref rid="ref77" ref-type="bibr"/> Thus, alterations in the formation, stability, or dissociation
of the dimers can influence the overall dynamics of aSyn aggregation.
For example, an <italic toggle="yes">in silico</italic> study on graphene quantum
dots accurately indicated a possible inhibition of aSyn dimerization
by disrupting interchain interactions, leading to a looser and more
unstable oligomeric conformation.<xref rid="ref78" ref-type="bibr"/> Another
therapeutic approach has been developed with covalent aSyn dimers,
exploiting the higher binding affinity of the dimers at fibril ends.
These covalent aSyn dimers were designed to bind fibril ends but block
further growth, thereby slowing down the progression of PD.<xref rid="ref77" ref-type="bibr"/> In addition, nonpeptide oxazole-based prolyl
oligopeptidase inhibitors have been shown to reduce aSyn dimerization.
When applied in <italic toggle="yes">in vivo</italic> studies in mice with aSyn
pathology, motor impairment was reversed and levels of oligomeric
aSyn were reduced in specific brain regions.<xref rid="ref79" ref-type="bibr"/> Furthermore, the relevance of the aSyn dimer was also highlighted
by the work of Papagiannakis <italic toggle="yes">et al.</italic> (2018), where
the amount of aSyn dimers and the dimer/monomer ratio in erythrocyte
membranes were suggested as a diagnostic tool for patients with genetic
and nongenetic forms of PD.<xref rid="ref80" ref-type="bibr"/> Taken together,
aSyn dimers may serve as a new target for future therapies and biomarkers
in PD research.</p></sec><sec id="sec3.5"><title>Higher Oligomeric States of FL-aSyn and pE-aSyn
Variants</title><p>The described aSyn dimer is the starting unit for
further oligomerization
as suggested by AUC (see <xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig"/>
</xref>) resulting in the stacking assembly comparable to
the previously published structure.<xref rid="ref61" ref-type="bibr"/> AUC
analysis did not allow for the detection of larger aggregates as most
of them had sedimented during the acceleration phase of the experiment,
however, they could be explored to some extent using SAXS. The <italic toggle="yes">R</italic>
<sub>g</sub> values for FL-aSyn, pE24-aSyn, and pE79-aSyn
were of 60&#x02013;64 &#x000c5; and <italic toggle="yes">D</italic>
<sub>max</sub> of
173&#x02013;220 &#x000c5; and the corresponding Kratky plots clearly indicate
that this oligomeric state exhibit folding and a more compact shape.</p><p>In line with this, the <italic toggle="yes">ab initio</italic> modeled FL-aSyn
oligomer (see <ext-link xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acschemneuro.5c00106/suppl_file/cn5c00106_si_001.pdf" ext-link-type="uri">Figure S4</ext-link>) showed the shape
of an annular structure, comparable to the shape of the oligomer of
pE24-aSyn, which resembles a corkscrew. These results are consistent
with the low-resolution SAXS model of Giehm <italic toggle="yes">et al.</italic> (2011), where a high protein concentration similar to this study
was used to determine a so-called &#x0201c;wreath-shaped oligomer&#x0201d;
with <italic toggle="yes">D</italic>
<sub>max</sub> of 180 &#x000b1; 30 &#x000c5;.<xref rid="ref72" ref-type="bibr"/> Furthermore, those results agree with the observation
of morphological studies employing high-resolution atomic force microscopy
(AFM) and electron microscopy (EM), which indicated pore-like structures
of oligomeric aSyn. While using AFM, an outer diameter of an aSyn
pore of 160 &#x000c5; was calculated<xref rid="ref81" ref-type="bibr"/> whereas
EM revealed an average diameter of 100&#x02013;120 &#x000c5; of a porous
structure derived from a mutated form of aSyn (A30P or A53P).<xref rid="ref73" ref-type="bibr"/> All of these descriptions of distinct oligomeric
states might however only be considered as snapshots of a whole array
of possible heterogeneous mixtures of species.<named-content content-type="bibref-group">
<xref rid="ref59" ref-type="bibr"/>,<xref rid="ref82" ref-type="bibr"/>
</named-content>
</p><p>The estimated number of monomers per oligomer may vary, depending
on the preparation protocol. Previously published data suggested &#x0223c;16
monomers by SAXS analysis,<xref rid="ref72" ref-type="bibr"/> 20&#x02013;25
monomers by gel filtration,<xref rid="ref83" ref-type="bibr"/> 14&#x02013;50
monomers by fluorescence intensity distribution analyses,<xref rid="ref84" ref-type="bibr"/> &#x0223c;20 monomers by fluorescence correlation
spectroscopy<xref rid="ref85" ref-type="bibr"/> and 11&#x02013;39 monomers
by nanopore-based, single-particle characterization, respectively.<xref rid="ref59" ref-type="bibr"/>
</p><p>For FL-aSyn, pE62-aSyn, and pE79-aSyn<xref rid="ref49" ref-type="bibr"/> significant cytotoxic potential of oligomeric
aggregates, and for
pE24-aSyn a tendency of reduced cell viability was observed in differentiated
neuronal SH-SY5Y cells (see <xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig"/>
</xref>b and for pE79-aSyn<xref rid="ref49" ref-type="bibr"/>).
It is hypothesized, that the central channel of these oligomers has
the potential to form a pore that can permeabilize the membrane.<named-content content-type="bibref-group">
<xref rid="ref86" ref-type="bibr"/>,<xref rid="ref87" ref-type="bibr"/>
</named-content> This membrane permeabilization was confirmed by <italic toggle="yes">in vitro</italic> experiments showing liposome disruption by the purified aSyn oligomers.<xref rid="ref88" ref-type="bibr"/> It can be hypothesized that the data analyzed
here correspond to the described amyloid pore and underline a possible
formation of toxic porous structures by the oligomeric states of aSyn.</p></sec></sec><sec id="sec4"><title>Conclusions</title><p>The characterization of the biophysical
properties of aSyn self-assembly
intermediates is essential for a better understanding of the structure&#x02013;toxicity
relationship. Our integrative strategy provided a series of observations
highlighting a variety of different structural characteristics among
the FL-aSyn and pE-aSyn variants. SRCD performed at temperatures ranging
from 27 to 97 &#x000b0;C revealed (i) the intrinsically disordered nature
and (ii) the reversibility of the heating process for all variants
in solution, except for pE62-aSyn, since the latter variant rapidly
evolved toward fibrillation. This instant fibril formation, occurring
even after short agitation time, may contribute to the toxicity and
seeding properties of pE62-aSyn compared to FL-aSyn and analysis of
fibril characteristics should be included in future studies. Furthermore,
all aSyn variants investigated, except pE79-aSyn, exhibited a capacity
to form &#x003b1;-helical content upon interaction with SDS micelles
mimicking a membrane environment. Apparently, the phenomenon was dependent
on the length of the (pE)-aSyn variant, with the shortest variant,
pE79-aSyn, showing significantly less &#x003b1;-helical content. This
impaired structural adaptation in the presence of membrane-like structures
might indicate a loss-of-function of these pE-modified aSyn forms
as compared to FL-aSyn in physiological processes such as presynaptic
vesicle fusion.</p><p>The formation of aSyn dimers is very likely
to represent the initial
and crucial step of oligomerization and further aggregation/fibrillation.
To the best of our knowledge, these are the first structural data
on FL-aSyn and pE-aSyn dimers obtained by SAXS. The analysis of larger
oligomeric shapes proved to be more challenging due to the low concentration
of these populations, their heterogeneity, and the resulting weak
signal-to-noise ratio. Nevertheless, the <italic toggle="yes">ab initio</italic> modeling of these oligomers observed for FL-aSyn and two pE-aSyn
variants seems consistent with previous SAXS analysis. This, in combination
with the cytotoxic potential of oligomeric (pE)-aSyn states, underlines
the amyloid pore hypothesis of aSyn oligomers.</p></sec><sec id="sec5"><title>Materials
and Methods</title><sec id="sec5.1"><title>Expression and Purification of aSyn Proteins</title><p>In order
to prepare the respective recombinant FL- and pE-modified aSyn proteins
(<xref rid="fig8" ref-type="fig">Figure <xref rid="fig8" ref-type="fig"/>
</xref>a), these
aSyn variants were expressed in <named-content content-type="genus-species">Escherichia coli</named-content> employing four different pGEX-4T-1 vectors encoding the gene of
human FL-aSyn, Q24-140-aSyn, Q62-140-aSyn, or Q79-140-aSyn proteins,
fused in 5&#x02032; with a sequence coding for His<sub>6</sub> and
GST tags for protein purification and TEV protease cleavage site,
to allow for N-terminal Q generation (<xref rid="fig8" ref-type="fig">Figure <xref rid="fig8" ref-type="fig"/>
</xref>b).</p><fig position="float" id="fig8" fig-type="figure"><label>8</label><caption><p>Schematic representation of (pE)-aSyn variants
of interest and
simplified depiction of the transformation plasmid for expression
and purification of recombinant proteins. (a) Generation of FL-aSyn
and pE-aSyn variants by truncation followed by QC-catalyzed pE cyclization
resulting in pE24-aSyn, pE62-aSyn, and pE79-aSyn. (b) FL-aSyn as well
as pE-modified aSyn variants are expressed in <named-content content-type="genus-species">E. coli</named-content> from pGEX-4T-1 vectors encoding Q24-aSyn, Q62-aSyn, and Q79-aSyn
fused to a TEV protease cleavage site (to allow for N-terminal Q generation)
and to His<sub>6</sub> and GST tags for protein purification. Proteins
expressed were first purified on a Ni-NTA column, followed by a glutathione
sepharose column. Subsequently proteins were cleaved by TEV protease,
incubated with QC to catalyze pE formation, and finally purified on
a RP column. GST: glutathione-S-transferase; NTA: nickel-nitrilotriacetic
acid; TEV: tobacco etch virus; QC: glutaminyl cyclase; RP: reversed
phase; His<sub>6</sub>: polyhistidine.</p></caption><graphic xlink:href="cn5c00106_0008" id="gr8" position="float"/></fig><p>The recombinant expression was described in detail
previously.<xref rid="ref89" ref-type="bibr"/> The first step of purification
included Ni<sup>2+&#x02011;</sup>chelating chromatography on Streamline
Chelating
resin (Streamline Chelating, GE Healthcare Life Sciences, Uppsala,
Sweden). Fractions containing the expression construct were further
purified via glutathione sepharose resin (Glutathione Sepharose 4FF,
GE Healthcare Life Sciences). The removal of the glutathione residue
was performed by overnight dialysis against a buffer containing 100
mM NaCl, 30 mM Tris/HCl pH 7.6, 0.1 mM DTT, and using a 6&#x02013;8
kDa cutoff membrane. To obtain a native N-terminus, the GST- and His-tag
were separated from the aSyn by TEV protease cleavage.<xref rid="ref90" ref-type="bibr"/> Subsequent cyclization of the Q-aSyn variants
to pE-aSyn was achieved by incubation with QC (1 &#x003bc;g human QC
per 1 mg peptide) overnight at room temperature, resulting in pE24-aSyn,
pE62-aSyn, and pE79-aSyn (<xref rid="fig8" ref-type="fig">Figure <xref rid="fig8" ref-type="fig"/>
</xref>). The reaction products were subjected to reverse
phase chromatography (Source 15 RPC, GE Healthcare Life Sciences),
followed by lyophilization and anion exchange chromatography (MonoQ
5/50GL, GE Healthcare Life Sciences). The purity of the samples was
assessed by SDS PAGE and mass spectrometry (not shown). Protein concentrations
of FL-aSyn, pE24-aSyn, pE62-aSyn, and pE79-aSyn were determined using
UV absorption at 280 nm. Finally, the lyophilized protein variants
were stored at &#x02212;20 &#x000b0;C.</p></sec><sec id="sec5.2"><title>Aggregation of Recombinant
FL-aSyn and pE-aSyn Proteins</title><p>To ensure a seedless starting
point at <italic toggle="yes">t</italic> = 0, samples
were treated with 1,1,1,3,3,3-hexafluoro-2-propanol and were aliquoted
prior to aggregation.<xref rid="ref91" ref-type="bibr"/> For SAXS and AUC
analysis, aSyn samples were prepared according to the modified aggregation
protocol of Paslawski <italic toggle="yes">et al.</italic> (2016).<xref rid="ref92" ref-type="bibr"/> Specifically, aliquoted samples were resuspended in 20
mM Tris/HCl pH 7.2 buffer with 100 mM NaCl to a final concentration
of 12 mg/mL and shaken at 900 rpm at 37 &#x000b0;C for 5 h (Grant Instruments
PCMT Thermoshaker, ThermoFisher Scientific). The agitation time of
pE62-aSyn was reduced to 30 min because of the instant fibril formation.
For removal of insoluble, fibrillary protein aggregates, samples were
centrifuged at 10,000<italic toggle="yes">g</italic>, 4 &#x000b0;C for 10 min. For
further analysis, the supernatant was transferred to a new tube and
stored at 4 &#x000b0;C for up to 7 days.</p></sec><sec id="sec5.3"><title>DLS and Static Light Scattering
(SLS)</title><p>Resuspended samples
were ultracentrifuged at 120,000<italic toggle="yes">g</italic>, 4 &#x000b0;C for
30 min (S45A rotor in Sorvall Hitachi Discovery M150E micro ultracentrifuge).
For each protein solution, 8 &#x003bc;L of the supernatant were transferred
into Wyatt disposable plastic microcuvettes, and scattered light was
collected at 20 &#x000b0;C using a DynaPro Nanostar I light scattering
instrument (Wyatt Technology, Santa Barbara, CA, USA) equipped with
a modular He&#x02013;Ne laser (10 to 100 mW) emitting at &#x003bb; =
659 nm. Five measurements, each composed of 5 acquisitions for 5 s,
were recorded at 20 &#x000b0;C and processed using DYNAMICS, version
7.8.1.3. (Wyatt Technology). Autocorrelation functions were analyzed
using the so-called regularization fitting algorithm in order to extract
characteristic times (hence, translational diffusion coefficients
Dt) and amplitudes of the components in protein solutions. Hydrodynamic
radii <italic toggle="yes">R</italic>
<sub>H</sub> of the corresponding species
were then calculated using the Stokes&#x02013;Einstein equation and
size distributions were reported along with the polydispersity of
each peak. Solvent refractive index (<italic toggle="yes">n</italic> = 1.351) and
dynamic viscosity (&#x003b7; = 1.463 cP) needed for the Stoke&#x02013;Einstein
calculations were estimated using Malvern Panalytical DLS software,
version 8, and the protein particle increment of the refractive index
(d<italic toggle="yes">n</italic>/d<italic toggle="yes">C</italic>) was assumed to be 0.185
mL/g.</p></sec><sec id="sec5.4"><title>SEC-MALS</title><p>Resuspended samples were immediately centrifuged
at 27,000<italic toggle="yes">g</italic>, 4 &#x000b0;C for 15 min and were filtered
by a Whatman PVDF filter device (pore size 0.2 &#x003bc;m) before measurements.
SEC was coupled to a triple detection (concentration detector: UV
detector and refractometer; static light scattering at 7 and 90&#x000b0;;
viscometer) on an Omnisec RESOLVE and REVEAL instrument (Malvern Panalytical).
Running buffer (20 mM Tris/HCl pH 7.2 with 100 mM NaCl) was filtered
through 0.2 nm filters (Filtermax TPP) before equilibration of the
column and detectors. Proteins were injected on a Yarra SEC 3000 column
(Phenomenex, Aschaffenburg, Germany) at 20 &#x000b0;C. Samples were eluted
at 0.5 mL/min after injection of a 100 &#x003bc;L sample at 5 mg/mL.
External calibration was done with bovine serum albumin (BSA) (Sigma
ref A1900) using an injection of 10 &#x003bc;L at 18.3 mg/mL. The refractive
index, static light scattering, and viscosity measurements were processed
to determine the average molecular mass and the intrinsic viscosity
using the OMNISEC V11.30 software (Malvern Panalytical, U.K.).</p></sec><sec id="sec5.5"><title>SRCD</title><p>SRCD spectra were recorded on the DISCO beamline<xref rid="ref93" ref-type="bibr"/> at SOLEIL synchrotron (Saint-Aubin, France).
The experimental setup was calibrated for magnitude and polarization
with a 5.9 mg/mL <sc>d</sc>-10-camphorsulfonic acid solution. Four
&#x003bc;L of FL-aSyn and of respective pE-aSyn variant solutions around
12 mg/mL were transferred to a CaF2 cuvette with an optical path of
27 &#x003bc;m. Three spectra from 180 to 262 nm were recorded at temperatures
ranging from 27 to 97 &#x000b0;C in increments of 5 &#x000b0;C.</p><p>An
equal volume of 200 mM SDS solution was added to the samples, resulting
in a final SDS concentration of 100 mM to mimic a membranous environment.
Indeed, in the presence of 100 mM NaCl, the critical micellar concentration
of SDS was estimated to be 2 mM,<xref rid="ref94" ref-type="bibr"/> which
would guarantee the presence of micelles in conditions described here
similar to those utilized in a previous NMR study.<xref rid="ref68" ref-type="bibr"/>
</p><p>Spectra were averaged, scaled, and normalized to
molar ellipticities
after solvent baseline subtraction using CDtoolX.<xref rid="ref95" ref-type="bibr"/> A data cutoff at 180 nm was applied based on photomultiplier
high-tension viability. Secondary structure prediction was estimated
from SRCD spectra using Web server BESTSEL (v1.3.230210).<xref rid="ref96" ref-type="bibr"/> Using BESTSEL, &#x003b1;-helices are distinguished
in regular helices with a middle part of &#x003b1;-helices and distorted
helices with two or two residues at the ends. For &#x003b2;-strands,
four subcategories are defined: (i) parallel &#x003b2;-strand, and antiparallel
&#x003b2;-strand of three different twists: (ii) left-hand twisted,
(iii) relaxed (slightly right-hand twisted), and (iv) right-hand twisted,
respectively. Further secondary structure elements are turns or unstructured
regions.<named-content content-type="bibref-group">
<xref rid="ref96" ref-type="bibr"/>,<xref rid="ref97" ref-type="bibr"/>
</named-content>
</p></sec><sec id="sec5.6"><title>SEC-SAXS</title><p>SEC-SAXS experiments were
performed on the
SWING beamline at the SOLEIL synchrotron (Saint-Aubin, France).<xref rid="ref98" ref-type="bibr"/> The beam wavelength was &#x003bb; = 1.033 &#x000c5;.
The Eiger X 4 M detector (Dectris) was positioned at a distance of
2000 mm from the sample with the direct beam off-centered. The resulting
exploitable <italic toggle="yes">q</italic>-range was 0.005&#x02013;0.5 &#x000c5;<sup>&#x02013;1</sup>, where the wave vector <italic toggle="yes">q</italic> = 4&#x003c0;sin
(&#x003b8;)/&#x003bb; and 2&#x003b8; is the scattering angle.</p><p>The
SEC-SAXS setup is illustrated in <ext-link xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acschemneuro.5c00106/suppl_file/cn5c00106_si_001.pdf" ext-link-type="uri">Figure S1</ext-link>.<xref rid="ref99" ref-type="bibr"/> Prior to analysis, agitated samples
were diluted with SEC running buffer 50 mM Tris/HCl pH 7.2 buffer
with 200 mM NaCl to a total volume of 110 &#x003bc;L and were filtered
by a Whatman PVDF filter device (pore size 0.2 &#x003bc;m). In <ext-link xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acschemneuro.5c00106/suppl_file/cn5c00106_si_001.pdf" ext-link-type="uri">Table S1</ext-link>, the exact volume of protein solution
loaded onto the Yarra SEC 3000 column (Phenomenex, Aschaffenburg,
Germany) installed on an Agilent HPLC system (20 &#x000b0;C) is described.
Proteins were eluted at a flow rate of 0.3 mL/min. The eluates were
analyzed by SAXS in a continuous flow capillary cell with a frame
duration of 2990 ms at intervals of 10 ms.</p><p>Data processing was
performed using Foxtrot<xref rid="ref98" ref-type="bibr"/> and data analysis
was conducted with the ATSAS 4.0.1 and
BioXTAS-RAW 2.3.0<named-content content-type="bibref-group">
<xref rid="ref100" ref-type="bibr"/>,<xref rid="ref101" ref-type="bibr"/>
</named-content> packages. Peak deconvolution
and baseline correction were performed in BioXTAS-RAW when required.
Radii of gyration (<italic toggle="yes">R</italic>
<sub>g</sub>) were derived from
Guinier approximation and used to estimate the molecular weight based
on various approaches: the Porod volume (<italic toggle="yes">V</italic>
<sub>p</sub>),<xref rid="ref102" ref-type="bibr"/> volume-of-correlation (<italic toggle="yes">V</italic>
<sub>c</sub>),<xref rid="ref103" ref-type="bibr"/> as well as Bayesian
inference with the molecular weight calculations (datmw Bayes).<xref rid="ref104" ref-type="bibr"/>
<italic toggle="yes">R</italic>
<sub>g</sub> and maximal
dimension (<italic toggle="yes">D</italic>
<sub>max</sub>) were also calculated
using the indirect transform package GNOM,<xref rid="ref105" ref-type="bibr"/> which provides the distance distribution function <italic toggle="yes">p</italic>(<italic toggle="yes">r</italic>) of the particle. All of the values derived from
these analyses are shown in <ext-link xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acschemneuro.5c00106/suppl_file/cn5c00106_si_001.pdf" ext-link-type="uri">Table S1</ext-link>.</p><p>EOM 3.0 (Ensemble Optimization Method)<named-content content-type="bibref-group">
<xref rid="ref106" ref-type="bibr"/>,<xref rid="ref107" ref-type="bibr"/>
</named-content> was used to generate extended flexible atomic models of monomers
and dimers of FL-aSyn and pE-aSyn variants (10,000 models of each)
and to search for ensembles of 20&#x02013;50 models that collectively
reproduce corresponding SAXS curves. <italic toggle="yes">Ab initio</italic> modeling
was performed with GASBOR for shape reconstruction by a chain-like
ensemble of dummy residues (<ext-link xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acschemneuro.5c00106/suppl_file/cn5c00106_si_001.pdf" ext-link-type="uri">Figure S3</ext-link>)
and DAMMIF (Dummy Atom Modeling Minimization Fast) for shape determination
based on single phase dummy atom models (<ext-link xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acschemneuro.5c00106/suppl_file/cn5c00106_si_001.pdf" ext-link-type="uri">Figure S4</ext-link>).<xref rid="ref108" ref-type="bibr"/> Series of 30 models were
produced with either software and were aligned using DAMAVER<xref rid="ref109" ref-type="bibr"/> to select the most representative model of
each series for comparison with other aSyn variants. Models were visualized
with PyMOL Molecular Graphics Systems (Version 3.0 Schr&#x000f6;dinger,
LLC).</p></sec><sec id="sec5.7"><title>AUC</title><p>Comparable to SAXS analysis, agitated samples were
diluted with SEC running buffer 50 mM Tris/HCl pH 7.2 buffer with
200 mM NaCl to a total volume of 110 &#x003bc;L prior to AUC measurements.
An additional measurement was carried out with doubled concentration.
FL-aSyn, pE24-aSyn, pE62-aSyn, and pE79-aSyn proteins were centrifuged
at 42,000 rpm in an Optima AUC analytical ultracentrifuge (Beckman
Coulter), at 20 &#x000b0;C using an 8-hole AN 50&#x02013;Ti rotor equipped
with 3 mm double-sector Epon charcoal center pieces. The concentrations
of the individual macromolecules were chosen to be detectable by the
AUC equipment without saturating the detectors. Detection of the biomolecule
concentration as a function of the radial position and time was performed
by interference detection. Sedimentation velocity data analysis was
performed by continuous size distribution analysis c(s) using Sedfit
16.36 software.<xref rid="ref110" ref-type="bibr"/> All of the c(s) distributions
were calculated with a fitted fractional ratio <italic toggle="yes">f</italic>/<italic toggle="yes">f</italic>
<sub>0</sub> and a maximum entropy regularization procedure
with a confidence level of 0.68. The detected peaks were integrated
to obtain sedimentation values and the percentage of each detected
species. Frictional ratios were calculated from the sedimentation
coefficient and the known molecular mass by using the Svedberg equation.
Buffer viscosity and density were calculated from Sednterp 3.0.4 software.
Partial specific volumes and theoretical monomer molecular weight
were also determined with Sednterp 3.0.4 (<ext-link xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acschemneuro.5c00106/suppl_file/cn5c00106_si_001.pdf" ext-link-type="uri">Table S2</ext-link>).</p></sec><sec id="sec5.8"><title>Toxicity Assay of Monomeric and Oligomeric
FL-aSyn and pE-aSyn
Variants in Differentiated SH-SY5Y Neuroblastoma Cells</title><p>The
potential cytotoxic effects of monomeric FL-aSyn, pE24-aSyn, and pE62-aSyn
and their corresponding oligomers on SH-SY5Y neuroblastoma cells were
assessed using a WST-1 assay (ThermoFisher, Darmstadt, Germany).</p><p>To generate FL-aSyn and pE-aSyn oligomers, an aggregation assay was
performed as previously described.<xref rid="ref111" ref-type="bibr"/> Recombinant
FL-aSyn, pE24-aSyn, or pE62-aSyn was prepared for agitation to a final
concentration of 250 &#x003bc;M in aggregation buffer (20 mM Tris/HCl,
100 mM NaCl, pH 7.0) and incubated with 20 &#x003bc;M ThT for monitoring
fibril formation or without ThT in parallel for subsequent purification.
Monomeric protein was incubated in a 96-well plate using a CLARIOstar
plate reader (BMG Labtech) with continuous shaking at 300 rpm and
37 &#x000b0;C, and signals were recorded at 15-min intervals. The excitation
and emission wavelengths were 440 and 490 nm, respectively. Analyses
of the obtained aggregation curves were conducted according to Hortschansky <italic toggle="yes">et al.</italic>
<xref rid="ref112" ref-type="bibr"/>
</p><p>Aggregated samples
of FL-aSyn, pE24-aSyn, or pE62-aSyn were taken
in the lag phase at different time points depending on the aggregation
velocity (FL-aSyn: 7 h, pE24-aSyn: 7 h, and pE62-aSyn: 1 h; see <xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig"/>
</xref>a) and purified by
SEC. The samples were centrifuged at 17,000<italic toggle="yes">g</italic> for
12 min to remove large aggregated particles. The supernatants were
diluted in PBS (pH 7.0) to a total volume of 250 &#x003bc;L, and subsequently
loaded at a flow rate of 0.8 mL/min onto a Superdex 75 Increase 10/300
GL column on an &#x000c4;KTA avant 25 system (Cytiva, Freiburg, Germany).
The eluted peaks were monitored at 220 and 280 nm.</p><p>SH-SY5Y cells
were grown in Dulbecco&#x02019;s modified Eagle&#x02019;s
medium (DMEM) medium supplemented with 10% fetal bovine serum (FBS)
at 37 &#x000b0;C and 10% CO<sub>2</sub>. To induce differentiation toward
a neuronal phenotype, 1.83 &#x000d7; 10<sup>4</sup> cells/well were seeded
in a transparent 96-well plate, and the medium was changed to DMEM
supplemented with 5% FBS and 10 &#x003bc;M all-trans retinoic acid (ThermoFisher,
Darmstadt, Germany) for 3 days. The medium was further exchanged to
Neurobasal-A medium without phenol red, supplemented with 1% (v/v)
Glutamax, 1% (v/v) N-2 supplement (ThermoFisher, Darmstadt, Germany),
and human BDNF (ThermoFisher, Darmstadt, Germany) at a concentration
of 50 ng/mL (v/v) for additional 4 days. On day 7 of differentiation,
the assay was carried out according to the manufacturer&#x02019;s protocol.
In brief, the cells were exposed to different aSyn proteins and aggregation
states and cultured at 37 &#x000b0;C in a humidified atmosphere containing
10% CO<sub>2</sub> for 72 h. Afterward, 10% WST-1 was added to the
cell medium and incubated for 30 min. The absorbance was determined
at 440 nm using a plate reader (Tecan Sunrise, Switzerland). The values
were normalized to the PBS control and directly correlated to the
number of viable cells. Corresponding data for pE79-aSyn have been
previously published and can be accessed at ref <xref rid="ref49" ref-type="bibr" specific-use="ref-style=base-text"/>.</p></sec></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material id="sifile1" position="float" content-type="local-data"><media xlink:href="cn5c00106_si_001.pdf"/></supplementary-material></sec></body><back><ack id="ACK-d14e1446-autogenerated"><p>The authors thank the teams of Institut
Pasteur, SWING-SAXS,
and DISCO-SRCD beamlines at Synchrotron SOLEIL for the beamtime allocation
and support to Proposal No. 20221032, and the MBIOFAST platform of
biophysics from IBMC. Further, the authors thank Julien Petit for
the Python interface for data processing of circular dichroism data
from the DISCO line. This work was supported by the German Research
Foundation (DFG grant #RO2226/13-1 to S.R.), the French Centre National
de la Recherche Scientifique (CNRS to C.S.), the University of Strasbourg
Institute of Advanced Science (USIAS-W21RSAUT to C.S.), and the LabEx
consortia &#x0201c;NetRNA&#x0201d; (ANR-10-LABX-0036_NETRNA to C.S.).
This project has received funding from the European Union&#x02019;s
Horizon 2020 Research and Innovation Programme under grant agreement
No. 101004806. A.B. received a Predoc Award funded by the Research
Academy of Leipzig University and funds have been provided by Alzheimer
Forschung Initiative e.V.</p></ack><notes id="notes-4" notes-type="data-availability"><p>The data
sets
used and analyzed during the current study are available from the
corresponding author on reasonable request.</p></notes><notes id="notes-3" notes-type="si"><p>The Supporting Information
is available free of charge at <ext-link xlink:href="https://pubs.acs.org/doi/10.1021/acschemneuro.5c00106?goto=supporting-info" ext-link-type="uri">https://pubs.acs.org/doi/10.1021/acschemneuro.5c00106</ext-link>.<list list-type="simple" id="silist"><list-item><p>Principle of the SEC-SAXS
setup (Figure S1); ensemble
modeling of monomers of FL-aSyn and pE-aSyn variants performed using
EOM 3.0 suite (Figure S2); <italic toggle="yes">ab initio</italic> reconstructions
of monomers and dimers of FL-aSyn and pE-aSyn variants (Figure S3); <italic toggle="yes">ab initio</italic> modeling of oligomeric states of FL-aSyn and pE-aSyn
variants based on SAXS data (Figure S4); structural parameters of
SEC-SAXS data analysis (Table S1); Biophysical constants used to analyze
AUC data (Table S2); Supporting data: EOM-aSyn-models.zip: archive
containing model ensembles generated with EOM to fit the SAXS curves
displayed in <xref rid="fig5" ref-type="fig">Figures <xref rid="fig5" ref-type="fig"/>
</xref> and S2, as well as spreadsheets with the experimental data and the
curves computed from the corresponding ensembles (FLmono, FLdimer,
pE24mono, pE62mono, pE79mono) in standard ODS format (<ext-link xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acschemneuro.5c00106/suppl_file/cn5c00106_si_001.pdf" ext-link-type="uri">PDF</ext-link>)</p></list-item></list>
</p></notes><notes id="notes-2" notes-type="author-contributions"><p>A.B. contributed
to conceptualization, funding acquisition, data curation, and visualization,
while also contributing to writing&#x0e5f8;original draft preparation.
W.X. provided resources and participated actively in writing&#x0e5f8;review
and editing. F.W. supported the project through data curation, formal
analysis, and methodology, as well as providing resources and software
expertise. A.T. played a key role in data curation, formal analysis,
and methodology, while also contributing to resources and software
development. M.C. was involved in data curation, formal analysis,
and methodology, while also contributing to resources and software
development. B.R. was involved in data curation, formal analysis,
and methodology, providing resources, software, and visualization
efforts. S.G. and M.W. contributed to investigation. S.S. contributed
to conceptualization, project administration, and funding acquisition.
P.B.&#x02019;s contributions focused on data curation, formal analysis,
methodology, and resources. M.H.-R. participated in conceptualization
and contributed to the writing&#x0e5f8;review and editing process.
A.S. contributed to conceptualization, investigation, and resources,
in addition to supervising the project and participating in funding
acquisition and writing&#x0e5f8;review and editing. C.S. contributed
to multiple aspects of the project, including conceptualization, funding
acquisition, investigation, and supervision, along with data curation,
formal analysis, methodology, resources, software, visualization,
and writing&#x0e5f8;review and editing. S.R. took charge of project
administration and supervision, conceptualization, funding acquisition,
and writing&#x0e5f8;review and editing.</p></notes><notes id="notes-6" notes-type="disclosure"><p>All the authors have
approved publication.</p></notes><notes id="notes-5" notes-type="conflict-of-interest"><p>The authors
declare no competing financial interest.</p></notes><notes id="notes-1" notes-type="author-status"><label>&#x025cb;</label><p>Shared senior
authors.</p></notes><glossary><def-list id="dl1"><title>List of Abbreviations</title><def-item><term>aSyn</term><def><p>&#x003b1;-synuclein</p></def></def-item><def-item><term>AUC</term><def><p>analytical ultracentrifugation</p></def></def-item><def-item><term>pE</term><def><p>pyroglutamate</p></def></def-item><def-item><term>SEC</term><def><p>size exclusion
chromatography</p></def></def-item><def-item><term>SAXS</term><def><p>small-angle X-ray scattering</p></def></def-item><def-item><term>SRCD</term><def><p>synchrotron radiation
circular
dichroism</p></def></def-item></def-list></glossary><ref-list><ref id="ref1"><element-citation publication-type="journal" id="cit1"><name><surname>Br&#x000e1;s</surname><given-names>I. C.</given-names></name><name><surname>Dominguez-Meijide</surname><given-names>A.</given-names></name><name><surname>Gerhardt</surname><given-names>E.</given-names></name><name><surname>Koss</surname><given-names>D.</given-names></name><name><surname>L&#x000e1;zaro</surname><given-names>D. F.</given-names></name><name><surname>Santos</surname><given-names>P. I.</given-names></name><name><surname>Vasili</surname><given-names>E.</given-names></name><name><surname>Xylaki</surname><given-names>M.</given-names></name><name><surname>Outeiro</surname><given-names>T. F.</given-names></name><article-title>Synucleinopathies:
Where we are and where we need to go</article-title><source>J. Neurochem.</source><year>2020</year><volume>153</volume><fpage>433</fpage><pub-id pub-id-type="doi">10.1111/jnc.14965</pub-id><pub-id pub-id-type="pmid">31957016</pub-id>
</element-citation></ref><ref id="ref2"><element-citation publication-type="journal" id="cit2"><name><surname>Villar-Piqu&#x000e9;</surname><given-names>A.</given-names></name><name><surname>Lopes da Fonseca</surname><given-names>T.</given-names></name><name><surname>Outeiro</surname><given-names>T. F.</given-names></name><article-title>Structure, function and toxicity
of alpha-synuclein: the Bermuda triangle in synucleinopathies</article-title><source>J. Neurochem.</source><year>2016</year><volume>139</volume><issue>Suppl 1</issue><fpage>240</fpage><lpage>255</lpage><pub-id pub-id-type="doi">10.1111/jnc.13249</pub-id><pub-id pub-id-type="pmid">26190401</pub-id>
</element-citation></ref><ref id="ref3"><element-citation publication-type="journal" id="cit3"><name><surname>Braak</surname><given-names>H.</given-names></name><name><surname>Braak</surname><given-names>E.</given-names></name><name><surname>Yilmazer</surname><given-names>D.</given-names></name><name><surname>de Vos</surname><given-names>R. A.</given-names></name><name><surname>Jansen</surname><given-names>E. N.</given-names></name><name><surname>Bohl</surname><given-names>J.</given-names></name><article-title>Pattern of brain destruction in Parkinson&#x02019;s and Alzheimer&#x02019;s
diseases</article-title><source>J. Neural Transm.</source><year>1996</year><volume>103</volume><fpage>455</fpage><lpage>490</lpage><pub-id pub-id-type="doi">10.1007/BF01276421</pub-id><pub-id pub-id-type="pmid">9617789</pub-id>
</element-citation></ref><ref id="ref4"><element-citation publication-type="journal" id="cit4"><name><surname>Papp</surname><given-names>M. I.</given-names></name><name><surname>Kahn</surname><given-names>J. E.</given-names></name><name><surname>Lantos</surname><given-names>P. L.</given-names></name><article-title>Glial cytoplasmic inclusions in the
CNS of patients with multiple system atrophy (striatonigral degeneration,
olivopontocerebellar atrophy and Shy-Drager syndrome)</article-title><source>J. Neurol. Sci.</source><year>1989</year><volume>94</volume><fpage>79</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1016/0022-510X(89)90219-0</pub-id><pub-id pub-id-type="pmid">2559165</pub-id>
</element-citation></ref><ref id="ref5"><element-citation publication-type="journal" id="cit5"><name><surname>Koga</surname><given-names>S.</given-names></name><name><surname>Sekiya</surname><given-names>H.</given-names></name><name><surname>Kondru</surname><given-names>N.</given-names></name><name><surname>Ross</surname><given-names>O. A.</given-names></name><name><surname>Dickson</surname><given-names>D. W.</given-names></name><article-title>Neuropathology
and molecular diagnosis of Synucleinopathies</article-title><source>Mol. Neurodegener.</source><year>2021</year><volume>16</volume><elocation-id>83</elocation-id><pub-id pub-id-type="doi">10.1186/s13024-021-00501-z</pub-id><pub-id pub-id-type="pmid">34922583</pub-id>
</element-citation><note><p>published online Dec 18, 2021</p></note></ref><ref id="ref6"><element-citation publication-type="journal" id="cit6"><name><surname>Winner</surname><given-names>B.</given-names></name><name><surname>Jappelli</surname><given-names>R.</given-names></name><name><surname>Maji</surname><given-names>S. K.</given-names></name><name><surname>Desplats</surname><given-names>P. A.</given-names></name><name><surname>Boyer</surname><given-names>L.</given-names></name><name><surname>Aigner</surname><given-names>S.</given-names></name><name><surname>Hetzer</surname><given-names>C.</given-names></name><name><surname>Loher</surname><given-names>T.</given-names></name><name><surname>Vilar</surname><given-names>M.</given-names></name><name><surname>Campioni</surname><given-names>S.</given-names></name><name><surname>Tzitzilonis</surname><given-names>C.</given-names></name><name><surname>Soragni</surname><given-names>A.</given-names></name><name><surname>Jessberger</surname><given-names>S.</given-names></name><name><surname>Mira</surname><given-names>H.</given-names></name><name><surname>Consiglio</surname><given-names>A.</given-names></name><name><surname>Pham</surname><given-names>E.</given-names></name><name><surname>Masliah</surname><given-names>E.</given-names></name><name><surname>Gage</surname><given-names>F. H.</given-names></name><name><surname>Riek</surname><given-names>R.</given-names></name><article-title>In vivo demonstration that &#x003b1;-synuclein
oligomers are toxic</article-title><source>Proc. Natl. Acad. Sci.
U.S.A.</source><year>2011</year><volume>108</volume><fpage>4194</fpage><lpage>4199</lpage><pub-id pub-id-type="doi">10.1073/pnas.1100976108</pub-id><pub-id pub-id-type="pmid">21325059</pub-id>
</element-citation><note><p>published online
Feb 15, 2011</p></note></ref><ref id="ref7"><element-citation publication-type="journal" id="cit7"><name><surname>Du</surname><given-names>X.-Y.</given-names></name><name><surname>Xie</surname><given-names>X.-X.</given-names></name><name><surname>Liu</surname><given-names>R.-T.</given-names></name><article-title>The Role
of &#x003b1;-Synuclein Oligomers
in Parkinson&#x02019;s Disease</article-title><source>Int. J. Mol.
Sci.</source><year>2020</year><volume>21</volume><fpage>8645</fpage><pub-id pub-id-type="doi">10.3390/ijms21228645</pub-id><pub-id pub-id-type="pmid">33212758</pub-id>
</element-citation></ref><ref id="ref8"><element-citation publication-type="journal" id="cit8"><name><surname>Fusco</surname><given-names>G.</given-names></name><name><surname>de Simone</surname><given-names>A.</given-names></name><name><surname>Gopinath</surname><given-names>T.</given-names></name><name><surname>Vostrikov</surname><given-names>V.</given-names></name><name><surname>Vendruscolo</surname><given-names>M.</given-names></name><name><surname>Dobson</surname><given-names>C. M.</given-names></name><name><surname>Veglia</surname><given-names>G.</given-names></name><article-title>Direct observation
of the three regions in &#x003b1;-synuclein that determine its membrane-bound
behaviour</article-title><source>Nat. Commun.</source><year>2014</year><volume>5</volume><elocation-id>3827</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms4827</pub-id><pub-id pub-id-type="pmid">24871041</pub-id>
</element-citation><note><p>published online May 29, 2014</p></note></ref><ref id="ref9"><element-citation publication-type="journal" id="cit9"><name><surname>Weinreb</surname><given-names>P. H.</given-names></name><name><surname>Zhen</surname><given-names>W.</given-names></name><name><surname>Poon</surname><given-names>A. W.</given-names></name><name><surname>Conway</surname><given-names>K. A.</given-names></name><name><surname>Lansbury</surname><given-names>P. T.</given-names></name><article-title>NACP, a
protein implicated in Alzheimer&#x02019;s disease and learning, is
natively unfolded</article-title><source>Biochemistry</source><year>1996</year><volume>35</volume><fpage>13709</fpage><lpage>13715</lpage><pub-id pub-id-type="doi">10.1021/bi961799n</pub-id><pub-id pub-id-type="pmid">8901511</pub-id>
</element-citation></ref><ref id="ref10"><element-citation publication-type="journal" id="cit10"><name><surname>Bisi</surname><given-names>N.</given-names></name><name><surname>Feni</surname><given-names>L.</given-names></name><name><surname>Peqini</surname><given-names>K.</given-names></name><name><surname>P&#x000e9;rez-Pe&#x000f1;a</surname><given-names>H.</given-names></name><name><surname>Ongeri</surname><given-names>S.</given-names></name><name><surname>Pieraccini</surname><given-names>S.</given-names></name><name><surname>Pellegrino</surname><given-names>S.</given-names></name><article-title>&#x003b1;-Synuclein:
An All-Inclusive Trip Around its Structure, Influencing Factors and
Applied Techniques</article-title><source>Front. Chem.</source><year>2021</year><volume>9</volume><elocation-id>666585</elocation-id><pub-id pub-id-type="doi">10.3389/fchem.2021.666585</pub-id><pub-id pub-id-type="pmid">34307295</pub-id>
</element-citation><note><p>published online Jul 7, 2021</p></note></ref><ref id="ref11"><element-citation publication-type="journal" id="cit11"><name><surname>Bartels</surname><given-names>T.</given-names></name><name><surname>Ahlstrom</surname><given-names>L. S.</given-names></name><name><surname>Leftin</surname><given-names>A.</given-names></name><name><surname>Kamp</surname><given-names>F.</given-names></name><name><surname>Haass</surname><given-names>C.</given-names></name><name><surname>Brown</surname><given-names>M. F.</given-names></name><name><surname>Beyer</surname><given-names>K.</given-names></name><article-title>The N-terminus of the intrinsically
disordered protein &#x003b1;-synuclein triggers membrane binding and
helix folding</article-title><source>Biophys. J.</source><year>2010</year><volume>99</volume><fpage>2116</fpage><lpage>2124</lpage><pub-id pub-id-type="doi">10.1016/j.bpj.2010.06.035</pub-id><pub-id pub-id-type="pmid">20923645</pub-id>
</element-citation></ref><ref id="ref12"><element-citation publication-type="journal" id="cit12"><name><surname>Cheng</surname><given-names>F.</given-names></name><name><surname>Vivacqua</surname><given-names>G.</given-names></name><name><surname>Yu</surname><given-names>S.</given-names></name><article-title>The role of
alpha-synuclein in neurotransmission
and synaptic plasticity</article-title><source>J. Chem. Neuroanat.</source><year>2011</year><volume>42</volume><fpage>242</fpage><lpage>248</lpage><pub-id pub-id-type="doi">10.1016/j.jchemneu.2010.12.001</pub-id><pub-id pub-id-type="pmid">21167933</pub-id>
</element-citation><note><p>published online Dec 16, 2010</p></note></ref><ref id="ref13"><element-citation publication-type="journal" id="cit13"><name><surname>Burr&#x000e9;</surname><given-names>J.</given-names></name><name><surname>Vivona</surname><given-names>S.</given-names></name><name><surname>Diao</surname><given-names>J.</given-names></name><name><surname>Sharma</surname><given-names>M.</given-names></name><name><surname>Brunger</surname><given-names>A. T.</given-names></name><name><surname>S&#x000fc;dhof</surname><given-names>T. C.</given-names></name><article-title>Properties of native brain &#x003b1;-synuclein</article-title><source>Nature</source><year>2013</year><volume>498</volume><fpage>E4</fpage><lpage>E6</lpage><pub-id pub-id-type="doi">10.1038/nature12125</pub-id><pub-id pub-id-type="pmid">23765500</pub-id>
</element-citation><note><p>discussion E6&#x02013;7</p></note></ref><ref id="ref14"><element-citation publication-type="journal" id="cit14"><name><surname>Lashuel</surname><given-names>H. A.</given-names></name><name><surname>Overk</surname><given-names>C. R.</given-names></name><name><surname>Oueslati</surname><given-names>A.</given-names></name><name><surname>Masliah</surname><given-names>E.</given-names></name><article-title>The many faces of &#x003b1;-synuclein:
from structure and toxicity to therapeutic target</article-title><source>Nat. Rev. Neurosci.</source><year>2013</year><volume>14</volume><fpage>38</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1038/nrn3406</pub-id><pub-id pub-id-type="pmid">23254192</pub-id>
</element-citation></ref><ref id="ref15"><element-citation publication-type="journal" id="cit15"><name><surname>Burr&#x000e9;</surname><given-names>J.</given-names></name><name><surname>Sharma</surname><given-names>M.</given-names></name><name><surname>Tsetsenis</surname><given-names>T.</given-names></name><name><surname>Buchman</surname><given-names>V.</given-names></name><name><surname>Etherton</surname><given-names>M. R.</given-names></name><name><surname>S&#x000fc;dhof</surname><given-names>T. C.</given-names></name><article-title>Alpha-synuclein promotes SNARE-complex assembly in
vivo and in vitro</article-title><source>Science</source><year>2010</year><volume>329</volume><fpage>1663</fpage><lpage>1667</lpage><pub-id pub-id-type="doi">10.1126/science.1195227</pub-id><pub-id pub-id-type="pmid">20798282</pub-id>
</element-citation><note><p>published online Aug 26, 2010</p></note></ref><ref id="ref16"><element-citation publication-type="journal" id="cit16"><name><surname>Goers</surname><given-names>J.</given-names></name><name><surname>Manning-Bog</surname><given-names>A. B.</given-names></name><name><surname>McCormack</surname><given-names>A. L.</given-names></name><name><surname>Millett</surname><given-names>I. S.</given-names></name><name><surname>Doniach</surname><given-names>S.</given-names></name><name><surname>Di Monte</surname><given-names>D. A.</given-names></name><name><surname>Uversky</surname><given-names>V. N.</given-names></name><name><surname>Fink</surname><given-names>A. L.</given-names></name><article-title>Nuclear localization
of &#x003b1;-synuclein and its interaction with histones</article-title><source>Biochemistry</source><year>2003</year><volume>42</volume><fpage>8465</fpage><lpage>8471</lpage><pub-id pub-id-type="doi">10.1021/bi0341152</pub-id><pub-id pub-id-type="pmid">12859192</pub-id>
</element-citation></ref><ref id="ref17"><element-citation publication-type="journal" id="cit17"><name><surname>Bendor</surname><given-names>J. T.</given-names></name><name><surname>Logan</surname><given-names>T. P.</given-names></name><name><surname>Edwards</surname><given-names>R. H.</given-names></name><article-title>The function of &#x003b1;-synuclein</article-title><source>Neuron</source><year>2013</year><volume>79</volume><fpage>1044</fpage><lpage>1066</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2013.09.004</pub-id><pub-id pub-id-type="pmid">24050397</pub-id>
</element-citation></ref><ref id="ref18"><element-citation publication-type="journal" id="cit18"><name><surname>Paiva</surname><given-names>I.</given-names></name><name><surname>Pinho</surname><given-names>R.</given-names></name><name><surname>Pavlou</surname><given-names>M. A.</given-names></name><name><surname>Hennion</surname><given-names>M.</given-names></name><name><surname>Wales</surname><given-names>P.</given-names></name><name><surname>Sch&#x000fc;tz</surname><given-names>A.-L.</given-names></name><name><surname>Rajput</surname><given-names>A.</given-names></name><name><surname>Szego</surname><given-names>&#x000c9;. M.</given-names></name><name><surname>Kerimoglu</surname><given-names>C.</given-names></name><name><surname>Gerhardt</surname><given-names>E.</given-names></name><name><surname>Rego</surname><given-names>A. C.</given-names></name><name><surname>Fischer</surname><given-names>A.</given-names></name><name><surname>Bonn</surname><given-names>S.</given-names></name><name><surname>Outeiro</surname><given-names>T. F.</given-names></name><article-title>Sodium butyrate rescues dopaminergic
cells from alpha-synuclein-induced transcriptional deregulation and
DNA damage</article-title><source>Hum. Mol. Genet.</source><year>2017</year><volume>26</volume><fpage>2231</fpage><lpage>2246</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddx114</pub-id><pub-id pub-id-type="pmid">28369321</pub-id>
</element-citation></ref><ref id="ref19"><element-citation publication-type="journal" id="cit19"><name><surname>Pinho</surname><given-names>R.</given-names></name><name><surname>Paiva</surname><given-names>I.</given-names></name><name><surname>Jercic</surname><given-names>K. G.</given-names></name><name><surname>Fonseca-Ornelas</surname><given-names>L.</given-names></name><name><surname>Gerhardt</surname><given-names>E.</given-names></name><name><surname>Fahlbusch</surname><given-names>C.</given-names></name><name><surname>Garcia-Esparcia</surname><given-names>P.</given-names></name><name><surname>Kerimoglu</surname><given-names>C.</given-names></name><name><surname>Pavlou</surname><given-names>M. A. S.</given-names></name><name><surname>Villar-Piqu&#x000e9;</surname><given-names>A.</given-names></name><name><surname>Szego</surname><given-names>&#x000c9;.</given-names></name><name><surname>Lopes da Fonseca</surname><given-names>T.</given-names></name><name><surname>Odoardi</surname><given-names>F.</given-names></name><name><surname>Soeroes</surname><given-names>S.</given-names></name><name><surname>Rego</surname><given-names>A. C.</given-names></name><name><surname>Fischle</surname><given-names>W.</given-names></name><name><surname>Schwamborn</surname><given-names>J. C.</given-names></name><name><surname>Meyer</surname><given-names>T.</given-names></name><name><surname>K&#x000fc;gler</surname><given-names>S.</given-names></name><name><surname>Ferrer</surname><given-names>I.</given-names></name><name><surname>Attems</surname><given-names>J.</given-names></name><name><surname>Fischer</surname><given-names>A.</given-names></name><name><surname>Becker</surname><given-names>S.</given-names></name><name><surname>Zweckstetter</surname><given-names>M.</given-names></name><name><surname>Borovecki</surname><given-names>F.</given-names></name><name><surname>Outeiro</surname><given-names>T. F.</given-names></name><article-title>Nuclear localization and phosphorylation
modulate pathological effects of alpha-synuclein</article-title><source>Hum. Mol. Genet.</source><year>2019</year><volume>28</volume><fpage>31</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddy326</pub-id><pub-id pub-id-type="pmid">30219847</pub-id>
</element-citation></ref><ref id="ref20"><element-citation publication-type="journal" id="cit20"><name><surname>Somayaji</surname><given-names>M.</given-names></name><name><surname>Lanseur</surname><given-names>Z.</given-names></name><name><surname>Choi</surname><given-names>S. J.</given-names></name><name><surname>Sulzer</surname><given-names>D.</given-names></name><name><surname>Mosharov</surname><given-names>E. V.</given-names></name><article-title>Roles for
&#x003b1;-Synuclein in Gene Expression</article-title><source>Genes</source><year>2021</year><volume>12</volume><fpage>1166</fpage><pub-id pub-id-type="doi">10.3390/genes12081166</pub-id><pub-id pub-id-type="pmid">34440340</pub-id>
</element-citation></ref><ref id="ref21"><element-citation publication-type="journal" id="cit21"><name><surname>Peqini</surname><given-names>K.</given-names></name><name><surname>Attanasio</surname><given-names>S.</given-names></name><name><surname>Feni</surname><given-names>L.</given-names></name><name><surname>Cappelletti</surname><given-names>G.</given-names></name><name><surname>Pellegrino</surname><given-names>S.</given-names></name><article-title>Breaking down
and building up alpha-synuclein: An insight
on its N-terminal domain</article-title><source>J. Peptide Sci.</source><year>2024</year><volume>30</volume><elocation-id>e3556</elocation-id><pub-id pub-id-type="doi">10.1002/psc.3556</pub-id><pub-id pub-id-type="pmid">38037257</pub-id>
</element-citation><note><p>published online Nov 30, 2023</p></note></ref><ref id="ref22"><element-citation publication-type="journal" id="cit22"><name><surname>Dettmer</surname><given-names>U.</given-names></name><name><surname>Selkoe</surname><given-names>D.</given-names></name><name><surname>Bartels</surname><given-names>T.</given-names></name><article-title>New insights into cellular &#x003b1;-synuclein
homeostasis in health and disease</article-title><source>Curr. Opin.
Neurobiol.</source><year>2016</year><volume>36</volume><fpage>15</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2015.07.007</pub-id><pub-id pub-id-type="pmid">26282834</pub-id>
</element-citation><note><p>published online
Aug 15, 2015</p></note></ref><ref id="ref23"><element-citation publication-type="journal" id="cit23"><name><surname>Ruggeri</surname><given-names>F. S.</given-names></name><name><surname>Flagmeier</surname><given-names>P.</given-names></name><name><surname>Kumita</surname><given-names>J. R.</given-names></name><name><surname>Meisl</surname><given-names>G.</given-names></name><name><surname>Chirgadze</surname><given-names>D. Y.</given-names></name><name><surname>Bongiovanni</surname><given-names>M. N.</given-names></name><name><surname>Knowles</surname><given-names>T. P. J.</given-names></name><name><surname>Dobson</surname><given-names>C. M.</given-names></name><article-title>The Influence of
Pathogenic Mutations in &#x003b1;-Synuclein on Biophysical and Structural
Characteristics of Amyloid Fibrils</article-title><source>ACS Nano</source><year>2020</year><volume>14</volume><fpage>5213</fpage><lpage>5222</lpage><pub-id pub-id-type="doi">10.1021/acsnano.9b09676</pub-id><pub-id pub-id-type="pmid">32159944</pub-id>
</element-citation><note><p>published online Mar 17, 2020</p></note></ref><ref id="ref24"><element-citation publication-type="journal" id="cit24"><name><surname>Narhi</surname><given-names>L.</given-names></name><name><surname>Wood</surname><given-names>S. J.</given-names></name><name><surname>Steavenson</surname><given-names>S.</given-names></name><name><surname>Jiang</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>G. M.</given-names></name><name><surname>Anafi</surname><given-names>D.</given-names></name><name><surname>Kaufman</surname><given-names>S. A.</given-names></name><name><surname>Martin</surname><given-names>F.</given-names></name><name><surname>Sitney</surname><given-names>K.</given-names></name><name><surname>Denis</surname><given-names>P.</given-names></name><name><surname>Louis</surname><given-names>J. C.</given-names></name><name><surname>Wypych</surname><given-names>J.</given-names></name><name><surname>Biere</surname><given-names>A. L.</given-names></name><name><surname>Citron</surname><given-names>M.</given-names></name><article-title>Both familial Parkinson&#x02019;s disease mutations
accelerate &#x003b1;-synuclein aggregation</article-title><source>J.
Biol. Chem.</source><year>1999</year><volume>274</volume><fpage>9843</fpage><lpage>9846</lpage><pub-id pub-id-type="doi">10.1074/jbc.274.14.9843</pub-id><pub-id pub-id-type="pmid">10092675</pub-id>
</element-citation></ref><ref id="ref25"><element-citation publication-type="journal" id="cit25"><name><surname>Zhao</surname><given-names>K.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Long</surname><given-names>H.</given-names></name><name><surname>Zhao</surname><given-names>C.</given-names></name><name><surname>Luo</surname><given-names>F.</given-names></name><name><surname>Sun</surname><given-names>Y.</given-names></name><name><surname>Tao</surname><given-names>Y.</given-names></name><name><surname>Su</surname><given-names>X.-D.</given-names></name><name><surname>Li</surname><given-names>D.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>C.</given-names></name><article-title>Parkinson&#x02019;s disease associated mutation E46K of &#x003b1;-synuclein
triggers the formation of a distinct fibril structure</article-title><source>Nat. Commun.</source><year>2020</year><volume>11</volume><elocation-id>2643</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-16386-3</pub-id><pub-id pub-id-type="pmid">32457390</pub-id>
</element-citation><note><p>published online May 26, 2020</p></note></ref><ref id="ref26"><element-citation publication-type="journal" id="cit26"><name><surname>Lai</surname><given-names>B. C. L.</given-names></name><name><surname>Marion</surname><given-names>S. A.</given-names></name><name><surname>Teschke</surname><given-names>K.</given-names></name><name><surname>Tsui</surname><given-names>J. K. C.</given-names></name><article-title>Occupational
and environmental risk factors for Parkinson&#x02019;s disease</article-title><source>Parkinsonism Relat. Disord.</source><year>2002</year><volume>8</volume><fpage>297</fpage><lpage>309</lpage><pub-id pub-id-type="doi">10.1016/S1353-8020(01)00054-2</pub-id><pub-id pub-id-type="pmid">15177059</pub-id>
</element-citation></ref><ref id="ref27"><element-citation publication-type="journal" id="cit27"><name><surname>Klingelhoefer</surname><given-names>L.</given-names></name><name><surname>Reichmann</surname><given-names>H.</given-names></name><article-title>Pathogenesis
of Parkinson disease--the gut-brain axis
and environmental factors</article-title><source>Nat. Rev. Neurol.</source><year>2015</year><volume>11</volume><fpage>625</fpage><lpage>636</lpage><pub-id pub-id-type="doi">10.1038/nrneurol.2015.197</pub-id><pub-id pub-id-type="pmid">26503923</pub-id>
</element-citation><note><p>published online Oct 27, 2015</p></note></ref><ref id="ref28"><element-citation publication-type="journal" id="cit28"><name><surname>Emamzadeh</surname><given-names>F. N.</given-names></name><name><surname>Surguchov</surname><given-names>A.</given-names></name><article-title>Parkinson&#x02019;s Disease: Biomarkers, Treatment,
and Risk Factors</article-title><source>Front. Neurosci.</source><year>2018</year><volume>12</volume><fpage>612</fpage><pub-id pub-id-type="doi">10.3389/fnins.2018.00612</pub-id><pub-id pub-id-type="pmid">30214392</pub-id>
</element-citation><note><p>published online Aug 30, 2018</p></note></ref><ref id="ref29"><element-citation publication-type="journal" id="cit29"><name><surname>Manzanza</surname><given-names>N. d. O.</given-names></name><name><surname>Sedlackova</surname><given-names>L.</given-names></name><name><surname>Kalaria</surname><given-names>R. N.</given-names></name><article-title>Alpha-Synuclein Post-translational
Modifications: Implications for Pathogenesis of Lewy Body Disorders</article-title><source>Front. Aging Neurosci.</source><year>2021</year><volume>13</volume><elocation-id>690293</elocation-id><pub-id pub-id-type="doi">10.3389/fnagi.2021.690293</pub-id><pub-id pub-id-type="pmid">34248606</pub-id>
</element-citation><note><p>published online Jun 25, 2021</p></note></ref><ref id="ref30"><element-citation publication-type="journal" id="cit30"><name><surname>Sorrentino</surname><given-names>Z. A.</given-names></name><name><surname>Giasson</surname><given-names>B. I.</given-names></name><article-title>The emerging role of &#x003b1;-synuclein truncation in
aggregation and disease</article-title><source>J. Biol. Chem.</source><year>2020</year><volume>295</volume><fpage>10224</fpage><lpage>10244</lpage><pub-id pub-id-type="doi">10.1074/jbc.REV120.011743</pub-id><pub-id pub-id-type="pmid">32424039</pub-id>
</element-citation><note><p>published online May 18, 2020</p></note></ref><ref id="ref31"><element-citation publication-type="journal" id="cit31"><name><surname>Anderson</surname><given-names>J. P.</given-names></name><name><surname>Walker</surname><given-names>D. E.</given-names></name><name><surname>Goldstein</surname><given-names>J. M.</given-names></name><name><surname>Laat</surname><given-names>R.</given-names></name><name><surname>de</surname></name><name><surname>Banducci</surname><given-names>K.</given-names></name><name><surname>Caccavello</surname><given-names>R. J.</given-names></name><name><surname>Barbour</surname><given-names>R.</given-names></name><name><surname>Huang</surname><given-names>J.</given-names></name><name><surname>Kling</surname><given-names>K.</given-names></name><name><surname>Lee</surname><given-names>M.</given-names></name><name><surname>Diep</surname><given-names>L.</given-names></name><name><surname>Keim</surname><given-names>P. S.</given-names></name><name><surname>Shen</surname><given-names>X.</given-names></name><name><surname>Chataway</surname><given-names>T.</given-names></name><name><surname>Schlossmacher</surname><given-names>M. G.</given-names></name><name><surname>Seubert</surname><given-names>P.</given-names></name><name><surname>Schenk</surname><given-names>D.</given-names></name><name><surname>Sinha</surname><given-names>S.</given-names></name><name><surname>Gai</surname><given-names>W. P.</given-names></name><name><surname>Chilcote</surname><given-names>T. J.</given-names></name><article-title>Phosphorylation of Ser-129 is the
dominant pathological modification of &#x003b1;-synuclein in familial
and sporadic Lewy body disease</article-title><source>J. Biol. Chem.</source><year>2006</year><volume>281</volume><fpage>29739</fpage><lpage>29752</lpage><pub-id pub-id-type="doi">10.1074/jbc.M600933200</pub-id><pub-id pub-id-type="pmid">16847063</pub-id>
</element-citation><note><p>published online Jul 17, 2006</p></note></ref><ref id="ref32"><element-citation publication-type="journal" id="cit32"><name><surname>Bluhm</surname><given-names>A.</given-names></name><name><surname>Schrempel</surname><given-names>S.</given-names></name><name><surname>H&#x000f6;rsten</surname><given-names>S.</given-names></name><name><surname>von</surname></name><name><surname>Schulze</surname><given-names>A.</given-names></name><name><surname>Ro&#x000df;ner</surname><given-names>S.</given-names></name><article-title>Proteolytic
&#x003b1;-Synuclein Cleavage in Health and Disease</article-title><source>Int. J. Mol. Sci.</source><year>2021</year><volume>22</volume><issue>11</issue><fpage>5450</fpage><pub-id pub-id-type="doi">10.3390/ijms22115450</pub-id><pub-id pub-id-type="pmid">34064208</pub-id>
</element-citation></ref><ref id="ref33"><element-citation publication-type="journal" id="cit33"><name><surname>Muntan&#x000e9;</surname><given-names>G.</given-names></name><name><surname>Ferrer</surname><given-names>I.</given-names></name><name><surname>Martinez-Vicente</surname><given-names>M.</given-names></name><article-title>&#x003b1;-synuclein
phosphorylation
and truncation are normal events in the adult human brain</article-title><source>Neuroscience</source><year>2012</year><volume>200</volume><fpage>106</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2011.10.042</pub-id><pub-id pub-id-type="pmid">22079575</pub-id>
</element-citation><note><p>published online Oct 29, 2011</p></note></ref><ref id="ref34"><element-citation publication-type="journal" id="cit34"><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>West</surname><given-names>N.</given-names></name><name><surname>Colla</surname><given-names>E.</given-names></name><name><surname>Pletnikova</surname><given-names>O.</given-names></name><name><surname>Troncoso</surname><given-names>J. C.</given-names></name><name><surname>Marsh</surname><given-names>L.</given-names></name><name><surname>Dawson</surname><given-names>T. M.</given-names></name><name><surname>J&#x000e4;k&#x000e4;l&#x000e4;</surname><given-names>P.</given-names></name><name><surname>Hartmann</surname><given-names>T.</given-names></name><name><surname>Price</surname><given-names>D. L.</given-names></name><name><surname>Lee</surname><given-names>M. K.</given-names></name><article-title>Aggregation promoting
C-terminal truncation of &#x003b1;-synuclein is a normal cellular process
and is enhanced by the familial Parkinson&#x02019;s disease-linked
mutations</article-title><source>Proc. Natl. Acad. Sci. U.S.A.</source><year>2005</year><volume>102</volume><fpage>2162</fpage><lpage>2167</lpage><pub-id pub-id-type="doi">10.1073/pnas.0406976102</pub-id><pub-id pub-id-type="pmid">15684072</pub-id>
</element-citation><note><p>published online Jan 31, 2005</p></note></ref><ref id="ref35"><element-citation publication-type="journal" id="cit35"><name><surname>Spillantini</surname><given-names>M. G.</given-names></name><name><surname>Schmidt</surname><given-names>M. L.</given-names></name><name><surname>Lee</surname><given-names>V. M.</given-names></name><name><surname>Trojanowski</surname><given-names>J. Q.</given-names></name><name><surname>Jakes</surname><given-names>R.</given-names></name><name><surname>Goedert</surname><given-names>M.</given-names></name><article-title>&#x003b1;-synuclein in Lewy bodies</article-title><source>Nature</source><year>1997</year><volume>388</volume><fpage>839</fpage><lpage>840</lpage><pub-id pub-id-type="doi">10.1038/42166</pub-id><pub-id pub-id-type="pmid">9278044</pub-id>
</element-citation></ref><ref id="ref36"><element-citation publication-type="journal" id="cit36"><name><surname>Murray</surname><given-names>I. V. J.</given-names></name><name><surname>Giasson</surname><given-names>B. I.</given-names></name><name><surname>Quinn</surname><given-names>S. M.</given-names></name><name><surname>Koppaka</surname><given-names>V.</given-names></name><name><surname>Axelsen</surname><given-names>P. H.</given-names></name><name><surname>Ischiropoulos</surname><given-names>H.</given-names></name><name><surname>Trojanowski</surname><given-names>J. Q.</given-names></name><name><surname>Lee</surname><given-names>V. M.-Y.</given-names></name><article-title>Role of &#x003b1;-synuclein
carboxy-terminus on fibril formation in vitro</article-title><source>Biochemistry</source><year>2003</year><volume>42</volume><fpage>8530</fpage><lpage>8540</lpage><pub-id pub-id-type="doi">10.1021/bi027363r</pub-id><pub-id pub-id-type="pmid">12859200</pub-id>
</element-citation></ref><ref id="ref37"><element-citation publication-type="journal" id="cit37"><name><surname>Levin</surname><given-names>J.</given-names></name><name><surname>Giese</surname><given-names>A.</given-names></name><name><surname>Boetzel</surname><given-names>K.</given-names></name><name><surname>Israel</surname><given-names>L.</given-names></name><name><surname>H&#x000f6;gen</surname><given-names>T.</given-names></name><name><surname>N&#x000fc;bling</surname><given-names>G.</given-names></name><name><surname>Kretzschmar</surname><given-names>H.</given-names></name><name><surname>Lorenzl</surname><given-names>S.</given-names></name><article-title>Increased &#x003b1;-synuclein
aggregation following limited cleavage by certain matrix metalloproteinases</article-title><source>Exp. Neurol.</source><year>2009</year><volume>215</volume><fpage>201</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1016/j.expneurol.2008.10.010</pub-id><pub-id pub-id-type="pmid">19022250</pub-id>
</element-citation><note><p>published online Oct 31, 2008</p></note></ref><ref id="ref38"><element-citation publication-type="journal" id="cit38"><name><surname>Kim</surname><given-names>K. S.</given-names></name><name><surname>Choi</surname><given-names>Y. R.</given-names></name><name><surname>Park</surname><given-names>J.-Y.</given-names></name><name><surname>Lee</surname><given-names>J.-H.</given-names></name><name><surname>Kim</surname><given-names>D. K.</given-names></name><name><surname>Lee</surname><given-names>S.-J.</given-names></name><name><surname>Paik</surname><given-names>S. R.</given-names></name><name><surname>Jou</surname><given-names>I.</given-names></name><name><surname>Park</surname><given-names>S. M.</given-names></name><article-title>Proteolytic
cleavage of extracellular &#x003b1;-synuclein by plasmin: implications
for Parkinson disease</article-title><source>J. Biol. Chem.</source><year>2012</year><volume>287</volume><fpage>24862</fpage><lpage>24872</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.348128</pub-id><pub-id pub-id-type="pmid">22619171</pub-id>
</element-citation><note><p>published online May 22, 2012</p></note></ref><ref id="ref39"><element-citation publication-type="journal" id="cit39"><name><surname>Sung</surname><given-names>J. Y.</given-names></name><name><surname>Park</surname><given-names>S. M.</given-names></name><name><surname>Lee</surname><given-names>C.-H.</given-names></name><name><surname>Um</surname><given-names>J. W.</given-names></name><name><surname>Lee</surname><given-names>H. J.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Oh</surname><given-names>Y. J.</given-names></name><name><surname>Lee</surname><given-names>S.-T.</given-names></name><name><surname>Paik</surname><given-names>S. R.</given-names></name><name><surname>Chung</surname><given-names>K. C.</given-names></name><article-title>Proteolytic
cleavage of extracellular secreted &#x003b1;-synuclein via matrix metalloproteinases</article-title><source>J. Biol. Chem.</source><year>2005</year><volume>280</volume><fpage>25216</fpage><lpage>25224</lpage><pub-id pub-id-type="doi">10.1074/jbc.M503341200</pub-id><pub-id pub-id-type="pmid">15863497</pub-id>
</element-citation><note><p>published online Apr 29, 2005</p></note></ref><ref id="ref40"><element-citation publication-type="journal" id="cit40"><name><surname>Bluhm</surname><given-names>A.</given-names></name><name><surname>Schrempel</surname><given-names>S.</given-names></name><name><surname>Moceri</surname><given-names>S.</given-names></name><name><surname>Stieler</surname><given-names>J.</given-names></name><name><surname>Feja</surname><given-names>M.</given-names></name><name><surname>Schilling</surname><given-names>S.</given-names></name><name><surname>Schulze</surname><given-names>A.</given-names></name><name><surname>H&#x000f6;rsten</surname><given-names>S. von.</given-names></name><name><surname>Hartlage-R&#x000fc;bsamen</surname><given-names>M.</given-names></name><name><surname>Richter</surname><given-names>F.</given-names></name><name><surname>Ro&#x000df;ner</surname><given-names>S.</given-names></name><article-title>Alpha synuclein
processing by MMP-3 - implications for synucleinopathies</article-title><source>Behav. Brain Res.</source><year>2022</year><volume>434</volume><elocation-id>114020</elocation-id><pub-id pub-id-type="doi">10.1016/j.bbr.2022.114020</pub-id><pub-id pub-id-type="pmid">35870616</pub-id>
</element-citation><note><p>published online Jul 21, 2022</p></note></ref><ref id="ref41"><element-citation publication-type="journal" id="cit41"><name><surname>Shinkai-Ouchi</surname><given-names>F.</given-names></name><name><surname>Koyama</surname><given-names>S.</given-names></name><name><surname>Ono</surname><given-names>Y.</given-names></name><name><surname>Hata</surname><given-names>S.</given-names></name><name><surname>Ojima</surname><given-names>K.</given-names></name><name><surname>Shindo</surname><given-names>M.</given-names></name><name><surname>duVerle</surname><given-names>D.</given-names></name><name><surname>Ueno</surname><given-names>M.</given-names></name><name><surname>Kitamura</surname><given-names>F.</given-names></name><name><surname>Doi</surname><given-names>N.</given-names></name><name><surname>Takigawa</surname><given-names>I.</given-names></name><name><surname>Mamitsuka</surname><given-names>H.</given-names></name><name><surname>Sorimachi</surname><given-names>H.</given-names></name><article-title>Predictions
of Cleavability of Calpain Proteolysis by Quantitative Structure-Activity
Relationship Analysis Using Newly Determined Cleavage Sites and Catalytic
Efficiencies of an Oligopeptide Array</article-title><source>Mol.
Cell. Proteomics</source><year>2016</year><volume>15</volume><fpage>1262</fpage><lpage>1280</lpage><pub-id pub-id-type="doi">10.1074/mcp.M115.053413</pub-id><pub-id pub-id-type="pmid">26796116</pub-id>
</element-citation><note><p>published online Jan 21, 2016</p></note></ref><ref id="ref42"><element-citation publication-type="journal" id="cit42"><name><surname>Qin</surname><given-names>Z.</given-names></name><name><surname>Hu</surname><given-names>D.</given-names></name><name><surname>Han</surname><given-names>S.</given-names></name><name><surname>Hong</surname><given-names>D.-P.</given-names></name><name><surname>Fink</surname><given-names>A. L.</given-names></name><article-title>Role of different
regions of &#x003b1;-synuclein in the assembly of fibrils</article-title><source>Biochemistry</source><year>2007</year><volume>46</volume><fpage>13322</fpage><lpage>13330</lpage><pub-id pub-id-type="doi">10.1021/bi7014053</pub-id><pub-id pub-id-type="pmid">17963364</pub-id>
</element-citation><note><p>published online Oct 27, 2007</p></note></ref><ref id="ref43"><element-citation publication-type="journal" id="cit43"><name><surname>Busby</surname><given-names>W. H.</given-names></name><name><surname>Quackenbush</surname><given-names>G. E.</given-names></name><name><surname>Humm</surname><given-names>J.</given-names></name><name><surname>Youngblood</surname><given-names>W. W.</given-names></name><name><surname>Kizer</surname><given-names>J. S.</given-names></name><article-title>An enzyme(s) that converts glutaminyl-peptides into
pyroglutamyl-peptides. Presence in pituitary, brain, adrenal medulla,
and lymphocytes</article-title><source>J. Biol. Chem.</source><year>1987</year><volume>262</volume><fpage>8532</fpage><lpage>8536</lpage><pub-id pub-id-type="doi">10.1016/S0021-9258(18)47446-7</pub-id><pub-id pub-id-type="pmid">3597387</pub-id>
</element-citation></ref><ref id="ref44"><element-citation publication-type="journal" id="cit44"><name><surname>Fischer</surname><given-names>W. H.</given-names></name><name><surname>Spiess</surname><given-names>J.</given-names></name><article-title>Identification of a
mammalian glutaminyl cyclase converting
glutaminyl into pyroglutamyl peptides</article-title><source>Proc.
Natl. Acad. Sci. U.S.A.</source><year>1987</year><volume>84</volume><fpage>3628</fpage><lpage>3632</lpage><pub-id pub-id-type="doi">10.1073/pnas.84.11.3628</pub-id><pub-id pub-id-type="pmid">3473473</pub-id>
</element-citation></ref><ref id="ref45"><element-citation publication-type="journal" id="cit45"><name><surname>Cynis</surname><given-names>H.</given-names></name><name><surname>Scheel</surname><given-names>E.</given-names></name><name><surname>Saido</surname><given-names>T. C.</given-names></name><name><surname>Schilling</surname><given-names>S.</given-names></name><name><surname>Demuth</surname><given-names>H.-U.</given-names></name><article-title>Amyloidogenic processing of amyloid precursor protein:
evidence of a pivotal role of glutaminyl cyclase in generation of
pyroglutamate-modified amyloid-beta</article-title><source>Biochemistry</source><year>2008</year><volume>47</volume><fpage>7405</fpage><lpage>7413</lpage><pub-id pub-id-type="doi">10.1021/bi800250p</pub-id><pub-id pub-id-type="pmid">18570439</pub-id>
</element-citation><note><p>published online Jun 21, 2008</p></note></ref><ref id="ref46"><element-citation publication-type="journal" id="cit46"><name><surname>Schilling</surname><given-names>S.</given-names></name><name><surname>Zeitschel</surname><given-names>U.</given-names></name><name><surname>Hoffmann</surname><given-names>T.</given-names></name><name><surname>Heiser</surname><given-names>U.</given-names></name><name><surname>Francke</surname><given-names>M.</given-names></name><name><surname>Kehlen</surname><given-names>A.</given-names></name><name><surname>Holzer</surname><given-names>M.</given-names></name><name><surname>Hutter-Paier</surname><given-names>B.</given-names></name><name><surname>Prokesch</surname><given-names>M.</given-names></name><name><surname>Windisch</surname><given-names>M.</given-names></name><name><surname>Jagla</surname><given-names>W.</given-names></name><name><surname>Schlenzig</surname><given-names>D.</given-names></name><name><surname>Lindner</surname><given-names>C.</given-names></name><name><surname>Rudolph</surname><given-names>T.</given-names></name><name><surname>Reuter</surname><given-names>G.</given-names></name><name><surname>Cynis</surname><given-names>H.</given-names></name><name><surname>Montag</surname><given-names>D.</given-names></name><name><surname>Demuth</surname><given-names>H.-U.</given-names></name><name><surname>Rossner</surname><given-names>S.</given-names></name><article-title>Glutaminyl cyclase
inhibition attenuates pyroglutamate A&#x003b2; and Alzheimer&#x02019;s
disease-like pathology</article-title><source>Nat. Med.</source><year>2008</year><volume>14</volume><fpage>1106</fpage><lpage>1111</lpage><pub-id pub-id-type="doi">10.1038/nm.1872</pub-id><pub-id pub-id-type="pmid">18836460</pub-id>
</element-citation><note><p>published online Sep 28, 2008</p></note></ref><ref id="ref47"><element-citation publication-type="journal" id="cit47"><name><surname>Alexandru</surname><given-names>A.</given-names></name><name><surname>Jagla</surname><given-names>W.</given-names></name><name><surname>Graubner</surname><given-names>S.</given-names></name><name><surname>Becker</surname><given-names>A.</given-names></name><name><surname>B&#x000e4;uscher</surname><given-names>C.</given-names></name><name><surname>Kohlmann</surname><given-names>S.</given-names></name><name><surname>Sedlmeier</surname><given-names>R.</given-names></name><name><surname>Raber</surname><given-names>K. A.</given-names></name><name><surname>Cynis</surname><given-names>H.</given-names></name><name><surname>R&#x000f6;nicke</surname><given-names>R.</given-names></name><name><surname>Reymann</surname><given-names>K. G.</given-names></name><name><surname>Petrasch-Parwez</surname><given-names>E.</given-names></name><name><surname>Hartlage-R&#x000fc;bsamen</surname><given-names>M.</given-names></name><name><surname>Waniek</surname><given-names>A.</given-names></name><name><surname>Rossner</surname><given-names>S.</given-names></name><name><surname>Schilling</surname><given-names>S.</given-names></name><name><surname>Osmand</surname><given-names>A. P.</given-names></name><name><surname>Demuth</surname><given-names>H.-U.</given-names></name><name><surname>von H&#x000f6;rsten</surname><given-names>S.</given-names></name><article-title>Selective
hippocampal neurodegeneration in transgenic mice expressing small
amounts of truncated A&#x003b2; is induced by pyroglutamate-A&#x003b2;
formation</article-title><source>J. Neurosci.</source><year>2011</year><volume>31</volume><fpage>12790</fpage><lpage>12801</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1794-11.2011</pub-id><pub-id pub-id-type="pmid">21900558</pub-id>
</element-citation></ref><ref id="ref48"><element-citation publication-type="journal" id="cit48"><name><surname>Nussbaum</surname><given-names>J. M.</given-names></name><name><surname>Schilling</surname><given-names>S.</given-names></name><name><surname>Cynis</surname><given-names>H.</given-names></name><name><surname>Silva</surname><given-names>A.</given-names></name><name><surname>Swanson</surname><given-names>E.</given-names></name><name><surname>Wangsanut</surname><given-names>T.</given-names></name><name><surname>Tayler</surname><given-names>K.</given-names></name><name><surname>Wiltgen</surname><given-names>B.</given-names></name><name><surname>Hatami</surname><given-names>A.</given-names></name><name><surname>R&#x000f6;nicke</surname><given-names>R.</given-names></name><name><surname>Reymann</surname><given-names>K.</given-names></name><name><surname>Hutter-Paier</surname><given-names>B.</given-names></name><name><surname>Alexandru</surname><given-names>A.</given-names></name><name><surname>Jagla</surname><given-names>W.</given-names></name><name><surname>Graubner</surname><given-names>S.</given-names></name><name><surname>Glabe</surname><given-names>C. G.</given-names></name><name><surname>Demuth</surname><given-names>H.-U.</given-names></name><name><surname>Bloom</surname><given-names>G. S.</given-names></name><article-title>Prion-like behaviour and tau-dependent
cytotoxicity of pyroglutamylated amyloid-&#x003b2;</article-title><source>Nature</source><year>2012</year><volume>485</volume><fpage>651</fpage><lpage>655</lpage><pub-id pub-id-type="doi">10.1038/nature11060</pub-id><pub-id pub-id-type="pmid">22660329</pub-id>
</element-citation><note><p>published online May
2, 2012</p></note></ref><ref id="ref49"><element-citation publication-type="journal" id="cit49"><name><surname>Hartlage-R&#x000fc;bsamen</surname><given-names>M.</given-names></name><name><surname>Bluhm</surname><given-names>A.</given-names></name><name><surname>Moceri</surname><given-names>S.</given-names></name><name><surname>Machner</surname><given-names>L.</given-names></name><name><surname>K&#x000f6;ppen</surname><given-names>J.</given-names></name><name><surname>Schenk</surname><given-names>M.</given-names></name><name><surname>Hilbrich</surname><given-names>I.</given-names></name><name><surname>Holzer</surname><given-names>M.</given-names></name><name><surname>Weidenfeller</surname><given-names>M.</given-names></name><name><surname>Richter</surname><given-names>F.</given-names></name><name><surname>Coras</surname><given-names>R.</given-names></name><name><surname>Serrano</surname><given-names>G. E.</given-names></name><name><surname>Beach</surname><given-names>T. G.</given-names></name><name><surname>Schilling</surname><given-names>S.</given-names></name><name><surname>von H&#x000f6;rsten</surname><given-names>S.</given-names></name><name><surname>Xiang</surname><given-names>W.</given-names></name><name><surname>Schulze</surname><given-names>A.</given-names></name><name><surname>Ro&#x000df;ner</surname><given-names>S.</given-names></name><article-title>A glutaminyl cyclase-catalyzed &#x003b1;-synuclein modification
identified in human synucleinopathies</article-title><source>Acta
Neuropathol.</source><year>2021</year><volume>142</volume><fpage>399</fpage><lpage>421</lpage><pub-id pub-id-type="doi">10.1007/s00401-021-02349-5</pub-id><pub-id pub-id-type="pmid">34309760</pub-id>
</element-citation><note><p>published online Jul 26, 2021</p></note></ref><ref id="ref50"><element-citation publication-type="journal" id="cit50"><name><surname>de
Marco</surname><given-names>A.</given-names></name><name><surname>Berrow</surname><given-names>N.</given-names></name><name><surname>Lebendiker</surname><given-names>M.</given-names></name><name><surname>Garcia-Alai</surname><given-names>M.</given-names></name><name><surname>Knauer</surname><given-names>S. H.</given-names></name><name><surname>Lopez-Mendez</surname><given-names>B.</given-names></name><name><surname>Matagne</surname><given-names>A.</given-names></name><name><surname>Parret</surname><given-names>A.</given-names></name><name><surname>Remans</surname><given-names>K.</given-names></name><name><surname>Uebel</surname><given-names>S.</given-names></name><name><surname>Raynal</surname><given-names>B.</given-names></name><article-title>Quality control of protein reagents for the improvement
of research data reproducibility</article-title><source>Nat. Commun.</source><year>2021</year><volume>12</volume><elocation-id>2795</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-021-23167-z</pub-id><pub-id pub-id-type="pmid">33990604</pub-id>
</element-citation><note><p>published online May 14, 2021</p></note></ref><ref id="ref51"><element-citation publication-type="journal" id="cit51"><name><surname>Lorber</surname><given-names>B.</given-names></name><name><surname>Fischer</surname><given-names>F.</given-names></name><name><surname>Bailly</surname><given-names>M.</given-names></name><name><surname>Roy</surname><given-names>H.</given-names></name><name><surname>Kern</surname><given-names>D.</given-names></name><article-title>Protein analysis
by dynamic light scattering: methods and techniques for students</article-title><source>Biochem. Mol. Biol. Educ.</source><year>2012</year><volume>40</volume><fpage>372</fpage><lpage>382</lpage><pub-id pub-id-type="doi">10.1002/bmb.20644</pub-id><pub-id pub-id-type="pmid">23166025</pub-id>
</element-citation><note><p>published online Oct 10, 2012</p></note></ref><ref id="ref52"><element-citation publication-type="journal" id="cit52"><name><surname>Miles</surname><given-names>A. J.</given-names></name><name><surname>Janes</surname><given-names>R. W.</given-names></name><name><surname>Wallace</surname><given-names>B. A.</given-names></name><article-title>Tools and methods for circular dichroism
spectroscopy of proteins: a tutorial review</article-title><source>Chem. Soc. Rev.</source><year>2021</year><volume>50</volume><fpage>8400</fpage><lpage>8413</lpage><pub-id pub-id-type="doi">10.1039/D0CS00558D</pub-id><pub-id pub-id-type="pmid">34132259</pub-id>
</element-citation><note><p>published online Jun 15, 2021</p></note></ref><ref id="ref53"><element-citation publication-type="journal" id="cit53"><name><surname>Kumagai</surname><given-names>P. S.</given-names></name><name><surname>DeMarco</surname><given-names>R.</given-names></name><name><surname>Lopes</surname><given-names>J. L. S.</given-names></name><article-title>Advantages of synchrotron radiation
circular dichroism spectroscopy to study intrinsically disordered
proteins</article-title><source>Eur. Biophys. J.</source><year>2017</year><volume>46</volume><fpage>599</fpage><lpage>606</lpage><pub-id pub-id-type="doi">10.1007/s00249-017-1202-1</pub-id><pub-id pub-id-type="pmid">28258312</pub-id>
</element-citation><note><p>published online Mar 3, 2017</p></note></ref><ref id="ref54"><mixed-citation publication-type="book" id="cit54">
<person-group person-group-type="allauthors">
<string-name>
<surname>Uversky</surname>, <given-names>V.</given-names>
</string-name>
</person-group>
<article-title>Instrumental Analysis
of Intrinsically Disordered Proteins</article-title>. In <source>Assessing
Structure and Conformation</source>, <edition>1</edition>st ed.; <publisher-name>John Wiley &#x00026; Sons Incorporated</publisher-name>: <publisher-loc>Hoboken</publisher-loc>, <year>2010</year>.</mixed-citation></ref><ref id="ref55"><mixed-citation publication-type="book" id="cit55">
<article-title>The IUPAC Compendium of Chemical Terminology</article-title>; <person-group person-group-type="editor">
<string-name>
<surname>Gold</surname>, <given-names>V.</given-names>
</string-name>
</person-group>, Ed.; <publisher-name>International
Union of Pure and Applied Chemistry (IUPAC)</publisher-name>: <publisher-loc>Research Triangle Park, NC</publisher-loc>, <year>2019</year>.</mixed-citation></ref><ref id="ref56"><element-citation publication-type="journal" id="cit56"><name><surname>Bisaglia</surname><given-names>M.</given-names></name><name><surname>Tessari</surname><given-names>I.</given-names></name><name><surname>Pinato</surname><given-names>L.</given-names></name><name><surname>Bellanda</surname><given-names>M.</given-names></name><name><surname>Giraudo</surname><given-names>S.</given-names></name><name><surname>Fasano</surname><given-names>M.</given-names></name><name><surname>Bergantino</surname><given-names>E.</given-names></name><name><surname>Bubacco</surname><given-names>L.</given-names></name><name><surname>Mammi</surname><given-names>S.</given-names></name><article-title>A topological
model of the interaction between &#x003b1;-synuclein and sodium dodecyl
sulfate micelles</article-title><source>Biochemistry</source><year>2005</year><volume>44</volume><fpage>329</fpage><lpage>339</lpage><pub-id pub-id-type="doi">10.1021/bi048448q</pub-id><pub-id pub-id-type="pmid">15628875</pub-id>
</element-citation></ref><ref id="ref57"><mixed-citation publication-type="book" id="cit57">
<person-group person-group-type="allauthors">
<string-name>
<surname>Burchard</surname>, <given-names>W.</given-names>
</string-name>
</person-group>
<article-title>Solution Properties
of Branched Macromolecules</article-title>. In <source>Branched Polymers
II.</source>; <person-group person-group-type="editor">
<string-name>
<surname>Roovers</surname>, <given-names>J.</given-names>
</string-name>
</person-group>,
Ed.; <publisher-name>Springer</publisher-name>: <publisher-loc>Berlin,
Heidelberg</publisher-loc>, <year>1999</year>.</mixed-citation></ref><ref id="ref58"><element-citation publication-type="journal" id="cit58"><name><surname>Svergun</surname><given-names>D. I.</given-names></name><name><surname>Koch</surname><given-names>M. H. J.</given-names></name><article-title>Small-angle scattering studies of biological macromolecules
in solution</article-title><source>Rep. Prog. Phys.</source><year>2003</year><volume>66</volume><fpage>1735</fpage><lpage>1782</lpage><pub-id pub-id-type="doi">10.1088/0034-4885/66/10/R05</pub-id></element-citation></ref><ref id="ref59"><element-citation publication-type="journal" id="cit59"><name><surname>Awasthi</surname><given-names>S.</given-names></name><name><surname>Ying</surname><given-names>C.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Mayer</surname><given-names>M.</given-names></name><article-title>Simultaneous Determination
of the Size and Shape of Single &#x003b1;-Synuclein Oligomers in Solution</article-title><source>ACS Nano</source><year>2023</year><volume>17</volume><fpage>12325</fpage><lpage>12335</lpage><pub-id pub-id-type="doi">10.1021/acsnano.3c01393</pub-id><pub-id pub-id-type="pmid">37327131</pub-id>
</element-citation><note><p>published online Jun 16, 2023</p></note></ref><ref id="ref60"><element-citation publication-type="journal" id="cit60"><name><surname>Bloomfield</surname><given-names>V.</given-names></name><name><surname>Dalton</surname><given-names>W. O.</given-names></name><name><surname>van Holde</surname><given-names>K. E.</given-names></name><article-title>Frictional coefficients of multisubunit
structures. I. Theory</article-title><source>Biopolymers</source><year>1967</year><volume>5</volume><fpage>135</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1002/bip.1967.360050202</pub-id><pub-id pub-id-type="pmid">6040712</pub-id>
</element-citation></ref><ref id="ref61"><element-citation publication-type="journal" id="cit61"><name><surname>Guerrero-Ferreira</surname><given-names>R.</given-names></name><name><surname>Taylor</surname><given-names>N. M.</given-names></name><name><surname>Mona</surname><given-names>D.</given-names></name><name><surname>Ringler</surname><given-names>P.</given-names></name><name><surname>Lauer</surname><given-names>M. E.</given-names></name><name><surname>Riek</surname><given-names>R.</given-names></name><name><surname>Britschgi</surname><given-names>M.</given-names></name><name><surname>Stahlberg</surname><given-names>H.</given-names></name><article-title>Cryo-EM structure
of alpha-synuclein fibrils</article-title><source>eLife</source><year>2018</year><volume>7</volume><elocation-id>e36402</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.36402</pub-id><pub-id pub-id-type="pmid">29969391</pub-id>
</element-citation></ref><ref id="ref62"><element-citation publication-type="journal" id="cit62"><name><surname>Alderson</surname><given-names>T. R.</given-names></name><name><surname>Markley</surname><given-names>J. L.</given-names></name><article-title>Biophysical characterization of &#x003b1;-synuclein and
its controversial structure</article-title><source>Intrinsically Disord.
Proteins</source><year>2013</year><volume>1</volume><elocation-id>e26255</elocation-id><pub-id pub-id-type="doi">10.4161/idp.26255</pub-id><pub-id pub-id-type="pmid">24634806</pub-id>
</element-citation><note><p>published online Apr 1, 2013</p></note></ref><ref id="ref63"><element-citation publication-type="journal" id="cit63"><name><surname>Araki</surname><given-names>K.</given-names></name><name><surname>Yagi</surname><given-names>N.</given-names></name><name><surname>Nakatani</surname><given-names>R.</given-names></name><name><surname>Sekiguchi</surname><given-names>H.</given-names></name><name><surname>So</surname><given-names>M.</given-names></name><name><surname>Yagi</surname><given-names>H.</given-names></name><name><surname>Ohta</surname><given-names>N.</given-names></name><name><surname>Nagai</surname><given-names>Y.</given-names></name><name><surname>Goto</surname><given-names>Y.</given-names></name><name><surname>Mochizuki</surname><given-names>H.</given-names></name><article-title>A small-angle X-ray scattering study of alpha-synuclein
from human red blood cells</article-title><source>Sci. Rep.</source><year>2016</year><volume>6</volume><elocation-id>30473</elocation-id><pub-id pub-id-type="doi">10.1038/srep30473</pub-id><pub-id pub-id-type="pmid">27469540</pub-id>
</element-citation><note><p>published online Jul 29, 2016</p></note></ref><ref id="ref64"><element-citation publication-type="journal" id="cit64"><name><surname>Uversky</surname><given-names>V. N.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Fink</surname><given-names>A. L.</given-names></name><article-title>Evidence for a partially folded intermediate in alpha-synuclein
fibril formation</article-title><source>J. Biol. Chem.</source><year>2001</year><volume>276</volume><fpage>10737</fpage><lpage>10744</lpage><pub-id pub-id-type="doi">10.1074/jbc.M010907200</pub-id><pub-id pub-id-type="pmid">11152691</pub-id>
</element-citation><note><p>published online Jan 10, 2001</p></note></ref><ref id="ref65"><element-citation publication-type="journal" id="cit65"><name><surname>Ariesandi</surname><given-names>W.</given-names></name><name><surname>Chang</surname><given-names>C.-F.</given-names></name><name><surname>Chen</surname><given-names>T.-E.</given-names></name><name><surname>Chen</surname><given-names>Y.-R.</given-names></name><article-title>Temperature-dependent
structural changes of Parkinson&#x02019;s alpha-synuclein reveal the
role of pre-existing oligomers in alpha-synuclein fibrillization</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><elocation-id>e53487</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0053487</pub-id><pub-id pub-id-type="pmid">23349712</pub-id>
</element-citation><note><p>published online Jan 22, 2013</p></note></ref><ref id="ref66"><mixed-citation publication-type="weblink" id="cit66">
<article-title>IUPAC
- International Union of Pure and Applied Chemistry (2006)
isosbestic point</article-title>. Friday, February 7, <year>2025</year>
<uri xlink:href="https://goldbook.iupac.org/terms/view/I03310">https://goldbook.iupac.org/terms/view/I03310</uri>.</mixed-citation></ref><ref id="ref67"><element-citation publication-type="journal" id="cit67"><name><surname>Rekas</surname><given-names>A.</given-names></name><name><surname>Ahn</surname><given-names>K. J.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Carver</surname><given-names>J. A.</given-names></name><article-title>The chaperone activity
of &#x003b1;-synuclein: Utilizing deletion mutants to map its interaction
with target proteins</article-title><source>Proteins</source><year>2012</year><volume>80</volume><fpage>1316</fpage><lpage>1325</lpage><pub-id pub-id-type="doi">10.1002/prot.24028</pub-id><pub-id pub-id-type="pmid">22274962</pub-id>
</element-citation><note><p>published online Feb 10, 2012</p></note></ref><ref id="ref68"><element-citation publication-type="journal" id="cit68"><name><surname>Ulmer</surname><given-names>T. S.</given-names></name><name><surname>Bax</surname><given-names>A.</given-names></name><name><surname>Cole</surname><given-names>N. B.</given-names></name><name><surname>Nussbaum</surname><given-names>R. L.</given-names></name><article-title>Structure and dynamics of micelle-bound
human &#x003b1;-synuclein</article-title><source>J. Biol. Chem.</source><year>2005</year><volume>280</volume><fpage>9595</fpage><lpage>9603</lpage><pub-id pub-id-type="doi">10.1074/jbc.M411805200</pub-id><pub-id pub-id-type="pmid">15615727</pub-id>
</element-citation><note><p>published online Dec 22, 2004</p></note></ref><ref id="ref69"><element-citation publication-type="journal" id="cit69"><name><surname>Munishkina</surname><given-names>L. A.</given-names></name><name><surname>Phelan</surname><given-names>C.</given-names></name><name><surname>Uversky</surname><given-names>V. N.</given-names></name><name><surname>Fink</surname><given-names>A. L.</given-names></name><article-title>Conformational behavior
and aggregation of &#x003b1;-synuclein in organic solvents: modeling
the effects of membranes</article-title><source>Biochemistry</source><year>2003</year><volume>42</volume><fpage>2720</fpage><lpage>2730</lpage><pub-id pub-id-type="doi">10.1021/bi027166s</pub-id><pub-id pub-id-type="pmid">12614167</pub-id>
</element-citation></ref><ref id="ref70"><element-citation publication-type="journal" id="cit70"><name><surname>Zhu</surname><given-names>M.</given-names></name><name><surname>Fink</surname><given-names>A. L.</given-names></name><article-title>Lipid binding inhibits
&#x003b1;-synuclein fibril formation</article-title><source>J. Biol.
Chem.</source><year>2003</year><volume>278</volume><fpage>16873</fpage><lpage>16877</lpage><pub-id pub-id-type="doi">10.1074/jbc.M210136200</pub-id><pub-id pub-id-type="pmid">12621030</pub-id>
</element-citation><note><p>published online
Mar 5, 2003</p></note></ref><ref id="ref71"><element-citation publication-type="journal" id="cit71"><name><surname>Jao</surname><given-names>C. C.</given-names></name><name><surname>Hegde</surname><given-names>B. G.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Haworth</surname><given-names>I. S.</given-names></name><name><surname>Langen</surname><given-names>R.</given-names></name><article-title>Structure
of membrane-bound &#x003b1;-synuclein from site-directed spin labeling
and computational refinement</article-title><source>Proc. Natl. Acad.
Sci. U.S.A.</source><year>2008</year><volume>105</volume><fpage>19666</fpage><lpage>19671</lpage><pub-id pub-id-type="doi">10.1073/pnas.0807826105</pub-id><pub-id pub-id-type="pmid">19066219</pub-id>
</element-citation><note><p>published online
Dec 9, 2008</p></note></ref><ref id="ref72"><element-citation publication-type="journal" id="cit72"><name><surname>Giehm</surname><given-names>L.</given-names></name><name><surname>Svergun</surname><given-names>D. I.</given-names></name><name><surname>Otzen</surname><given-names>D. E.</given-names></name><name><surname>Vestergaard</surname><given-names>B.</given-names></name><article-title>Low-resolution
structure of a vesicle disrupting &#x003b1;-synuclein oligomer that
accumulates during fibrillation</article-title><source>Proc. Natl.
Acad. Sci. U.S.A.</source><year>2011</year><volume>108</volume><fpage>3246</fpage><lpage>3251</lpage><pub-id pub-id-type="doi">10.1073/pnas.1013225108</pub-id><pub-id pub-id-type="pmid">21300904</pub-id>
</element-citation><note><p>published online Feb 7, 2011</p></note></ref><ref id="ref73"><element-citation publication-type="journal" id="cit73"><name><surname>Lashuel</surname><given-names>H. A.</given-names></name><name><surname>Petre</surname><given-names>B. M.</given-names></name><name><surname>Wall</surname><given-names>J.</given-names></name><name><surname>Simon</surname><given-names>M.</given-names></name><name><surname>Nowak</surname><given-names>R. J.</given-names></name><name><surname>Walz</surname><given-names>T.</given-names></name><name><surname>Lansbury</surname><given-names>P. T.</given-names></name><article-title>&#x003b1;-synuclein, especially the
Parkinson&#x02019;s disease-associated mutants, forms pore-like annular
and tubular protofibrils</article-title><source>J. Mol. Biol.</source><year>2002</year><volume>322</volume><fpage>1089</fpage><lpage>1102</lpage><pub-id pub-id-type="doi">10.1016/S0022-2836(02)00735-0</pub-id><pub-id pub-id-type="pmid">12367530</pub-id>
</element-citation></ref><ref id="ref74"><element-citation publication-type="journal" id="cit74"><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Wei</surname><given-names>G.</given-names></name><name><surname>Ding</surname><given-names>F.</given-names></name><name><surname>Sun</surname><given-names>Y.</given-names></name><article-title>Molecular Insights into the Misfolding
and Dimerization Dynamics
of the Full-Length &#x003b1;-Synuclein from Atomistic Discrete Molecular
Dynamics Simulations</article-title><source>ACS Chem. Neurosci.</source><year>2022</year><volume>13</volume><fpage>3126</fpage><lpage>3137</lpage><pub-id pub-id-type="doi">10.1021/acschemneuro.2c00531</pub-id><pub-id pub-id-type="pmid">36278939</pub-id>
</element-citation><note><p>published online Oct 24, 2022</p></note></ref><ref id="ref75"><element-citation publication-type="journal" id="cit75"><name><surname>Savva</surname><given-names>L.</given-names></name><name><surname>Platts</surname><given-names>J. A.</given-names></name><article-title>Computational investigation of copper-mediated conformational
changes in &#x003b1;-synuclein dimer</article-title><source>Phys. Chem.
Chem. Phys.</source><year>2024</year><volume>26</volume><fpage>2926</fpage><lpage>2935</lpage><pub-id pub-id-type="doi">10.1039/D3CP04697D</pub-id><pub-id pub-id-type="pmid">38193190</pub-id>
</element-citation><note><p>published online Jan
24, 2024</p></note></ref><ref id="ref76"><element-citation publication-type="journal" id="cit76"><name><surname>Zamel</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Zaer</surname><given-names>S.</given-names></name><name><surname>Harris</surname><given-names>P. D.</given-names></name><name><surname>Drori</surname><given-names>P.</given-names></name><name><surname>Lebendiker</surname><given-names>M.</given-names></name><name><surname>Kalisman</surname><given-names>N.</given-names></name><name><surname>Dokholyan</surname><given-names>N. V.</given-names></name><name><surname>Lerner</surname><given-names>E.</given-names></name><article-title>Structural and dynamic
insights into &#x003b1;-synuclein
dimer conformations</article-title><source>Structure</source><year>2023</year><volume>31</volume><fpage>411</fpage><lpage>423.e6</lpage><pub-id pub-id-type="doi">10.1016/j.str.2023.01.011</pub-id><pub-id pub-id-type="pmid">36809765</pub-id>
</element-citation><note><p>published online Feb 20, 2023</p></note></ref><ref id="ref77"><element-citation publication-type="journal" id="cit77"><name><surname>Kyriukha</surname><given-names>Y. A.</given-names></name><name><surname>Afitska</surname><given-names>K.</given-names></name><name><surname>Kurochka</surname><given-names>A. S.</given-names></name><name><surname>Sachan</surname><given-names>S.</given-names></name><name><surname>Galkin</surname><given-names>M.</given-names></name><name><surname>Yushchenko</surname><given-names>D. A.</given-names></name><name><surname>Shvadchak</surname><given-names>V. V.</given-names></name><article-title>&#x003b1;-Synuclein Dimers as Potent
Inhibitors of Fibrillization</article-title><source>J. Med. Chem.</source><year>2019</year><volume>62</volume><fpage>10342</fpage><lpage>10351</lpage><pub-id pub-id-type="doi">10.1021/acs.jmedchem.9b01400</pub-id><pub-id pub-id-type="pmid">31625739</pub-id>
</element-citation><note><p>published online Nov 4, 2019</p></note></ref><ref id="ref78"><element-citation publication-type="journal" id="cit78"><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>G.</given-names></name><name><surname>Zhao</surname><given-names>Z.</given-names></name><name><surname>Qian</surname><given-names>Z.</given-names></name><article-title>In silico study on
graphene quantum dots modified with various functional groups inhibiting
&#x003b1;-synuclein dimerization</article-title><source>J. Colloid Interface
Sci.</source><year>2024</year><volume>667</volume><fpage>723</fpage><lpage>730</lpage><pub-id pub-id-type="doi">10.1016/j.jcis.2024.04.111</pub-id><pub-id pub-id-type="pmid">38641462</pub-id>
</element-citation><note><p>published online
Apr 16, 2024</p></note></ref><ref id="ref79"><element-citation publication-type="journal" id="cit79"><name><surname>Kilpel&#x000e4;inen</surname><given-names>T.
P.</given-names></name><name><surname>P&#x000e4;tsi</surname><given-names>H. T.</given-names></name><name><surname>Svarcbahs</surname><given-names>R.</given-names></name><name><surname>Julku</surname><given-names>U. H.</given-names></name><name><surname>Etel&#x000e4;inen</surname><given-names>T. S.</given-names></name><name><surname>Cui</surname><given-names>H.</given-names></name><name><surname>Auno</surname><given-names>S.</given-names></name><name><surname>Sipari</surname><given-names>N.</given-names></name><name><surname>Norrbacka</surname><given-names>S.</given-names></name><name><surname>Leino</surname><given-names>T. O.</given-names></name><name><surname>J&#x000e4;ntti</surname><given-names>M.</given-names></name><name><surname>My&#x000f6;h&#x000e4;nen</surname><given-names>T. T.</given-names></name><name><surname>Wall&#x000e9;n</surname><given-names>E. A. A.</given-names></name><article-title>Nonpeptidic Oxazole-Based Prolyl Oligopeptidase Ligands
with Disease-Modifying Effects on &#x003b1;-Synuclein Mouse Models of
Parkinson&#x02019;s Disease</article-title><source>J. Med. Chem.</source><year>2023</year><volume>66</volume><fpage>7475</fpage><lpage>7496</lpage><pub-id pub-id-type="doi">10.1021/acs.jmedchem.3c00235</pub-id><pub-id pub-id-type="pmid">37248563</pub-id>
</element-citation><note><p>published online May 29, 2023</p></note></ref><ref id="ref80"><element-citation publication-type="journal" id="cit80"><name><surname>Papagiannakis</surname><given-names>N.</given-names></name><name><surname>Koros</surname><given-names>C.</given-names></name><name><surname>Stamelou</surname><given-names>M.</given-names></name><name><surname>Simitsi</surname><given-names>A.-M.</given-names></name><name><surname>Maniati</surname><given-names>M.</given-names></name><name><surname>Antonelou</surname><given-names>R.</given-names></name><name><surname>Papadimitriou</surname><given-names>D.</given-names></name><name><surname>Dermentzaki</surname><given-names>G.</given-names></name><name><surname>Moraitou</surname><given-names>M.</given-names></name><name><surname>Michelakakis</surname><given-names>H.</given-names></name><name><surname>Stefanis</surname><given-names>L.</given-names></name><article-title>Alpha-synuclein dimerization
in erythrocytes of patients with genetic and non-genetic forms of
Parkinson&#x02019;s Disease</article-title><source>Neurosci. Lett.</source><year>2018</year><volume>672</volume><fpage>145</fpage><lpage>149</lpage><pub-id pub-id-type="doi">10.1016/j.neulet.2017.11.012</pub-id><pub-id pub-id-type="pmid">29129675</pub-id>
</element-citation><note><p>published online Nov 10, 2017</p></note></ref><ref id="ref81"><element-citation publication-type="journal" id="cit81"><name><surname>Quist</surname><given-names>A.</given-names></name><name><surname>Doudevski</surname><given-names>I.</given-names></name><name><surname>Lin</surname><given-names>H.</given-names></name><name><surname>Azimova</surname><given-names>R.</given-names></name><name><surname>Ng</surname><given-names>D.</given-names></name><name><surname>Frangione</surname><given-names>B.</given-names></name><name><surname>Kagan</surname><given-names>B.</given-names></name><name><surname>Ghiso</surname><given-names>J.</given-names></name><name><surname>Lal</surname><given-names>R.</given-names></name><article-title>Amyloid ion
channels: a common structural link for protein-misfolding disease</article-title><source>Proc. Natl. Acad. Sci. U.S.A.</source><year>2005</year><volume>102</volume><fpage>10427</fpage><lpage>10432</lpage><pub-id pub-id-type="doi">10.1073/pnas.0502066102</pub-id><pub-id pub-id-type="pmid">16020533</pub-id>
</element-citation><note><p>published online Jul 14, 2005</p></note></ref><ref id="ref82"><element-citation publication-type="journal" id="cit82"><name><surname>Alam</surname><given-names>P.</given-names></name><name><surname>Bousset</surname><given-names>L.</given-names></name><name><surname>Melki</surname><given-names>R.</given-names></name><name><surname>Otzen</surname><given-names>D. E.</given-names></name><article-title>&#x003b1;-synuclein
oligomers and fibrils: a spectrum of species, a spectrum of toxicities</article-title><source>J. Neurochem.</source><year>2019</year><volume>150</volume><fpage>522</fpage><lpage>534</lpage><pub-id pub-id-type="doi">10.1111/jnc.14808</pub-id><pub-id pub-id-type="pmid">31254394</pub-id>
</element-citation><note><p>published online Aug 2, 2019</p></note></ref><ref id="ref83"><element-citation publication-type="journal" id="cit83"><name><surname>Lashuel</surname><given-names>H. A.</given-names></name><name><surname>Hartley</surname><given-names>D.</given-names></name><name><surname>Petre</surname><given-names>B. M.</given-names></name><name><surname>Walz</surname><given-names>T.</given-names></name><name><surname>Lansbury</surname><given-names>P. T.</given-names></name><article-title>Neurodegenerative
disease: amyloid pores from pathogenic mutations</article-title><source>Nature</source><year>2002</year><volume>418</volume><fpage>291</fpage><pub-id pub-id-type="doi">10.1038/418291a</pub-id></element-citation></ref><ref id="ref84"><element-citation publication-type="journal" id="cit84"><name><surname>H&#x000f6;gen</surname><given-names>T.</given-names></name><name><surname>Levin</surname><given-names>J.</given-names></name><name><surname>Schmidt</surname><given-names>F.</given-names></name><name><surname>Caruana</surname><given-names>M.</given-names></name><name><surname>Vassallo</surname><given-names>N.</given-names></name><name><surname>Kretzschmar</surname><given-names>H.</given-names></name><name><surname>B&#x000f6;tzel</surname><given-names>K.</given-names></name><name><surname>Kamp</surname><given-names>F.</given-names></name><name><surname>Giese</surname><given-names>A.</given-names></name><article-title>Two different
binding modes of &#x003b1;-synuclein to lipid vesicles depending on
its aggregation state</article-title><source>Biophys. J.</source><year>2012</year><volume>102</volume><fpage>1646</fpage><lpage>1655</lpage><pub-id pub-id-type="doi">10.1016/j.bpj.2012.01.059</pub-id><pub-id pub-id-type="pmid">22500765</pub-id>
</element-citation><note><p>published online Apr 3, 2012</p></note></ref><ref id="ref85"><element-citation publication-type="journal" id="cit85"><name><surname>Kostka</surname><given-names>M.</given-names></name><name><surname>H&#x000f6;gen</surname><given-names>T.</given-names></name><name><surname>Danzer</surname><given-names>K. M.</given-names></name><name><surname>Levin</surname><given-names>J.</given-names></name><name><surname>Habeck</surname><given-names>M.</given-names></name><name><surname>Wirth</surname><given-names>A.</given-names></name><name><surname>Wagner</surname><given-names>R.</given-names></name><name><surname>Glabe</surname><given-names>C. G.</given-names></name><name><surname>Finger</surname><given-names>S.</given-names></name><name><surname>Heinzelmann</surname><given-names>U.</given-names></name><name><surname>Garidel</surname><given-names>P.</given-names></name><name><surname>Duan</surname><given-names>W.</given-names></name><name><surname>Ross</surname><given-names>C. A.</given-names></name><name><surname>Kretzschmar</surname><given-names>H.</given-names></name><name><surname>Giese</surname><given-names>A.</given-names></name><article-title>Single particle characterization
of iron-induced pore-forming alpha-synuclein oligomers</article-title><source>J. Biol. Chem.</source><year>2008</year><volume>283</volume><fpage>10992</fpage><lpage>11003</lpage><pub-id pub-id-type="doi">10.1074/jbc.M709634200</pub-id><pub-id pub-id-type="pmid">18258594</pub-id>
</element-citation><note><p>published online Feb 7, 2008</p></note></ref><ref id="ref86"><element-citation publication-type="journal" id="cit86"><name><surname>van
Rooijen</surname><given-names>B. D.</given-names></name><name><surname>Claessens</surname><given-names>M. M. A. E.</given-names></name><name><surname>Subramaniam</surname><given-names>V.</given-names></name><article-title>Membrane Permeabilization
by Oligomeric &#x003b1;-Synuclein: In Search of the Mechanism</article-title><source>PLoS One</source><year>2010</year><volume>5</volume><elocation-id>e14292</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0014292</pub-id><pub-id pub-id-type="pmid">21179192</pub-id>
</element-citation><note><p>published online Dec 13, 2010</p></note></ref><ref id="ref87"><element-citation publication-type="journal" id="cit87"><name><surname>Musteikyt&#x00117;</surname><given-names>G.</given-names></name><name><surname>Jayaram</surname><given-names>A. K.</given-names></name><name><surname>Xu</surname><given-names>C. K.</given-names></name><name><surname>Vendruscolo</surname><given-names>M.</given-names></name><name><surname>Krainer</surname><given-names>G.</given-names></name><name><surname>Knowles</surname><given-names>T. P. J.</given-names></name><article-title>Interactions of &#x003b1;-synuclein
oligomers with lipid membranes</article-title><source>Biochim. Biophys.
Acta, Biomembr.</source><year>2021</year><volume>1863</volume><elocation-id>183536</elocation-id><pub-id pub-id-type="doi">10.1016/j.bbamem.2020.183536</pub-id><pub-id pub-id-type="pmid">33373595</pub-id>
</element-citation><note><p>published online Dec 26, 2020</p></note></ref><ref id="ref88"><element-citation publication-type="journal" id="cit88"><name><surname>&#x00160;neiderien&#x00117;</surname><given-names>G.</given-names></name><name><surname>Czekalska</surname><given-names>M. A.</given-names></name><name><surname>Xu</surname><given-names>C. K.</given-names></name><name><surname>Jayaram</surname><given-names>A. K.</given-names></name><name><surname>Krainer</surname><given-names>G.</given-names></name><name><surname>Arter</surname><given-names>W. E.</given-names></name><name><surname>Peter</surname><given-names>Q. A. E.</given-names></name><name><surname>Castellana-Cruz</surname><given-names>M.</given-names></name><name><surname>Saar</surname><given-names>K. L.</given-names></name><name><surname>Levin</surname><given-names>A.</given-names></name><name><surname>Mueller</surname><given-names>T.</given-names></name><name><surname>Fiedler</surname><given-names>S.</given-names></name><name><surname>Devenish</surname><given-names>S. R. A.</given-names></name><name><surname>Fiegler</surname><given-names>H.</given-names></name><name><surname>Kumita</surname><given-names>J. R.</given-names></name><name><surname>Knowles</surname><given-names>T. P. J.</given-names></name><article-title>&#x003b1;-Synuclein
Oligomers Displace Monomeric &#x003b1;-Synuclein from Lipid Membranes</article-title><source>ACS Nano</source><year>2024</year><volume>18</volume><fpage>17469</fpage><lpage>17482</lpage><pub-id pub-id-type="doi">10.1021/acsnano.3c10889</pub-id><pub-id pub-id-type="pmid">38916260</pub-id>
</element-citation><note><p>published online Jun 25, 2024</p></note></ref><ref id="ref89"><element-citation publication-type="journal" id="cit89"><name><surname>K&#x000f6;ppen</surname><given-names>J.</given-names></name><name><surname>Schulze</surname><given-names>A.</given-names></name><name><surname>Machner</surname><given-names>L.</given-names></name><name><surname>Wermann</surname><given-names>M.</given-names></name><name><surname>Eichentopf</surname><given-names>R.</given-names></name><name><surname>Guthardt</surname><given-names>M.</given-names></name><name><surname>H&#x000e4;hnel</surname><given-names>A.</given-names></name><name><surname>Klehm</surname><given-names>J.</given-names></name><name><surname>Kriegeskorte</surname><given-names>M.-C.</given-names></name><name><surname>Hartlage-R&#x000fc;bsamen</surname><given-names>M.</given-names></name><name><surname>Morawski</surname><given-names>M.</given-names></name><name><surname>H&#x000f6;rsten</surname><given-names>S.</given-names></name><name><surname>von</surname></name><name><surname>Demuth</surname><given-names>H.-U.</given-names></name><name><surname>Ro&#x000df;ner</surname><given-names>S.</given-names></name><name><surname>Schilling</surname><given-names>S.</given-names></name><article-title>Amyloid-Beta Peptides Trigger Aggregation
of Alpha-Synuclein In Vitro</article-title><source>Molecules</source><year>2020</year><volume>25</volume><issue>3</issue><fpage>580</fpage><pub-id pub-id-type="doi">10.3390/molecules25030580</pub-id><pub-id pub-id-type="pmid">32013170</pub-id>
</element-citation></ref><ref id="ref90"><element-citation publication-type="journal" id="cit90"><name><surname>Kapust</surname><given-names>R. B.</given-names></name><name><surname>T&#x000f6;zs&#x000e9;r</surname><given-names>J.</given-names></name><name><surname>Copeland</surname><given-names>T. D.</given-names></name><name><surname>Waugh</surname><given-names>D. S.</given-names></name><article-title>The P1&#x02032; specificity
of tobacco etch virus protease</article-title><source>Biochem. Biophys.
Res. Commun.</source><year>2002</year><volume>294</volume><fpage>949</fpage><lpage>955</lpage><pub-id pub-id-type="doi">10.1016/S0006-291X(02)00574-0</pub-id><pub-id pub-id-type="pmid">12074568</pub-id>
</element-citation></ref><ref id="ref91"><element-citation publication-type="journal" id="cit91"><name><surname>Schlenzig</surname><given-names>D.</given-names></name><name><surname>Manhart</surname><given-names>S.</given-names></name><name><surname>Cinar</surname><given-names>Y.</given-names></name><name><surname>Kleinschmidt</surname><given-names>M.</given-names></name><name><surname>Hause</surname><given-names>G.</given-names></name><name><surname>Willbold</surname><given-names>D.</given-names></name><name><surname>Funke</surname><given-names>S. A.</given-names></name><name><surname>Schilling</surname><given-names>S.</given-names></name><name><surname>Demuth</surname><given-names>H.-U.</given-names></name><article-title>Pyroglutamate formation influences solubility and amyloidogenicity
of amyloid peptides</article-title><source>Biochemistry</source><year>2009</year><volume>48</volume><fpage>7072</fpage><lpage>7078</lpage><pub-id pub-id-type="doi">10.1021/bi900818a</pub-id><pub-id pub-id-type="pmid">19518051</pub-id>
</element-citation></ref><ref id="ref92"><element-citation publication-type="journal" id="cit92"><name><surname>Paslawski</surname><given-names>W.</given-names></name><name><surname>Lorenzen</surname><given-names>N.</given-names></name><name><surname>Otzen</surname><given-names>D. E.</given-names></name><article-title>Formation
and Characterization of
&#x003b1;-Synuclein Oligomers</article-title><source>Methods Mol. Biol.</source><year>2016</year><volume>1345</volume><fpage>133</fpage><lpage>150</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-2978-8_9</pub-id><pub-id pub-id-type="pmid">26453210</pub-id>
</element-citation></ref><ref id="ref93"><element-citation publication-type="journal" id="cit93"><name><surname>R&#x000e9;fr&#x000e9;giers</surname><given-names>M.</given-names></name><name><surname>Wien</surname><given-names>F.</given-names></name><name><surname>Ta</surname><given-names>H. P.</given-names></name><name><surname>Premvardhan</surname><given-names>L.</given-names></name><name><surname>Bac</surname><given-names>S.</given-names></name><name><surname>Jamme</surname><given-names>F.</given-names></name><name><surname>Rouam</surname><given-names>V.</given-names></name><name><surname>Lagarde</surname><given-names>B.</given-names></name><name><surname>Polack</surname><given-names>F.</given-names></name><name><surname>Giorgetta</surname><given-names>J. L.</given-names></name><name><surname>Ricaud</surname><given-names>J. P.</given-names></name><name><surname>Bordessoule</surname><given-names>M.</given-names></name><name><surname>Giuliani</surname><given-names>A.</given-names></name><article-title>DISCO synchrotron-radiation
circular-dichroism endstation
at SOLEIL</article-title><source>J. Synchrotron Radiat.</source><year>2012</year><volume>19</volume><fpage>831</fpage><lpage>835</lpage><pub-id pub-id-type="doi">10.1107/S0909049512030002</pub-id><pub-id pub-id-type="pmid">22898965</pub-id>
</element-citation><note><p>published online Jul 28, 2012</p></note></ref><ref id="ref94"><element-citation publication-type="journal" id="cit94"><name><surname>E</surname><given-names>D.</given-names></name><name><surname>Jakubowska</surname><given-names>A.</given-names></name><article-title>Effect of electrolytes on the physicochemical behaviour
of sodium dodecyl sulphate micelles</article-title><source>Colloid
Polym. Sci.</source><year>2002</year><volume>280</volume><fpage>1009</fpage><lpage>1014</lpage><pub-id pub-id-type="doi">10.1007/s00396-002-0723-y</pub-id></element-citation></ref><ref id="ref95"><element-citation publication-type="journal" id="cit95"><name><surname>Miles</surname><given-names>A. J.</given-names></name><name><surname>Wallace</surname><given-names>B. A.</given-names></name><article-title>CDtoolX, a downloadable
software package for processing
and analyses of circular dichroism spectroscopic data</article-title><source>Protein Sci.</source><year>2018</year><volume>27</volume><fpage>1717</fpage><lpage>1722</lpage><pub-id pub-id-type="doi">10.1002/pro.3474</pub-id><pub-id pub-id-type="pmid">30168221</pub-id>
</element-citation></ref><ref id="ref96"><element-citation publication-type="journal" id="cit96"><name><surname>Micsonai</surname><given-names>A.</given-names></name><name><surname>Moussong</surname><given-names>&#x000c9;.</given-names></name><name><surname>Wien</surname><given-names>F.</given-names></name><name><surname>Boros</surname><given-names>E.</given-names></name><name><surname>Vad&#x000e1;szi</surname><given-names>H.</given-names></name><name><surname>Murvai</surname><given-names>N.</given-names></name><name><surname>Lee</surname><given-names>Y.-H.</given-names></name><name><surname>Moln&#x000e1;r</surname><given-names>T.</given-names></name><name><surname>R&#x000e9;fr&#x000e9;giers</surname><given-names>M.</given-names></name><name><surname>Goto</surname><given-names>Y.</given-names></name><name><surname>Tantos</surname><given-names>&#x000c1;.</given-names></name><name><surname>Kardos</surname><given-names>J.</given-names></name><article-title>BeStSel: webserver for secondary structure and fold
prediction for protein CD spectroscopy</article-title><source>Nucleic
Acids Res.</source><year>2022</year><volume>50</volume><fpage>W90</fpage><lpage>W98</lpage><pub-id pub-id-type="doi">10.1093/nar/gkac345</pub-id><pub-id pub-id-type="pmid">35544232</pub-id>
</element-citation></ref><ref id="ref97"><element-citation publication-type="journal" id="cit97"><name><surname>Micsonai</surname><given-names>A.</given-names></name><name><surname>Wien</surname><given-names>F.</given-names></name><name><surname>Kernya</surname><given-names>L.</given-names></name><name><surname>Lee</surname><given-names>Y.-H.</given-names></name><name><surname>Goto</surname><given-names>Y.</given-names></name><name><surname>R&#x000e9;fr&#x000e9;giers</surname><given-names>M.</given-names></name><name><surname>Kardos</surname><given-names>J.</given-names></name><article-title>Accurate secondary
structure prediction and fold recognition for circular dichroism spectroscopy</article-title><source>Proc. Natl. Acad. Sci. U.S.A.</source><year>2015</year><volume>112</volume><fpage>E3095</fpage><lpage>e3103</lpage><pub-id pub-id-type="doi">10.1073/pnas.1500851112</pub-id><pub-id pub-id-type="pmid">26038575</pub-id>
</element-citation><note><p>published online Jun 2, 2015</p></note></ref><ref id="ref98"><element-citation publication-type="journal" id="cit98"><name><surname>Thureau</surname><given-names>A.</given-names></name><name><surname>Roblin</surname><given-names>P.</given-names></name><name><surname>P&#x000e9;rez</surname><given-names>J.</given-names></name><article-title>BioSAXS on the SWING beamline at
Synchrotron SOLEIL</article-title><source>J. Appl. Crystallogr.</source><year>2021</year><volume>54</volume><fpage>1698</fpage><lpage>1710</lpage><pub-id pub-id-type="doi">10.1107/S1600576721008736</pub-id></element-citation></ref><ref id="ref99"><element-citation publication-type="journal" id="cit99"><name><surname>Th&#x000e9;obald-Dietrich</surname><given-names>A.</given-names></name><name><surname>Wijn</surname><given-names>R. de.</given-names></name><name><surname>Rollet</surname><given-names>K.</given-names></name><name><surname>Bluhm</surname><given-names>A.</given-names></name><name><surname>Rudinger-Thirion</surname><given-names>J.</given-names></name><name><surname>Paulus</surname><given-names>C.</given-names></name><name><surname>Lorber</surname><given-names>B.</given-names></name><name><surname>Thureau</surname><given-names>A.</given-names></name><name><surname>Frugier</surname><given-names>M.</given-names></name><name><surname>Sauter</surname><given-names>C.</given-names></name><article-title>Structural Analysis of RNA by Small-Angle X-ray Scattering</article-title><source>Methods Mol. Biol.</source><year>2020</year><volume>2113</volume><fpage>189</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1007/978-1-0716-0278-2_14</pub-id><pub-id pub-id-type="pmid">32006316</pub-id>
</element-citation></ref><ref id="ref100"><element-citation publication-type="journal" id="cit100"><name><surname>Manalastas-Cantos</surname><given-names>K.</given-names></name><name><surname>Konarev</surname><given-names>P. V.</given-names></name><name><surname>Hajizadeh</surname><given-names>N. R.</given-names></name><name><surname>Kikhney</surname><given-names>A. G.</given-names></name><name><surname>Petoukhov</surname><given-names>M. V.</given-names></name><name><surname>Molodenskiy</surname><given-names>D. S.</given-names></name><name><surname>Panjkovich</surname><given-names>A.</given-names></name><name><surname>Mertens</surname><given-names>H. D. T.</given-names></name><name><surname>Gruzinov</surname><given-names>A.</given-names></name><name><surname>Borges</surname><given-names>C.</given-names></name><name><surname>Jeffries</surname><given-names>C. M.</given-names></name><name><surname>Svergun</surname><given-names>D. I.</given-names></name><name><surname>Franke</surname><given-names>D.</given-names></name><article-title>ATSAS 3.0: expanded
functionality and new tools for small-angle scattering data analysis</article-title><source>J. Appl. Crystallogr.</source><year>2021</year><volume>54</volume><fpage>343</fpage><lpage>355</lpage><pub-id pub-id-type="doi">10.1107/S1600576720013412</pub-id><pub-id pub-id-type="pmid">33833657</pub-id>
</element-citation><note><p>published online Feb 1, 2021</p></note></ref><ref id="ref101"><element-citation publication-type="journal" id="cit101"><name><surname>Hopkins</surname><given-names>J. B.</given-names></name><article-title>BioXTAS
RAW 2: new developments for a free open-source
program for small-angle scattering data reduction and analysis</article-title><source>J. Appl. Crystallogr.</source><year>2024</year><volume>57</volume><fpage>194</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1107/S1600576723011019</pub-id><pub-id pub-id-type="pmid">38322719</pub-id>
</element-citation><note><p>published online Feb 1, 2024</p></note></ref><ref id="ref102"><element-citation publication-type="journal" id="cit102"><name><surname>Piiadov</surname><given-names>V.</given-names></name><name><surname>Ares de Ara&#x000fa;jo</surname><given-names>E.</given-names></name><name><surname>Oliveira
Neto</surname><given-names>M.</given-names></name><name><surname>Craievich</surname><given-names>A. F.</given-names></name><name><surname>Polikarpov</surname><given-names>I.</given-names></name><article-title>SAXSMoW 2.0: Online calculator of
the molecular weight of proteins in dilute solution from experimental
SAXS data measured on a relative scale</article-title><source>Protein
Sci.</source><year>2019</year><volume>28</volume><fpage>454</fpage><lpage>463</lpage><pub-id pub-id-type="doi">10.1002/pro.3528</pub-id><pub-id pub-id-type="pmid">30371978</pub-id>
</element-citation><note><p>published online Dec
13, 2018</p></note></ref><ref id="ref103"><element-citation publication-type="journal" id="cit103"><name><surname>Rambo</surname><given-names>R. P.</given-names></name><name><surname>Tainer</surname><given-names>J. A.</given-names></name><article-title>Accurate assessment
of mass, models
and resolution by small-angle scattering</article-title><source>Nature</source><year>2013</year><volume>496</volume><fpage>477</fpage><lpage>481</lpage><pub-id pub-id-type="doi">10.1038/nature12070</pub-id><pub-id pub-id-type="pmid">23619693</pub-id>
</element-citation></ref><ref id="ref104"><element-citation publication-type="journal" id="cit104"><name><surname>Hajizadeh</surname><given-names>N. R.</given-names></name><name><surname>Franke</surname><given-names>D.</given-names></name><name><surname>Jeffries</surname><given-names>C. M.</given-names></name><name><surname>Svergun</surname><given-names>D. I.</given-names></name><article-title>Consensus
Bayesian assessment of protein molecular mass from solution X-ray
scattering data</article-title><source>Sci. Rep.</source><year>2018</year><volume>8</volume><elocation-id>7204</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-018-25355-2</pub-id><pub-id pub-id-type="pmid">29739979</pub-id>
</element-citation><note><p>published online May 8, 2018</p></note></ref><ref id="ref105"><element-citation publication-type="journal" id="cit105"><name><surname>Svergun</surname><given-names>D. I.</given-names></name><article-title>Determination
of the regularization parameter in indirect-transform
methods using perceptual criteria</article-title><source>J. Appl.
Crystallogr.</source><year>1992</year><volume>25</volume><fpage>495</fpage><lpage>503</lpage><pub-id pub-id-type="doi">10.1107/S0021889892001663</pub-id></element-citation></ref><ref id="ref106"><element-citation publication-type="journal" id="cit106"><name><surname>Bernad&#x000f3;</surname><given-names>P.</given-names></name><name><surname>Mylonas</surname><given-names>E.</given-names></name><name><surname>Petoukhov</surname><given-names>M. V.</given-names></name><name><surname>Blackledge</surname><given-names>M.</given-names></name><name><surname>Svergun</surname><given-names>D. I.</given-names></name><article-title>Structural characterization of flexible
proteins using small-angle X-ray scattering</article-title><source>J. Am. Chem. Soc.</source><year>2007</year><volume>129</volume><fpage>5656</fpage><lpage>5664</lpage><pub-id pub-id-type="doi">10.1021/ja069124n</pub-id><pub-id pub-id-type="pmid">17411046</pub-id>
</element-citation><note><p>published online Apr 6, 2007</p></note></ref><ref id="ref107"><element-citation publication-type="journal" id="cit107"><name><surname>Tria</surname><given-names>G.</given-names></name><name><surname>Mertens</surname><given-names>H. D. T.</given-names></name><name><surname>Kachala</surname><given-names>M.</given-names></name><name><surname>Svergun</surname><given-names>D. I.</given-names></name><article-title>Advanced
ensemble modelling of flexible macromolecules using X-ray solution
scattering</article-title><source>IUCrJ</source><year>2015</year><volume>2</volume><fpage>207</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1107/S205225251500202X</pub-id></element-citation><note><p>published online Feb 26, 2015</p></note></ref><ref id="ref108"><element-citation publication-type="journal" id="cit108"><name><surname>Svergun</surname><given-names>D. I.</given-names></name><name><surname>Petoukhov</surname><given-names>M. V.</given-names></name><name><surname>Koch</surname><given-names>M. H.</given-names></name><article-title>Determination of
domain structure of proteins from X-ray solution scattering</article-title><source>Biophys. J.</source><year>2001</year><volume>80</volume><fpage>2946</fpage><lpage>2953</lpage><pub-id pub-id-type="doi">10.1016/S0006-3495(01)76260-1</pub-id><pub-id pub-id-type="pmid">11371467</pub-id>
</element-citation></ref><ref id="ref109"><element-citation publication-type="journal" id="cit109"><name><surname>Volkov</surname><given-names>V. V.</given-names></name><name><surname>Svergun</surname><given-names>D. I.</given-names></name><article-title>Uniqueness of ab initio shape determination
in small-angle scattering</article-title><source>J. Appl. Crystallogr.</source><year>2003</year><volume>36</volume><fpage>860</fpage><lpage>864</lpage><pub-id pub-id-type="doi">10.1107/S0021889803000268</pub-id></element-citation></ref><ref id="ref110"><element-citation publication-type="journal" id="cit110"><name><surname>Schuck</surname><given-names>P.</given-names></name><article-title>Size-distribution analysis of macromolecules
by sedimentation
velocity ultracentrifugation and lamm equation modeling</article-title><source>Biophys. J.</source><year>2000</year><volume>78</volume><fpage>1606</fpage><lpage>1619</lpage><pub-id pub-id-type="doi">10.1016/S0006-3495(00)76713-0</pub-id><pub-id pub-id-type="pmid">10692345</pub-id>
</element-citation></ref><ref id="ref111"><element-citation publication-type="journal" id="cit111"><name><surname>Schlenzig</surname><given-names>D.</given-names></name><name><surname>R&#x000f6;nicke</surname><given-names>R.</given-names></name><name><surname>Cynis</surname><given-names>H.</given-names></name><name><surname>Ludwig</surname><given-names>H.-H.</given-names></name><name><surname>Scheel</surname><given-names>E.</given-names></name><name><surname>Reymann</surname><given-names>K.</given-names></name><name><surname>Saido</surname><given-names>T.</given-names></name><name><surname>Hause</surname><given-names>G.</given-names></name><name><surname>Schilling</surname><given-names>S.</given-names></name><name><surname>Demuth</surname><given-names>H.-U.</given-names></name><article-title>N-Terminal pyroglutamate formation
of A&#x003b2;38 and A&#x003b2;40 enforces oligomer formation and potency
to disrupt hippocampal long-term potentiation</article-title><source>J. Neurochem.</source><year>2012</year><volume>121</volume><fpage>774</fpage><lpage>784</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.2012.07707.x</pub-id><pub-id pub-id-type="pmid">22375951</pub-id>
</element-citation><note><p>published online Mar 28, 2012</p></note></ref><ref id="ref112"><element-citation publication-type="journal" id="cit112"><name><surname>Hortschansky</surname><given-names>P.</given-names></name><name><surname>Schroeckh</surname><given-names>V.</given-names></name><name><surname>Christopeit</surname><given-names>T.</given-names></name><name><surname>Zandomeneghi</surname><given-names>G.</given-names></name><name><surname>F&#x000e4;ndrich</surname><given-names>M.</given-names></name><article-title>The aggregation kinetics of Alzheimer&#x02019;s
&#x003b2;-amyloid peptide is controlled by stochastic nucleation</article-title><source>Protein Sci.</source><year>2005</year><volume>14</volume><fpage>1753</fpage><lpage>1759</lpage><pub-id pub-id-type="doi">10.1110/ps.041266605</pub-id><pub-id pub-id-type="pmid">15937275</pub-id>
</element-citation><note><p>published online Jun 3, 2005</p></note></ref></ref-list></back></article><!--Stylesheet Name and Version:openaccess.xsl v2.1
Date and Time: 2025-05-23T06:28:24.87-04:00
XML Format:jats-->